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FSP Section 11,000
Checklists and Illustrative Financial
Statements for Health Care Organizations
Description
.01 Health care organizations may be classified by sponsorship or legal structure within the following
broad categories:

Not-for-profit business-oriented: These are essentially self-sustaining from fees charged for goods and
services. The fees charged by such organizations generally are intended to help the organization
maintain its self-sustaining status rather than to maximize profits for the owner's benefit. Such
organizations often are exempt from federal income taxes and may receive contributions of relatively
small amounts from resource providers that do not expect commensurate or proportionate pecuniary
returns.
Not-for-profit non-business-oriented: These are voluntary health and welfare organizations as defined
in FASB Statement of Financial Accounting Standards (SFAS) No. 117, Financial Statements ofNot-forProfit Organizations. Such organizations are within the scope of the AICPA Audit and Accounting
Guide Not-for-Profit Organizations rather than that of the Health Care Organizations Guide.

Governmental: Often called public health care entities, the entities are owned and operated by federal,
state, city, or county governments or other political subdivisions.
Investor- (or operator-) owned: These organizations operate as stock corporations, partnerships, or sole
proprietorships.

.02 Health care organizations include, but are not limited to, the following:
•

Clinics, medical group practices, individual practitioners and practice associations, and other ambu
latory care organizations

•

Continuing care retirement communities (CCRCs)

•

Health maintenance organizations and similar prepaid health care plans

•

Home health agencies

•

Hospitals

•

Nursing homes that provide skilled, intermediate, and less intensive levels of health care

•

Parent companies, holding companies, and other organizations that primarily plan, organize, and
oversee health care services

Applicability of This Checklist
.03 This checklist, and the illustrative financial statements included herein, follow the guidance con
tained in the AICPA Audit and Accounting Guide Health Care Organizations (with conforming changes as of
May 1,1997), referred to as "the Guide." The checklist and illustrative financial statements should be used
for not-for-profit business-oriented and investor-owned health care organizations. Not-for-profit health care pro
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viders that receive federal financial assistance may be required to have an audit conducted in accordance
with Office of Management and Budget (OMB) Circular A-133, Audits of Organizations ofHigher Education and
Other Nonprofit Organizations. Section 11,300 includes guidance for auditors' reports for audits performed
under OMB Circular A-133.
.04 Although the Guide also applies to state and local government-owned health care providers, this
checklist does not include disclosures or sample financial statements of government-owned providers. Chapter
1 of the Guide discusses the application of generally accepted accounting principles (GAAP) to governmental
health care providers.

.05 In addition, this checklist does not apply to not-for-profit non-business-oriented health care organiza
tions. For these types of organizations, follow the guidance in the AICPA Audit and Accounting Guide
Not-for-Profit Organizations, and the AICPA's disclosure checklist entitled Not-for-Profit Organizations.

Legislation and Regulation
.06 Significant aspects of health care organization operations are affected by government legislation and
regulation with many states adopting laws governing the granting of licenses, as well as scope of services to
be rendered. In addition, many independent organizations and governmental agencies, including Medicare
and Medicaid, evaluate programs and services of health care organizations to determine compliance with
set standards.

Basic Financial Statements
.07 The financial reporting for not-for-profit business-oriented organizations and investor-owned health
care enterprises generally is consistent except for transactions that clearly are not applicable. For example,
not-for-profit business-oriented organizations, by their nature, do not have shareholders' equity. On the
other hand, investor-owned health care enterprises typically do not receive contributions. Throughout this
checklist, disclosure/presentation questions are preceded by certain icons. Not-for-profit business-oriented
organizations should complete all disclosure items denoted with a star (★). Investor-owned health care
enterprises should complete all disclosure items denoted with a diamond (♦).
.08 The basic financial statements of health care providers generally consist of a statement of financial
position or balance sheet, a statement of activities or income statement or statement of operations, a statement
of changes in net assets (equity), a statement of cash flows, and notes to the financial statements. The titles
of the financial statements will depend upon the business form of the provider (i.e., not-for-profit, investorowned, etc.). See the chart below.

Basic Financial Statements
Not-for-Profit
Business-Oriented Organization

Investor-Owned Organization
Balance Sheet
Statement of Operations/Income Statement
Statement of Changes in Equity
*
Statement of Cash Flows

Balance Sheet/Statement of Financial Position
Statement of Operations/Statement of Activities
Statement of Changes in Net Assets (Fund Balance)
*
Statement of Cash Flows
*May be combined with the Statement of Operations.

Note: This publication was extracted from sections 11,000 through 11,500 of the AICPA Financial Statement
Preparation Manual (FSP).
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FSP Section 11,100
Instructions
Purpose
.01 The checklists and illustrative financial statements included in this section have been developed by
the staff of the Accounting and Auditing Publications Team of the AICPA as nonauthoritative technical
practice aids to be used as a memory jogger to aid in the audit of financial statements of health care
organizations.

The checklists have been updated to include guidance relevant to health care organizations
contained in official pronouncements through:
•

FASB Statement of Financial Accounting Standards No. 129, Disclosure of Information
about Capital Structure

•

FASB Interpretation No. 42, Accountingfor Transfers ofAssets in Which a Not-for-Profit
Organization Is Granted Variance Power

•

FASB Technical Bulletin No. 94-1, Application of Statement 115 to Debt Securities
Restructured in a Troubled Debt Restructuring

•

AICPA Statement on Auditing Standards No. 82, Consideration of Fraud in a Financial
Statement Audit

•

AICPA Statement of Position No. 96-1, Environmental Remediation Liabilities

•

AICPA Statement on Standards for Accounting and Review Services No. 7, Omnibus
Statement on Standards for Accounting and Review Services—1992

•

AICPA Audit and Accounting Guide Health Care Organizations (with conforming
changes as of May 1,1997)

•

AICPA Practice Bulletin No. 15, Accounting by the Issuer of Surplus Notes

•

FASB EITF consensuses adopted up to and including the March 13,1997 Emerging
Issues Task Force meeting

The checklists and illustrative financial statements should be modified, as appropriate, for
subsequent pronouncements. In determining the applicability of a pronouncement, its effective
date should also be considered.

Instructions
.02 The checklists consist of a number of questions or statements that are accompanied by references to
the applicable authoritative pronouncements. The checklists provide for checking off or initialing each
question or point to show that it has been considered. Users should check: "yes" if the disclosure has been
appropriately made, "no" if the disclosure has not been made, or "n/a" if the disclosure is not applicable to
the organization. The auditor should consider the effect of a "no" answer on his/her report. A "no" answer
that is material to the financial statements may warrant a departure from an unqualified opinion. (See para
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graphs 20-63 of SAS No. 58, Reports on Audited Financial Statements, as amended [AICPA, Professional
Standards, vol. 1, AU sec. 508.20-.63].) If a "no" answer is checked, the authors recommend that a note be
made in the right margin to explain why the disclosure was not made (for example, if the disclosure was not
made because it was not material to the financial statements, write "not material" in the right margin). The
right margin may be used for other remarks or comments as appropriate, including cross-referencing to
applicable workpapers where the support to a disclosure may be found. Use of the checklists requires the
exercise of individual professional judgment and may likely require some modification based on the
circumstances of individual engagements.
.03 This checklist is applicable to not-for-profit business-oriented and investor-owned health care organiza
tions. While financial reporting for these types of organizations is generally consistent, there are requirements
that apply to only not-for-profit business-oriented organizations and those that apply to only investor-owned
enterprises. Icons have been used to indicate the applicability of presentation and disclosure requirements
to these types of organizations. Not-for-profit business-oriented organizations should complete all disclosure
items denoted with a star (★). Investor-owned organizations should complete all disclosure items denoted
with a diamond (♦).

.04 The checklist is not a substitute for the authoritative pronouncements. Users of the checklists and
illustrative financial statements are urged to refer directly to applicable authoritative pronouncements when
appropriate. The checklists and illustrative financial statements do not include all disclosures and presenta
tion items promulgated nor do they represent minimum requirements. Pronouncements deemed remote for
health care organizations are not included in this document. The checklists and illustrative financial
statements are "tools" and in no way represent official positions or pronouncements of the AICPA.
.05 If you have further questions, call the AICPA Technical Hotline at 1-800-TO AICPA.
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FSP Section 11,200
Financial Statements and Notes Checklist
.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of
the AICPA as a nonauthoritative practice aid. The checklists and illustrative financial statements do not
include all disclosures and presentation items required by GAAP; as a result, pronouncements deemed
unlikely to be encountered in financial statements of health care providers are not included.

.02 Explanation of References:

★=

Disclosure applicable for not-for-profit organizations

♦=

Disclosure applicable for investor-owned organizations

AAG =

The May 1997 AICPA Audit and Accounting Guide Health Care Organizations

AC =

Reference to section number in FASB Accounting Standards—Current Text

APB =

AICPA Accounting Principles Board Opinion

ARB =

AICPA Accounting Research Bulletin

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

EITF =

FASB Emerging Issues Task Force consensus

FASBI =

FASB Interpretation

FASCON =

FASB Statement of Financial Accounting Concepts

SAS =

AICPA Statement on Auditing Standards

SFAS =

FASB Statement of Financial Accounting Standards

SOP =

AICPA Statement of Position

TB =

FASB Technical Bulletin

.03 Checklist Questionnaire:
This checklist is organized into the sections listed below. Carefully review the topics listed and consider
whether they represent potential disclosure items for the health care provider. Place a check mark by the
topics or sections considered not applicable; these sections need not be completed. For example, if the entity
does not have any extraordinary items, place a check by "Extraordinary Items" and skip this section when
completing the checklist.

Place by
Sections Not Applicable

•

General
A. Titles and References
B.
Disclosure of Accounting Policies
C.
Accounting Changes
D.
Comparative Financial Statements
E.
Related Organizations and Economic Dependency
F.
Financial Instruments
G. Nonmonetary Transactions
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Place S by
Sections Not Applicable

H.
I.
J.
K.
L.
M.
N.
O.

Commitments and Contingencies
Risks and Uncertainties
Subsequent Events
Pension Plans
Postretirement Benefits Other Than Pensions
Costs to Exit an Activity
Derivatives
Business Combinations

•

Statement of Financial Position/Balance Sheet
A. General
B.
Cash and Cash Equivalents
C.
Investments
D.
Receivables
E.
Property and Equipment, Supplies, and Other Assets
F.
Current Liabilities, Notes Payable, and Other Debt
G.
Other Liabilities and Deferred Credits
H. Lessor Leases
I.
Lessee Leases
J.
Net Assets
K.
Restricted Resources

•

Statement of Activities/ Income Statement/ Statement of
Operations/Statement of Changes in Net Assets
A.
General
B.
Revenue
C.
Income Taxes
D.
Discontinued Operations
E.
Extraordinary Items
F.
Unusual or Infrequent Items
G.
Advertising Costs
H. Donated or Contributed Services
I.
Fund Raising
J.
Contributions/Pledges
K.
Expenses
L.
Wills
M. Endowments

•

Statement of Cash Flows

•

Continuing Care Retirement Communities (CCRCs)
A.
Refundable Advance Fees
B.
Fees Refundable to Residents Only From Reoccupancy
Proceeds of a Contract Holder's Unit
C.
Nonrefundable Advance Fees
D.
Obligation to Provide Future Services and Use of Facilities
to Current Residents
E.
Costs of Acquiring Initial Continuing-Care Contracts
F.
Other

•

Exhibit A—Stock-Based Compensation

•

Auditors' Reports

•

Auditors' Reports on Audits Performed Under Government Auditing
Standards and Under OMB Circular A-133
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Yes

I. General
A. Titles and References
1.

Are the financial statements suitably titled?
[SFAS 62, par. 7 (AU 623.07)]

2.

Does each statement include a general reference that the notes are an
integral part of the financial statement presentation?
[Generally Accepted]

★ 3.

Do the basic financial statements of the health care organization
include:

a. Statement of financial position (balance sheet)?
b. Statement of activities (statement of operations/income state
ment)?
c. Statement of cash flows?

d. Statement of changes in net assets (equity)? [Note that this state
ment may be combined with the statement of activities.]
[SFAS 117, pars. 1 and 6 (AC No5.104); AAG, par. 1.05]

B. Disclosure of Accounting Policies

★♦1.

Is a description of all pertinent accounting policies of the provider
presented as an integral part of the financial statements?
[APB 22, pars. 8 and 9 (AC A10.102 and .103)]

2.

Does disclosure of significant accounting policies encompass impor
tant judgments as to the appropriateness of principles concerning
recognition of revenue and allocation of asset costs to current and
future periods?
[APB 22, par. 12 (AC A10.105)]

3.

Does disclosure of significant accounting policies include appropriate
reference to details presented elsewhere (in the statements and notes
thereto) so duplication of details is avoided?
[APB 22, par. 14 (AC A10.107)]

C. Accounting Changes

★ 1.

In the initial year of application of SFAS 117, is the nature of any
restatement and its effect on the change in net assets for each period
presented disclosed?
[SFAS 117, par. 31]

★ 2.

For a not-for-profit health care organization, in the initial year of
application of SFAS 116, is the nature of any restatement and its effect
on the change in net assets for each period presented disclosed?
[SFAS 116, par. 30]

★ 3.

For an investor-owned health care organization, in the initial year of
application of SFAS 116, is the restatement accounted for as a change
in accounting principle applied retroactively in accordance with APB
20, paragraphs 27 and 28?
[SFAS 116, par. 30]
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No

N/A

Yes

★ 4.

For a not-for-profit health care organization, if SFAS116 is not applied
retroactively, is the cumulative effect of the change in accounting on
each class of net assets reported in the statement of activities between
the captions "extraordinary items," if any, and "change in unre
stricted net assets," "change in temporarily restricted net assets," and
"change in permanently restricted net assets"?
[SFAS 116, par. 29]

♦ 5.

For an investor-owned health care organization, if SFAS 116 is not
applied retroactively, is the cumulative effect of the change in ac
counting reported in the income statement between the captions
"extraordinary items," if any, and "net income"?
[SFAS 116, par. 29]

★ 6.

For a not-for-profit health care organization, in the initial year of
application of the June 1996 Guide, is the nature of any restatement
and its effect on the change in net assets for each period presented
disclosed?
[AAG, Preface]

♦ 7.

For an investor-owned health care organization, in the initial year of
application of the June 1996 Guide, is the restatement accounted for
as a change in accounting principle applied retroactively in accord
ance with APB 20, paragraphs 27 and 28?
[AAG, Preface]

★ 8.

For a not-for-profit health care organization, if the June 1996 Guide is
not applied retroactively, is the cumulative effect of the change in
accounting on each class of net assets reported in the statement of
activities between the captions "extraordinary items," if any, and
"change in unrestricted net assets," "change in temporarily restricted
net assets," and "change in permanently restricted net assets"?
[AAG, Preface]

♦ 9.

For an investor-owned health care organization, if the June 1996
Guide is not applied retroactively, is the cumulative effect of the
change in accounting reported in the income statement between the
captions "extraordinary items," if any, and "net income"?
[AAG, Preface]

10. For an accounting change, does disclosure in the period of the change
include:
a. Nature of the change?
b. Justification for the change, including a clear explanation of why
the newly adopted principle is preferable?

c. Effect on income?
[APB 20, par. 17 (AC A06.113)]

11. For other changes in accounting principle (excluding specific excep
tions related to an initial public offering, change in the reporting
entity, or adoption of certain authoritative pronouncements), is the
presentation and disclosure guidance in APB 20 properly applied?
[APB 20, pars. 17-22 and 24-26 (AC A06.113-.118, .121, and .122);
FASBI20, par. 5 (A06.127)]
8

Yes

12. Is the correction of an error shown as a prior-period adjustment with
disclosure of the following in the period of its discovery and correc
tion:

a. Nature of the error in previously issued financial statements?
b. Effect of its correction on revenue and gains in excess of expenses
and losses (income) before extraordinary items and net revenue
and gains in excess of expenses and losses (net income) (and
related per share amounts if applicable)?
[APB 20, par. 37 (AC A35.105); SFAS109, par. 288n (AC A35.103)]

D. Comparative Financial Statements

E.

1.

Has presentation of comparative statements been considered?
[SFAS 117, par. 69; ARB 43, Ch. 2A, pars. 1 and 2 (AC F43.101 and
.102)]

2.

Are the disclosures included in the prior year's financial statements
repeated, or at least referred to, to the extent that they continue to be
of significance?
[ARB 43, Ch. 2A, par. 2 (AC F43.102)]

3.

If changes have occurred in the manner of or basis for presenting
corresponding items for two or more periods, are appropriate expla
nations of the changes disclosed?
[ARB 43, Ch. 2A, par. 3 (AC F43.103)]

★ 4.

If comparative annual financial statements are presented for earlier
periods, are those financial statements reclassified (or restated) to
reflect retroactive application of the provisions of SFAS 116 and SFAS
117?
[SFAS 116, par. 30; SFAS 117, par. 31]

Related Organizations and Economic Dependency
1.

Consolidation and combination:

a. If the provider and another entity are related and they meet the
criteria for consolidation or combination ("consolidation"), are
consolidated or combined ("consolidated") financial statements
presented?
[AAG, pars. 11.10 and 11.11; ARB 51 (AC C51); SFAS 94 (AC C51)]
b. If consolidated statements are presented:

(1)

Is the consolidation policy disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]

(2)

When the financial reporting periods of consolidated entities
differ, is recognition given, by disclosure or otherwise, to the
effect of intervening events that materially affect financial
position or results of operations?
[APB 51, par. 4 (AC C51.107)]

c. Do disclosures about formerly unconsolidated subsidiaries that
are now consolidated include summarized information about the
assets, liabilities, and results of operations (or separate statements)
in the consolidated financial statements or notes?
[SFAS 94, par. 14 (AC C51.120A)]
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No

N/A

Yes

2.

Related parties and economic dependency:

a. If the reporting entity controls a separate not-for-profit entity
through a form other than majority ownership or voting interest,
has an economic interest in that other entity, and consolidated
financial statements are not presented, is identification of the other
entity and the nature of its relationship with the reporting entity
disclosed; and is summarized financial data of the related organi
zation disclosed?
[AAG, par. 11.12]
b. If the reporting entity has control over a related party, or has an
economic interest in a related party, but the related party is not
consolidated, are the following disclosures made:

(1)

The nature of the relationship between the entity and the
related party?

(2)

If there are material transactions between the entity and the
related party:

(i)

A description of the transactions, including transactions
to which nominal or no amounts were ascribed?

(ii) The amount of such transactions?

(iii) Amounts due from or to the related party and, if not
apparent, the terms and manner of settlement?
[AAG, par. 11.13; SFAS 13, par. 29 (AC L10.125); SFAS
57, pars. 2-4 (AC R36.102-.104)]
c. If consolidated financial statements are presented and they in
clude a controlled not-for-profit organization, are the following
disclosed:

(1)

Restrictions made by entities outside of the reporting entity
on distributions from the controlled not-for-profit organiza
tion to the reporting entity?
and

(2)

Any resulting unavailability of the net assets of the controlled
not-for-profit organization for use by the reporting entity?
[AAG, par. 11.14]

d. Are significant relationships and transactions not in the ordinary
course of business with directors, management, medical staff, etc.
disclosed in the financial statements?
[AAG, par. 11.25]
F.

Financial Instruments

★♦1.

Except for certain excluded items (SFAS 105, pars. 14 and 15 (AC
F25.104 and .105)), are the following disclosed in the financial state
ments or notes for each class of financial instruments with off-balancesheet risk (health care organizations that enter into certain types of
receivable financing arrangements should disclose their off-balancesheet risk):

a. The face or contract amount, or notional principal amount if there
is no face or contract amount?
b. The nature and terms, including, at a minimum, a discussion of:
(1)

Credit and market risk of those instruments?

(2)

Cash requirements of those instruments?
10

Yes
(3)

2.

Related accounting policy, as required by APB 22, Disclosure
of Accounting Policies (AC A10)?
[SFAS 105, par. 17 (AC F25.112)]

____

For financial instruments with off-balance-sheet credit risk (except for
the items excluded in SFAS 105 (AC F25)), are the following disclosed,
either in the financial statements or in the notes, by class of financial
instrument:

a. The amount of accounting loss the entity would incur if any party
to the financial instrument failed completely to perform according
to the terms of the contract and if the collateral or other security,
if any, for the amount due proved to be of no value to the entity?

____

b. Regarding collateral or other security to support financial instru
ments subject to credit risk:

(1)

The entity's policy of requiring such collateral or other secu
rity?

____

(2) Information about the entity's access to that collateral or other
security?

____

(3) The nature and a brief description of the collateral or other
security supporting those financial instruments?
[SFAS 105, par. 18 (AC F25.113)]
3.

Do disclosures of all significant concentrations of credit risk arising
from all financial instruments, whether from an individual counter
party or groups of counterparties (except for certain insurance and
investment contracts, purchase and pension obligations and substan
tively extinguished debt), include:

Note: Health care providers that enter into certain types of receivable
financing arrangements should disclose their off-balance-sheet risk.

a. Information about the (shared) activity, region, or economic char
acteristic that identifies the concentration?
b. The amount of the accounting loss due to credit risk the entity
would incur if any party to the financial instruments that make up
the concentration failed completely to perform according to the
terms of the contracts and if the collateral or other security, if any,
for the amount due proved to be of no value to the entity?

c. Regarding collateral or other security to support financial instru
ments subject to credit risk:

4.

(1)

The entity's policy of requiring such collateral or other secu
rity?

(2)

Information about the entity's access to that collateral or other
security?

(3)

The nature and a brief description of the collateral or other
security supporting those financial instruments?
[SFAS 105, pars. 14 and 20 (AC F25.104 and .115)]

Is disclosure made of the primary geographic sources of patients?
[AAG, par. 5.19]
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____

No

N/A

Yes
Note: SFAS 126, Exemption from Certain Required Disclosures about finan
cial Instruments for Certain Nonpublic Entities, states that disclosures about
the fair value of financial instruments prescribed in SFAS 107 shall be
optional for an entity that meets all of the following criteria:
a. The entity is a nonpublic company.
b. The entity's total assets are less than $100 million on the date of the
financial statements.
c. The entity has not held or issued any derivative financial instru
ments as defined in SFAS 119 other than loan commitments, during
the reporting period.
Consider this exemption when reviewing items 5 through 10 below.

5.

Is the fair value of financial instruments for which it is practicable to
estimate that value (except for those excluded in paragraphs 8 and 13
of SFAS 107) disclosed, together with the related carrying amount in
a form that makes it clear whether the fair value and carrying amount
represent assets or liabilities and how the carrying amounts relate to
what is reported in the statement of financial position? [Note: If
disclosed in more than a single note, one of the notes should include
a summary table containing the fair value and related carrying
amounts and cross-references to the location(s) of the remaining
disclosures required by SFAS 107, as amended.]
[SFAS 107, par. 10, as amended by SFAS 119, par. 15 (AC F25.115C)]

6.

Do the disclosures in Step 5 distinguish between financial instruments
held or issued for trading purposes, including dealing and other
trading activities measured at fair value with gains and losses recog
nized in earnings, and financial instruments held or issued for pur
poses other than trading?
[SFAS 107, par. 10, as amended by SFAS 119, par. 15 (AC F25.115C)]

7.

Are the methods and significant assumptions used to estimate the fair
value of financial instruments disclosed?
[SFAS 107, par. 10 (AC F25.115C)]

8.

If it is not practicable to estimate the fair market value of a financial
instrument, do disclosures include:

a. Information pertinent to estimating the fair value of the financial
instrument or class of financial instruments, such as the carrying
amount, effective interest rate, and maturity?
b. The reasons why it is not practicable to estimate fair value?
[SFAS 107, par. 14 (AC F25.115J)]

9.

If the offsetting of derivative financial instruments against nonderi
vative financial instruments is not permitted under FASBI 39,
Offsetting of Amounts Related to Certain Contracts, does the organi
zation, in disclosing the fair value of a derivative financial instru
ment, not:
a. Combine, aggregate, or net the fair value with the fair value of a
nonderivative financial instrument?
b. Net the fair value with the fair value of other derivative financial
instruments?
[SFAS 107, par. 13, as amended by SFAS 119, par. 15 (AC F25.115I)]
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No

N/A

Yes
10. For all fiscal years subsequent to the year of transition, are SFAS 107
disclosures included for each year for which a statement of financial
position is presented for comparative purposes?
[SFAS 107, par. 17]
11. For contracts that are indexed to, and potentially settled in, an entity's
own stock, and the counterparty has choice of net cash settlement or
settlement in shares, are any gains or losses on those contracts in
cluded in earnings and disclosed in the financial statements?
[EITF 94-7 and EITF 96-1 (see EITF issues for further guidance and
more details)]

____

____

G. Nonmonetary Transactions
1.

Do disclosures include:

a. Nature of the transactions?

____

b. Basis of accounting for the assets transferred?

____

c. Gains or losses recognized on the transfers?
[APB 29, par. 28 (AC 01.102 and N35.120)]

____

H. Commitments and Contingencies
1.

Uninsured medical malpractice claims:

a. If a minimum amount of a probable loss (usually associated with
litigating or settling malpractice claims) is accrued, is there disclo
sure as to a reasonable possibility of an additional potential loss
in excess of the amount accrued?
[AAG, par. 8.07; SFAS 5 (AC C59)]

____

b. If a range of loss cannot be reasonably estimated, is a contingency
disclosed?
[AAG, par. 8.11; SFAS 5 (AC C59)]

____

c. Is the program of medical malpractice coverage and basis for loss
accruals disclosed?
[AAG, par. 8.12; SFAS 5 (AC C59)]

____

d. If the provider discounts accrued malpractice claims, are the fol
lowing disclosed:

2.

(1)

The carrying amount of the claims?

____

(2)

The interest rates or other rates used to discount the claims?
[AAG, par. 8.12]

____

Retrospectively rated premiums:

a. If the provider cannot estimate losses from asserted or unasserted
malpractice claims, is the existing contingency disclosed?
[AAG, par. 8.14; SFAS 5 (AC C59)]

____

b. Does the provider disclose that it is insured under a retrospec
tively rated policy?
[AAG, par. 8.15]

____

c. Does the provider disclose that premiums are accrued based on
the ultimate cost of the experience to date of a group of entities?
[AAG, par. 8.15]

____
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No

N/A

Yes
3.

Medical malpractice claims insured with captive insurance compa
nies (controlled by a parent entity for the main purpose of providing
insurance for the parent):

a. Does the provider disclose that it is insured under a retrospec
tively rated policy of a multiprovider captive?
[AAG, par. 8.18]

____

b. Does the provider disclose that premiums are accrued based on
the captive's experience to date?
[AAG, par. 8.18]

____

c. Is the provider's ownership percentage in the captive disclosed?
[AAG, par. 8.19]

d. Is the method of accounting for its investment in and the opera
tions of the captive disclosed?
[AAG, par. 8.19]

e. If the provider cannot make the necessary estimates of losses from
asserted or unasserted claims, does it disclose the existing contin
gency?
[AAG, par. 8.19; SFAS 5 (AC C59)]

4.

____

____

____

Trust funds:

★♦a. If trust funds (revocable or irrevocable) are included in the
provider's financial statements:

(1)

(2)

(3)

(4)

(5)

5.

Is a portion of the funds (the amount of assets expected to be
liquidated to pay malpractice claims classified as current
liabilities) classified as a current asset in a classified balance
sheet/statement of financial position?
[AAG, par. 8.20]
Is the balance of the funds, if any, classified as a noncurrent
asset in a classified balance sheet/statement of financial po
sition?
[AAG, par. 8.20]

____

____

Are trust fund revenue and administrative expenses included
in the statement of activities (statement of operations)?
[AAG, par. 8.20]

____

Are estimated losses from asserted and unasserted claims
reported?
[AAG, par. 8.21]

____

Is the existence of trust funds and whether they are irrevoca
ble disclosed?
[AAG, par. 8.22]

____

Prepaid health care services:

a. Health care costs:
(1)

Is the basis for accruing health care costs disclosed?

(2) Are significant business and contractual arrangements with
hospitals, physicians, and other associated entities disclosed?
[AAG, par. 13.04]

____
____

b. Stop-loss insurance:

(1)

Are receivables representing amounts recoverable from in
surers reported as assets net of any valuation allowance?
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____

No

N/A

Yes
(2) Are the nature, amounts, and effects of significant stop-loss
insurance contracts disclosed?
[AAG, par. 13.08]

____

c. Loss contracts:
(1) Are losses recognized, in accordance with SFAS 5, when it is
probable that expected future health care costs and mainte
nance costs under a group of existing contracts will exceed
anticipated future premiums and stop-loss insurance on
those contracts?
[AAG, par. 13.06]

____

d. Contract acquisition costs:

(1) Are acquisition costs of providers of prepaid health care
services, other than costs of advertising, expensed as in
curred?
[AAG, par. 13.10]

6.

____

Other disclosures:
a. Are the nature and, if applicable, amount (or a statement that no
loss estimate can be made) disclosed for loss contingencies (includ
ing guarantees)?
[SFAS 5, pars. 9-12 and FASBI34, pars. 2 and 3 (AC C59.108-.114]
b. If exposure to loss exists in excess of the amount accrued for a loss
contingency, do disclosures include the excess amount or state that
no estimate is possible?
[SFAS 5, par. 10 (AC C59.109)]

____

____

c. Are gain contingencies adequately disclosed with care to avoid
misleading implications as to the likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]

____

d. Are the nature, term, amount and other required information
disclosed for long-term unconditional purchase obligations?
[SFAS 47, pars. 7 and 10a (AC C32.102 and .105a)]

____

e. Are the nature and amount of guarantees disclosed (for example,
of indebtedness of others)?
[SFAS 5, par. 12 (AC C59.113); FASBI 34, pars. 2 and 3 (AC
C59.114)]
Is there adequate disclosure of commitments such as those for
capital expenditures, restrictive covenants in financing agree
ments, and employment contracts?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

____

____

★♦g. If an obligation for postemployment benefits (other than pensions)
is not accrued in accordance with SFAS 5 (AC C59) or SFAS 43 (AC
C44) only because the amount cannot reasonably be estimated, is
the fact of nonaccrual disclosed in the financial statements?
[SFAS 112, par. 7 (AC P32.105)]

h. Are environmental remediation obligations reported and dis
closed in accordance with SOP 96-1?
[SOP 96-1]
I.

____

____

Risks and Uncertainties

1.

Are the following disclosed:
a. A description of the principal services performed by the health
care provider and the revenue sources for the entity's services?
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____

No

N/A

Yes

No

N/A

b. The fact that financial statements prepared in accordance with
GAAP require the use of management's estimates?
[SOP 94-6, pars. 10 and 11]

★♦2.

If (1) it is at least reasonably possible that the estimate(s) used in
preparing the financial statements will change in the near term, and
(2) the effect(s) of the change will be material, are the following
disclosed:

a. The nature of uncertainties inherent in estimates used to deter
mine the carrying amounts of assets and liabilities, or used to
disclose gain or loss contingencies?
b. That a material change in the estimate could occur in the near
term?
[SOP 94-6, pars. 12-14]

3.

If the estimate in Step 2 above involves a loss contingency covered by
SFAS 5, Accounting for Contingencies, do disclosures include an esti
mate of the possible loss or range of loss, or state that such an estimate
cannot be made?1
[SOP 94-6, par. 14]

★♦4.

If (1) concentrations exist at the financial statement date, and (2) the
concentrations could cause the provider a near-term severe impact,
are the following disclosed:

a. Concentrations in the volume of the business transacted with a
particular customer (patient), supplier, lender, grantor, or con
tributor?
b. Concentrations in revenue from particular services provided or
fund-raising events?
c. Concentrations in the available sources of supply of labor, serv
ices, or of applicable licenses necessary to provide services?
d. Concentrations in the market or geographical area in which an
entity conducts its operations, including the carrying amounts of
net assets and their locations?

e. Concentrations of labor subject to collective bargaining agree
ments, including the percentage of the labor force covered by a
collective bargaining agreement and the percentage of the labor
force covered by a collective bargaining agreement that will expire
within one year?
f.

J.

Information adequate to inform users of the general nature of the
risk associated with the concentration?
[SOP 94-6, pars. 21-24]

Subsequent Events

★♦1.

Are the financial statements adjusted for any changes in estimates
resulting from subsequent events that provide additional evidence

1 If risk reduction techniques are used to mitigate losses or the uncertainty that may result from certain events, these disclosures are
encouraged but not required.
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about conditions that existed at the balance-sheet/statement-of-fi
nancial-position date?
[SFAS 5, par. 8 (AC C59.105); SAS1, secs. 560.03, .04, .07, and 561.01.09 (AU 560.03, .04, .07, and 561.01-.09)]

2.

Are subsequent events that provide evidence about conditions that
did not exist at the date of the balance sheet, but arose subsequent to
that date, adequately disclosed to keep the financial statements from
being misleading?
[SFAS 5, par. 11 (AC C59.112); APB 16 (AC B50.120); SAS 1, secs.
560.05-.07, .09, and 561.01-.09 (AU 560.05-.07, .09, and 561.01-.09)]

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

K. Pension Plans
1.

If there is a defined benefit plan, do disclosures include:

a. A description of the plan, including employee groups covered,
type of benefit formula, funding policy, types of assets held and
significant nonbenefit liabilities, if any, and the nature and effect
of significant matters affecting comparability of information for all
periods presented?
[SFAS 87, par. 54a (AC P16.150a)]
b. The amount of net periodic pension cost for the period showing
separately the service cost component, the interest cost compo
nent, the actual return on assets for the period, and the net total of
other components?2
[SFAS 87, par. 54b (AC P16.150b)]

c. Measurement of plan assets and obligations within three months
of the balance-sheet date using consistent date from year to year
(estimates may be necessary)?
[SFAS 87, par. 52 (AC P16.148)]

d. A schedule reconciling the funded status of the plan with amounts
reported in the employer's balance sheet/statement of financial
position, showing separately:

(1)

The fair value of plan assets?

____

____

____

(2)

The projected benefit obligation identifying the accumulated
benefit obligation and the vested benefit obligation?

____

____

____

(3)

The amount of unrecognized prior-service cost?

____

____

____

(4)

The amount of unrecognized net gain or loss (including asset
gains and losses not yet reflected in market-related value)?

____

____

____

The amount of any remaining unrecognized net obligation or
net asset existing at the date of initial application of SFAS 87
(AC P16)?

____

____

____

The amount of any additional liability recognized pursuant
to SFAS 87, paragraph 36 (AC P16.130)?

____

____

____

(5)

(6)

2 The net total of other components is the net effect during the period of certain delayed recognition provisions of SFAS 87 (AC P16).
That net total includes:
a. The net asset gain or loss during the period deferred for later recognition (in effect, and offset or a supplement to the actual re
turn on assets).
b. Amortization of the net gain or loss from earlier periods.
c. Amortization of unrecognized prior service cost.
d. Amortization of unrecognized net obligation or net asset existing at the date of initial application of SFAS 87 (AC P16).
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Yes

(7)

The amount of net pension asset or liability recognized in the
balance sheet/statement of financial position pursuant to
SFAS 87, paragraphs 35 and 36 (AC P16.129 and .130) (which
is the net result of combining the preceding six items)?

e. The weighted-average assumed discount rate and the rate of
compensation increase (if applicable) used to measure the pro
jected benefit obligation and the weighted-average expected long
term rate of return on plan assets?
[SFAS 87, par. 54d (AC P16.150d)]

f.

If applicable, the amount and types of securities of the employer
and related parties included in plan assets and the approximate
amount of annual benefits of employees and retirees covered by
annuity contracts issued by the employer and related parties (also,
if applicable, the alternative amortization methods used pursuant
to SFAS 87, paragraphs 26 and 33 (AC P16.120 and .127), and the
existence and nature of the commitment discussed in SFAS 87,
paragraph 41 (AC P16.135))?
[SFAS 87, par. 54 (AC P16.150e)]

g. If more than one defined benefit plan exists:
(1) Are the disclosures required by Step G.1. above aggregated
for all of the employer's single-employer defined benefit
plans or disaggregated in groups so as to provide the most
useful information?
(2) Are plans with assets in excess of accumulated benefit obli
gations not aggregated with plans that have accumulated
benefit obligations that exceed plan assets?
[SFAS 87, par. 56 (AC P16.153)]

2.

If there are one or more defined contribution plans, do disclosures
include:
a. A description of the plans, including employee groups covered,
the basis for determining contributions, and the nature and effect
of significant matters affecting comparability of information for all
periods presented?
b. The amount of cost recognized during the period?
[SFAS 87, par. 65 (AC P16.162)]

★♦3.

If the substance of a plan having characteristics of both defined
benefits and contributions is to provide a defined benefit, are disclo
sures in accordance with the requirements applicable to a defined
benefit plan as described in Step 1 above?
[SFAS 87, par. 66 (AC P16.163)]

4.

If there are one or more multiemployer plans, do disclosures include:

a. A description of the multiemployer plans, including the employee
groups covered, the type of benefits provided (defined benefit or
defined contribution), and the nature and effect of significant
matters affecting comparability of information for all periods
presented?
b. The amount of cost recognized during the period?
[SFAS 87, par. 69a (AC P16.166a)]
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No

N/A

Yes
c. If the situation arises where the withdrawal from a multiemployer
plan may result in the employer having an obligation to the plan
for a portion of its unfunded benefit obligations that is either
probable or reasonably possible, are the provisions of SFAS 5 (AC
C59) applied?
[SFAS 87, par. 70 (AC P16.167)]
5.

6.

If there is a settlement and/or curtailment of a defined benefit pension
plan and/or termination benefits under such plan, do disclosures
include:
a. A description of the nature of the event(s)?

____

b. The amount of gain or loss recognized?
[SFAS 88, par. 17 (AC P16.187)]

____

If the entity terminates a defined benefit plan and (1) contributes the
assets withdrawn to a defined contribution plan, (2) the amount
contributed is in excess of the employer's required annual contribu
tion to the plan, and (3) the risk and rewards of the ownership of the
assets are retained by the employer, were the following considered
for the defined contribution plan:

a. Is the excess contribution that is not allocated to individual par
ticipants accounted for as an asset regardless of the source of
funds?

____

b. Is the unallocated amount treated as if it were part of the em
ployer's investments portfolio and recorded as an asset?

____

(1)

Is the income attributed to such securities including divi
dends, interest, and realized gains and losses reported in a
manner consistent with the employer's reporting of similar
items?

____

c. Are the unallocated assets consisting of the employer's own stock
recorded as treasury stock in the employer's financial statements?

____

d. Are the unallocated assets consisting of the employer's debt secu
rities recorded as assets (rather than debt extinguishment) in the
employer's financial statements?
[EITF 86-27]

L.

____

____

Postretirement Benefits Other Than Pensions

★♦1.

If there are one or more defined benefit postretirement plans, do
disclosures include:

a. A description of the substantive plans that is the basis for the
accounting for the postretirement benefits, including the nature of
the plans, any modifications of the existing cost-sharing provi
sions that are encompassed by the substantive plans, and the
existence and nature of any commitment to increase monetary
benefits provided by the plans, employee groups covered, types
of benefits provided, funding policy, types of assets held and
significant nonbenefit liabilities, and the nature and effect of sig
nificant matters affecting the comparability of information for all
periods presented, such as the effect of a business combination or
divestiture?
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____

No

N/A

b. The amount of net periodic postretirement benefit cost showing
separately the service cost component, the interest cost compo
nent, the actual return on plan assets for the period, amortization
of the unrecognized transition obligation or transition asset, and
the net total of other components?3

Yes

No

N/A

____

____

____

c. A schedule reconciling the funded status of the plans with
amounts reported in the employer's balance sheet, showing sepa
rately:

(1)

The fair value of plan assets?

____

____

____

(2)

The accumulated postretirement benefit obligation, identify
ing separately the portion attributable to retirees, other fully
eligible plan participants, and other active plan participants?

____

____

____

(3)

The amount of unrecognized prior-service cost?

____

____

____

(4)

The amount of unrecognized net gain or loss (including plan
asset gains and losses not yet reflected in market-related
value)?

____

____

____

The amount of any remaining unrecognized transition obli
gation or transition asset?

____

____

____

The amount of net postretirement benefit asset or liability
recognized in the balance sheet, which is the net result of
combining the preceding five items?

____

____

____

d. The assumed health care cost trend rate(s) used to measure the
expected cost of benefits covered by the plan (gross eligible
changes) for the next year and a general description of the direc
tion and pattern of change in the assumed trend rate(s) thereafter,
together with the ultimate trend rate(s) and when the rate(s) is
expected to be achieved?

____

____

____

e. The weighted average of the assumed discount rate(s) and rate(s)
of compensation increase (for pay-related plans) used to measure
the accumulated postretirement benefit obligation and the
weighted average of the expected long-term rate(s) of return on
plan assets and, for plans whose income is segregated from the
employer's investment income for tax purposes, the estimated
income tax rate(s) included in that rate of return?

____

____

____

The aggregate of the service and interest cost components of
net periodic postretirement health care benefit cost?

____

____

____

The accumulated postretirement benefit obligation for health
care benefits (for purposes of this disclosure, all other as
sumptions shall be held constant and the effects shall be
measured based on the substantive plan that is the basis for
the accounting)?

____

____

____

(5)
(6)

f.

The effect of a one-percentage-point increase in the assumed
health care cost trend rates for each future year on:

(1)
(2)

3 The net total of other components is generally the net effect during the period of certain delayed recognition provisions of SFAS106
(AC P40). The net total includes:
a. The net asset gain or loss during the period deferred for later recognition (in effect, an offset or supplement to the actual return
on plan assets).
b. Amortization of unrecognized prior service cost.
c. Amortization of the net gain or loss from earlier periods.
d. Any gain or loss recognized due to temporary deviation from the substantive plan (of SFAS 106, par. 61 (AC P40.156)).
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★♦2.

Yes

No

g. The amounts and types of securities of the employer and related
parties included in plan assets, and the approximate amount of
future annual benefits of plan participants covered by insurance
contracts issued by the employer and related parties?

____

___

h. Any alternative amortization method used?

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

____

___

i.

The amount of gain or loss recognized during the period for a
settlement or curtailment and a description of the nature of the
event(s)?

j.

The cost of providing special or contractual termination benefits
recognized during the period and a description of the nature of
the event(s)?
[SFAS 106, par. 74 (AC P40.169)]

If more than one defined benefit postretirement plan exists:

a. Are the disclosures aggregated for all of an employer's single-em
ployer defined benefit postretirement plans or disaggregated in
groups so as to provide the most useful information (except that
the aggregate plan assets and the aggregate accumulated postre
tirement benefit obligation of the underfunded plans should be
separately disclosed)?
[SFAS 106, par. 77 (AC P40.172)]
b. Are plans that primarily provide postretirement health care bene
fits and plans that primarily provide other postretirement welfare
benefits separately disclosed if the accumulated postretirement
benefit obligation of the latter plans is significant relative to the
aggregate accumulated postretirement benefit obligation for all of
the plans?
[SFAS 106, par. 78 (AC P40.173)]

3.

If there is a multiemployer plan, do disclosures include:

a. A description of the multiemployer plan(s), including the em
ployee groups covered, the type of benefits provided (defined
benefit or defined contribution), and the nature and effect of
significant matters affecting comparability of information for all
periods presented?
b. The amount of postretirement benefit cost recognized during the
period, if available (otherwise, the amount of the aggregate re
quired contribution for file period to the general health and wel
fare benefit plan that provides health and welfare benefits to both
active employees and retirees)?
[SFAS 106, par. 82 (AC P40.178)]

c. Are the provisions of SFAS 5 (AC C59) applied if the situation
arises where withdrawal from a multiemployer plan may result
in an employer's having an obligation to the plan for a portion of
the plan's unfunded accumulated postretirement benefit obliga
tion and it is probable or reasonably possible that:

(1)

(2)

An employer would withdraw from the plan under circum
stances that would give rise to an obligation?
or

An employer's contribution to the fund would be increased
during the remainder of the shortfall in the funds necessary
to maintain the negotiated level of benefit coverage?
[SFAS 106, par. 83 (AC P40.179)]
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N/A

Yes

★♦4.

If there are one or more defined contribution postretirement plans,
are the following items disclosed separately from defined benefit
postretirement plan information:
a. A description of the plan(s), including employee groups covered,
the basis for determining contributions, and the nature and effect
of significant matters affecting comparability of information for all
periods presented?
b. The amount of cost recognized during the period?
[SFAS 106, par. 106 (AC P40.198)]

____
____

M. Costs to Exit an Activity
1.

★♦2.

If a material liability is recognized for certain employee termination
benefits in accordance with Section A of EITF 94-3, Liability Recognition
for Certain Employee Termination Benefits and Other Costs to Exit an
Activity (including Certain Costs Incurred in a Restructuring), are the
following disclosures made in all periods until the plan of termination
is completed:

a. The amount of termination benefits accrued and charged to ex
pense and the classification of those costs in the income state
ment/statement of activities?

____

b. The number of employees to be terminated?

____

c. A description of the employee group(s) to be terminated?

____

d. The amount of actual termination benefits paid and charged
against the liability and the number of employees actually termi
nated as a result of the plan to terminate employees?

____

e. The amount of any adjustment(s) to the liability?

____

If management commits to an exit plan that meets the criteria in
Section B of EITF 94-3, are the following reporting requirements
followed:

a. Reporting the income statement effect of recognizing a liability at
the commitment date in income from continuing operations and
not on the face of the income statement net of taxes?

____

b. No disclosure made on the face of the income statement for
earnings per share effect?

____

c. Revenue and related costs and expenses of activities that will not
be continued should not be combined and reported as a separate
component of income?
[EITF 94-3, Section B]

3.

____

If the activities that will not be continued are significant to the enter
prise's revenue or operating results, or if the exit costs recognized at
the commitment date are material, are the following disclosures made
in all periods until the exit plan is completed:

a. A description of the major actions comprising the exit plan, activi
ties that will not be continued, including the method of disposi
tion, and the anticipated date of completion?

____

b. A description of the type and amount of exit costs recognized as
liabilities and the classification of those costs in the income state
ment/statement of activities?

____

c. A description of the type and amount of exit costs paid and
charged against the liability?

____
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No

N/A

Yes
d. The amount of any adjustment(s) to the liability?

e. For all periods presented, the revenue and net operating income
or losses from activities that will not be continued if those activities
have separately identifiable operations?
[EITF 94-3, Section B]
N. Derivatives
1.

For options held and other derivative financial instruments not within
the scope of SFAS105 that do not have off-balance-sheet risk, are the
following disclosures made by category of financial instrument:

a. The face or contract amount (or notional principal amount if there
is no face or contract amount)?
b. The nature and terms, including a discussion of:

(1)

Credit and market risk?

(2)

Cash requirements?

(3)

Related accounting policy as required by APB 22?

c. Do disclosures in Steps a. and b. above distinguish between finan
cial instruments held or issued for:

★♦2.

(1)

Trading purposes, including dealing and other trading activi
ties measured at fair value with gains and losses recognized
in earnings?

(2)

Purposes other than trading?
[SFAS 119, pars. 8 and 9]

Does the provider that holds or issues derivative financial instru
ments for trading purposes disclose:

a. The average fair value during the reporting period and the related
end-of-period fair value, distinguishing between assets and liabili
ties?
b. The net gains or losses (net trading revenue) arising from trading
activities during the reporting period disaggregated by class, busi
ness activity, risk or other category consistent with management
of those activities and where those net trading gains or losses are
reported in the income statement?

(1)

If the disaggregation is other than by class, did the provider
also disclose for each category the classes of derivative finan
cial instruments, other financial instruments, and nonfinan
cial assets and liabilities from which the net trading gains and
losses arose?

c. The average fair value for assets and liabilities from the trading of
other types of financial instruments or non financial assets? (This
disclosure is encouraged but not required.)
[SFAS 119, par. 10]
3.

Does a provider that holds or issues derivative financial instruments
for purposes other than trading disclose:

a. A description of:
(1)

The objectives for holding or issuing?

(2)

The context needed to understand those objectives?
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No

N/A

Yes
(3)

The strategies for achieving those objectives?

____

(4)

The classes of derivative financial instruments used?

____

b. A description of how each class of derivative financial instrument
is reported in the financial statements, including:

(1)
(2)

The policies for recognition and measurement or nonrecog
nition of the derivative financial instruments?

____

When recognized, where the instruments and related gains
and losses are reported?

____

c. For derivative financial instruments that are held or issued and
accounted for as hedges of anticipated transactions, both firm and
forecasted transactions for which there is no firm commitment,
including:

★♦4.

(1)

A description of the anticipated transactions whose risks are
hedged, including the expected time period of occurrence?

____

(2)

A description of the classes of derivative financial instru
ments used to hedge?

____

(3)

The amount of explicitly deferred hedging gains and losses?

____

(4)

A description of the transaction or events that result in recog
nition in earnings of the deferred gains or losses?
[SFAS119, par. 11]

____

Are the following encouraged, but not required, quantitative disclo
sures made:
a. Interest rate?

____

b. Foreign exchange?

____

c. Commodity price?

____

d. Other market risks consistent with management's strategies?

____

e. Information of the risk of other financial instruments or nonfinan
cial assets and liabilities related by risk management strategy
pertaining to the objectives for holding or issuing derivative finan
cial instruments?
[SFAS 119, pars. 12 and 13]
O. Business Combinations

★♦1.

If a business combination occurred during the period and met the
specified conditions for a pooling-of-interests, do the statements and
notes include the required disclosures?
[APB 16, pars. 45-48 and 63-65 (AC B50.104-.107 and .122-.124)]

Note: Not-for-profit organizations are, under certain circumstances, per
mitted to use the pooling-of-interests method, even though they generally
do not issue common stock. [AAG, pars. 1.33 and 1.34]
2.

If a business combination does not meet the specified conditions for
a pooling-of-interests:

a. Is the combination accounted for by the purchase method?
[APB 16, pars. 66-88 and 90-94 (AC B50.125-.146 and .159-.163);
SFAS 38 (AC B50.148-.150 and .166); FASBI 4 (AC B50.151 and
.152) concerns research and development activities of an acquired
subsidiary]
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____

No

N/A

Yes
b. Do the statements and notes include the required disclosures?
[APB 16, pars. 95 and 96 (AC B50.164 and .165); SFAS 79, par. 6
(AC B50.165)]

II. Statement of Financial Position/Balance Sheet
A. General

★♦1.

★♦2.

★ 3.

★4.

For classified statements of financial position/balance sheets, are
assets and liabilities segregated into current and noncurrent classifi
cations, with totals presented for current assets and current liabilities?
[ARB 43, Ch. 3A, par. 3; SFAS 78, pars. 5 and 13 (AC B05.102-.109B);
SFAS 6, par. 15 (AC B05.118); FASBI 8, par. 3 (AC B05.117); TB 79-3,
par. 2 (AC B05.501-.503); SFAS 117, par. 12 (AC No5.110)]

Are assets not expected to be realized during the current operating
cycle classified as noncurrent?
[ARB 43, Ch. 3A, pars. 5 and 6 (AC B05.106 and .107)]
Does the statement of financial position/balance sheet report total
assets, liabilities, and net assets as well as separate amounts for each
of three classes of net assets with captions used to describe their
meaning as explained in SFAS 117?
[SFAS 117, pars. 10,13, and 100 (AC No5.131, fn. a)]

6.

____

____

Does the entity provide information about liquidity by one or more
of the following presentations:
a. Sequencing assets according to their nearness of conversion to
cash and sequencing liabilities according to the nearness of their
maturity and resulting use of cash?

____

b. Classifying assets and liabilities as current and noncurrent?

____

c. Disclosing in notes to financial statements relevant information
about the liquidity or maturity of assets and liabilities, including
restrictions on the use of particular assets?
[SFAS 117, par. 12 (AC No5.110)]

5.

____

Are valuation allowances for assets shown as deductions from their
related assets with appropriate disclosure?
[APB 12, par. 3 (AC V18.102)]

Is the need for disclosure of the impact of a new FASB Statement,
issued but not yet effective where restatement of prior periods is
required, considered?
[SAS 1, sec. 9410.13-.18 (AU 9410.13-.18)]

____

____

____

B. Cash and Cash Equivalents

★♦1. Is restricted cash appropriately segregated from cash available for
current operations?
[ARB 43, Ch. 3A, par. 6 (AC B05.107); AAG, par. 3.01]
2.

Are restrictions on cash (such as for plant acquisition, debt reduction
or working capital maintenance) appropriately disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]
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____

____

No

N/A

Yes
3.

Are personal funds of patients, residents and others under an agency
arrangement reported as unrestricted assets and corresponding li
abilities in the balance sheet/statement of financial position?
[AAG, par. 3.02]

★♦4.

If a concentration of credit risk arises from deposits in excess of
federally insured limits, is it disclosed?
[SFAS 105, par. 20 (AC F25.115)]

5.

If the organization has material bank overdrafts or material balance
of undelivered checks as of the statement-of-financial-position/bal
ance-sheet date, are:

a. Bank overdrafts presented as a separate caption within current
liabilities?
b. Undelivered checks classified as accounts payable?
[Generally Accepted]

C.

6.

Are internally designated funds reported separately from externally
designated funds?
[AAG, par. 3.01]

7.

Is the policy for determining cash equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]

Investments
1.

Are investments reported as current or noncurrent assets in conform
ity with GAAP?
[AAG, par. 4.13]

★♦2.

Are the appropriate disclosures made for investments in common
stock accounted for by the equity method?
[APB 18, par. 20 (AC I82.110)]

3.

Are other securities (such as real estate) reported at amortized cost, or
at lower of cost or market if an impairment in value is deemed to be
other than temporary?
[AAG, par. 4.02]

♦ 4.

Are debt and equity securities classified as (a) held-to-maturity, (b)
available-for-sale, or (c) trading?
[SFAS 115, par. 6 (AC I80.103)]

♦ 5.

For debt and marketable equity securities classified as available-forsale or held-to-maturity, are the following disclosures made, by ma
jor-security type, for each balance sheet presented:

a. Aggregate fair value?
b. Gross unrealized holding gains or losses?
c. Amortized cost basis?

d. Disclosure of major-security types, including:

(1)

Equity securities?

(2)

Debt securities issued by the U.S. Treasury and other U.S.
government corporations and agencies?
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No

N/A

Yes

♦ 6.

(3)

Debt securities issued by states of the U.S. and political sub
divisions of the states?

(4)

Debt securities issued by foreign governments?

(5)

Corporate-backed securities?

(6)

Mortgage-backed securities?

(7)

Other debt securities?

(8)

Other security types, as deemed appropriate?
[SFAS115, par. 19 (AC I80.118)]

For investments in debt securities classified as available-for-sale or
held-to-maturity is:

a. Disclosure made about their contractual maturities, as of the date
of the latest balance-sheet date presented (maturity information
may be combined in appropriate groupings)?
b. Disclosure made of the fair value and the amortized cost of debt
securities in at least four maturity groupings:

(1)

Within one year?

(2)

After one year through five years?

(3)

After five years through ten years?

(4)

After ten years?
[SFAS 115, par. 20 (AC I80.119)]

♦ 7.

Is consideration given to separate disclosure for securities not due at
a single date and the basis for allocation if such securities are allo
cated?
[SFAS 115, par. 20 (AC I80.119)]

♦ 8.

If an option (to purchase securities that will be accounted for under
SFAS 115) is classified as held-to-maturity or available-for-sale, is the
accounting policy for the premium paid to acquire the option dis
closed?
[EITF 96-11]

♦ 9.

For each period for which an earnings statement is presented, are the
following disclosures made:

a. The proceeds from sales of available-for-sale securities and gross
realized gains and losses on those sales?
b. The basis on which cost was determined in computing realized
gain or loss (i.e., specified identification, average cost, or other
method used)?

c. The gross gains and losses included in earnings from transfers of
securities from the available-for-sale category to the trading cate
gory?

d. The change in net unrealized holding gain or loss on available-forsale securities that is included in the separate component of share
holders' equity during the period?
e. The change in net unrealized holding gain or loss on trading
securities that is included in earnings during the period?
[SFAS 115, par. 21 (AC I80.120)]
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No

NLA

Yes
★ 10. For any sales of or transfers from securities classified as held-to-ma
turity, are the following disclosed for each period for which an earn
ings statement is presented:
a. Amortized cost amount of the sold or transferred security?

____

b. Related realized or unrealized gain or loss?

____

c. The circumstances leading to the decision to sell or transfer the
security?
[SFAS115, par. 22 (AC I80.114-.122)]

____

11. Are concentrations of securities of a particular issuer disclosed?
[SFAS 105, par. 20 (AC F25.115)]

★ 12. Are investments in equity securities with readily determinable fair
values and all investments in debt securities measured at fair value in
the statement of financial position?
[SFAS 124, par. 7 (AC No5.152); AAG, par. 4.06]

★ 13. Are realized gains and losses; unrealized gains and losses; dividend,
interest, and other similar investment income; and other than tempo
rary impairment losses reported in the statement of activities as
increases or decreases in unrestricted net assets or in temporarily
restricted net assets or in permanently restricted net assets, depending
on the existence of or lack of donor restrictions or law?
[SFAS 124, pars. 8 and 9 (AC No5.154 and .155); AAG, pars. 4.07 and
4.08]
★ 14. Are realized gains and losses; dividend, interest and other similar
investment income; and other than temporary impairment losses
included in the performance indicator within the statement of activi
ties?
[SFAS 124, par. 49; AAG, par. 4.07]

____

____

____

____

★ 15. Are unrealized gains and losses on trading securities (as defined in
SFAS 115) included in the performance indicator within the statement
____

of activities?
[SFAS 124, par. 49; AAG, par. 4.07]

★ 16. Are unrealized gains and losses on available-for-sale and held-to-ma
turity securities excluded from the performance indicator within the
____

statement of activities?
[SFAS 124, par. 49; AAG, par. 4.07]

★ 17. If a provider reports gains and investment income that are limited to
specific uses by donor-imposed restrictions as increases in unre
stricted net assets because the restrictions are met in the same report
ing period as the gains and income are recognized, does the provider:
a. Have a similar policy for reporting contributions received?

____

b. Report consistently from period to period?

____

c. Disclose its accounting policy?
[SFAS 124, par. 10 (AC No5.156); AAG, par. 4.09]

____

★ 18. For each period that a statement of activities is presented, are the
following disclosures made on the face of the financial statements or
in the notes thereto:
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No

N/A

Yes
a. The composition of investment return including, at a minimum,
investment income, net realized gains or losses on investments
reported at other than fair value, and net gains or losses on
investments reported at fair value?
b. A reconciliation of investment return to amounts reported in the
statement of activities, if investment return is separated into oper
ating and nonoperating amounts?

c. A description of the policy used to determine the amount of
investment return included in the measure of operations, if invest
ment return is separated into operating and nonoperating
amounts?
d. A discussion of circumstances leading to a change, if any, in the
policy referred to in Step 13 above?
[SFAS 124, par. 14 (AC No5.161); AAG, par. 4.11]

★ 19. For each period for which a statement of financial position is pre
sented, are the following disclosures made on the face of the financial
statements or in the notes thereto:
a. The aggregate carrying amount of investments by major types
(e.g., equity securities, corporate debt securities, etc.)?
b. The basis for determining the carrying amount for investments
other than equity securities with readily determinable fair values
and all debt securities?
c. The methods and assumptions used to estimate the fair values of
investments other than financial instruments, if those other invest
ments are reported at fair value?

d. The aggregate amount of the deficiencies for all donor-restricted
endowment funds, for which the fair value of the assets at the
reporting date is less than the level required by donor stipulations
or law?
[SFAS 124, par. 15 (AC No5.162); AAG, par. 4.11]

★ 20. For the most recent period for which a statement of financial position
is presented, does the provider disclose the nature of and carrying
amount for every individual investment or group of investments that
represents a significant concentration of market risk (market risk may
result from the nature of the investments, a lack of diversity of
industry, currency, or geographic location)?
[SFAS 124, par. 16 (AC No5.163); AAG, par. 4.11]

★ 21. In the period that SFAS 124 is first applied, does the provider disclose
the nature of any restatements and its effect on the change in net assets
and on each class of net assets for each period presented?
[SFAS 124, par. 19]
★ 22. If SFAS 124 is not applied retroactively, is the cumulative effect of the
change in accounting on each class of net assets reported in the
statement of activities between the captions "extraordinary items," if
any, and "change in unrestricted net assets," "change in temporarily
restricted net assets," and "change in permanently restricted net
assets"?
[SFAS 124, par. 19]
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No

N/A

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

b. Reported in the current period unless they meet the criteria for
prior-period adjustments?
[AAG, par. 5.07; SFAS 16 (AC A35)]

____

____

____

Are advances from third-party payors reported as a liability (unless
the right of setoff against a related receivable applies)?
[AAG, par. 7.01]

____

____

____

Are deposits received from individuals reported as a liability (to the
extent that a right of setoff does not exist)?
[AAG, par. 7.01]

____

____

____

Are receivables (less an allowance for uncollectibles, discounts, and
contractual adjustments) reported as current assets?

____

____

____

a. If the terms of payment are extended beyond one year from the
balance-sheet date, is that portion classified as noncurrent?

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

★♦ 23. Are significant net realized and net unrealized gains and losses that
arose after the latest statement of financial position date, but before
issuance of the financial statements, disclosed?
[SAS 1, sec. 560, pars. 5 and 7 (AU 560.05 and .07)]
★ 24. If the provider elects to report investment revenues net of related
expenses, does the provider disclose the amount of expenses, either
on the face of the statement of activities or in the notes to the financial
statements?
[SFAS 117, par. 24 (AC No5.121)]
D.

Receivables

★♦ 1.

★♦ 2.

Are charity care revenue and receivables excluded from the financial
statements?
[AAG, par. 5.03]

Are differences between the estimates originally reported and final
settlements:
a. Included in the statement of activities/income statement in the
period the settlements are made and disclosed, if material?

★♦3.

★♦4.

★♦ 5.

b. Are amounts due from third-party payors for retroactive adjust
ments of items (such as final settlements or appeals) reported
separately in the financial statements?
[AAG, pars. 5.17 and 5.18]

★ 6.

★ 7.

When displaying total assets and total liabilities, are interfund assets
and liabilities eliminated?4
Do entities that receive unconditional promises to give disclose the
following:
a. The amounts of promises receivable in less than one year, in one
to five years, and in more than five years?
b. The amount of any allowance for uncollectible promises receiv

able?
[SFAS 116, par. 24 (AC C67.121)]

4 The display of interfund items in a statement of financial position is not prohibited by SFAS 117. However, since interfund items are
not organizational assets or liabilities, those interfund items must be clearly labeled and arranged in the statement of financial position
to eliminate their amounts when total assets and liabilities are displayed.
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Yes

★ 8.

Do entities that receive conditional promises to give disclose the
following:

a. The total of the amounts promised?

____

b. A description and amount for each group of promises having
similar characteristics (such as amount of promises conditioned
on establishing new programs, completing a new building, and
raising matching gifts by a specified date)?
[SFAS 116, par. 25 (AC C67.122)]

9.

Are all receivables reported net of any related allowance for uncol
lectible amounts, with appropriate disclosure?
[AAG, par. 5.17; APB 12, par. 3 (AC V18.102)]

★♦10. Are accounts and notes receivable from officers, employees, and
affiliated organizations shown separately with appropriate disclo
sures?
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]
E.

____

____

____

Property and Equipment, Supplies, and Other Assets

★ 1.

★♦ 2.

★♦ 3.

★ 4.

★♦5.

★ 6.

★ 7.

Is property and equipment that is donor-restricted reported as tem
porarily or permanently restricted assets?
[SFAS 116, par. 14]

____

Are donor or legal restrictions on the proceeds from the disposition
of property and equipment disclosed?
[AAG, par. 6.07]

____

For depreciable assets, do the financial statements or notes disclose:

a. Depreciation expense for each period?

____

b. Balances of major classes of depreciable assets by nature or func
tion?

____

c. Accumulated depreciation, either by major classes of assets or in
total?

____

d. The method or methods used in computing depreciation with
respect to major classes of depreciable assets?
[APB 12, par. 5 (AC D40.105)]

____

Are denoted materials and supplies recognized when received at their
fair values?
[SFAS 116, pars. 5 and 8 (AC C67.104 and .108)]

____

Do disclosures include the method and period of amortization of
intangible assets?
[APB 22, par. 13 (AC A10.106)]

____

Is donated property or equipment recognized when received at its fair
value?
[SFAS 116, pars. 5 and 8 (AC C67.104 and .108)]

____

In a classified balance sheet:
a. Are deferred tax assets and deferred tax liabilities classified as
current or noncurrent based on the classification of the related
asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
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____

No

N/A

Yes
b. Are deferred tax assets or liabilities not related to an asset or
liability for financial reporting (including those related to carry
forwards) classified according to the expected reversal date of the
temporary difference?
[SFAS 109, pars. 41 and 288p (AC I27.140)]

No

____

___

____

___

(1) All current deferred tax liabilities and assets?

____

___

(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]

____

___

____

___

Is the net change during the year in the total valuation allowance
disclosed?
[SFAS 109, par. 43 (AC I27.142)]

____

___

10. Is an asset (prepaid pension cost) recognized if net periodic pension
cost is less than amounts the employer has contributed to the plan?
[SFAS 87, par. 35 (P16.129)]

____

___

____

___

____

___

____

___

____

___

____

___

____

___

c. Is the valuation allowance for a particular tax jurisdiction allocated
between current and noncurrent deferred tax assets for that tax
jurisdiction on a pro rata basis?
[SFAS 109, par. 41 (AC I27.140)]

d. Are the following items offset and presented as a single amount
for a particular taxpaying component and within a particular
taxpaying jurisdiction:

♦ 8.

♦ 9.

Are the totals of (a) all deferred tax liabilities, (b) all deferred tax assets,
and (c) the related valuation allowance recognized in the balance sheet
disclosed?
[SFAS 109, par. 43 (AC I27.142)]

11. If an additional minimum pension liability is recognized, is an equal
amount recognized as an intangible asset, provided that the asset
recognized does not exceed the amount of unrecognized prior-service
cost?
[SFAS 87, pars. 36 and 37 (AC P16.130 and .131)]

★♦ 12. Are investments in life insurance reported at amounts that can be
realized as of the statement-of-financial-position/balance-sheet date?
[TB 85-4, par. 2 (AC I50.508)]

13. Is the amount of interest cost incurred and charged to expense during
the period disclosed for an accounting period in which no interest cost
is capitalized?
[SFAS 34, par. 21a (AC I67.118)]
14. Is the amount of interest cost incurred during the period and the
amount that has been capitalized disclosed for an accounting period
in which some interest cost is capitalized?
[SFAS 34, par. 21b (AC I67.118)]
15. Are material commitments for property expenditures disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

★♦16. For an existing property with an asbestos problem, are the costs
incurred to treat the problem, if charged to expense, not classified as
an extraordinary item?
[EITF 89-13]
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N/A

Yes

17. If an impairment loss is recognized for assets to be held and used, are
the following disclosures made in financial statements that include
the period of the impairment write-down:

a. A description of the impaired assets and the facts and circum
stances leading to the impairment?
b. The amount of the impairment loss and how fair value was deter
mined?

c. The caption in the income statement or statement of activities in
which the impairment loss is aggregated if that loss has not been
presented as a separate caption or reported parenthetically on the
face of the statement?
[SFAS 121, par. 14 (AC I08.133)]

★♦18. If assets to be disposed of are accounted for in accordance with
paragraphs 15-17 of SFAS 121, are all of the following disclosed in
financial statements that include a period during which those assets
are held:

a. A description of assets to be disposed of, the facts and circum
stances leading to the expected disposal, the expected disposal
date, and the carrying amount of those assets?
b. The loss resulting from the application of paragraph 15 of SFAS
121?
c. The gain or loss, resulting from changes in the carrying amounts
of assets to be disposed of that arises from application of para
graph 17 of SFAS 121?

d. The caption in the statement of activities/income statement in
which the gains or losses in b. and c. are aggregated if those gains
or losses have not been presented as a separate caption or reported
parenthetically on the face of the statement?
e. The results of operations for assets to be disposed of to the extent
that those results are included in the entity's results of operations
for the period and can be identified?
[SFAS 121, par. 19 (AC I08.138)]

★♦ 19. If an impairment loss is recognized, is it reported as a component of
income from continuing operations before income taxes, or similar
caption, in the statement of activities or income statement?
[SFAS 121, pars. 13 and 18]
F. Current Liabilities, Notes Payable, and Other Debt
1.

Current liabilities:

★♦ a. For classified balance sheets and classified statements of financial
position, do current liabilities include:

(1)

Obligations for items that entered the operating cycle?

(2)

Collections received in advance of the performance of serv
ices?

(3)

Debts that arise from operations directly related to the oper
ating cycle?
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No

N/A

Yes
(4)

Other liabilities whose regular and ordinary liquidation is
likely to occur within a relatively short time period?

(5)

Obligations that, by their terms, are due on demand or will
be due within one year (or operating cycle, if longer) from the
balance-sheet date, even though liquidation may not be ex
pected within that period?
[ARB 43, Ch. 3A, pars. 7 and 8 (AC B05.108 and .109); SFAS
78, par. 5 (AC B05.109A)]

b. Do current liabilities exclude short-term obligations that the
provider intends to refinance on a long-term basis, provided the
provider has demonstrated the ability to consummate the long
term financing?
[SFAS 6, pars. 8-14 (AC B05.113-.116); FASBI 8, pars. 2-4 (AC
B05.117, .138, and .139)]

c. In classified statements of financial position and in classified bal
ance sheets, are current portions of debt obligations presented as
current liabilities?
[ARB 43, Ch. 3A, pars. 7 and 8 (AC B05.108 and .109)]

2. Notes payable and other debt:
a. Is there adequate disclosure of interest rates, maturities, and other
terms and conditions provided in loan agreements and bond
indentures (such as assets pledged as collateral, and covenants to
reduce debt, and maintain working capital)?
[FASCON 5, par. 11; SFAS 5, par. 18 (AC C59.120)]
b. Are the combined aggregate amounts of maturities and sinking
fund requirements for all long-term borrowings disclosed for each
of the five years following the date of the latest balance sheet
presented?
[SFAS 47, par. 10b (AC C32.105b)]

c. For unconditional purchase obligations that have been recorded
in accordance with SFAS 47, paragraph 6, is the amount of pay
ments due in the aggregate and for every year during the five years
following the date of the latest statement of financial position/bal
ance sheet presented disclosed?
[SFAS 47, par. 10a (AC C32.105a)]
d. If a note is non-interest-bearing or has an inappropriate stated
interest rate:

(1)

Is the discount or premium presented as a deduction from or
addition to the face amount of the note?

(2)

Does the disclosure include the effective interest rate and face
amount of the note?

(3)

Is amortization of the discount or premium reported as inter
est expense?

(4) Are issue costs reported in the balance sheet/statement of
financial position as deferred charges?
[APB 21, par. 16 (AC I69.109)]

e. Are debt conversion features (such as rates and pertinent dates)
disclosed?
[FASCON 5, par. 11; APB 14 (AC D10)]
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No

N/A

Yes

If a short-term obligation is to be excluded from current liabilities
in a classified balance sheet/statement of financial position, do
disclosures include:
(1) General description of the financing agreement?

Terms of any new obligation incurred or expected to be
incurred, or equity securities issued or expected to be issued
as a result of the refinancing?
[SFAS 6, par. 15 (AC B05.118)]
g. For troubled debt restructuring occurring during the current pe
riod, do disclosures include:
(1) Description of the principal changes in terms and/or the
major features of settlement?
(2) Aggregate gain on restructuring of payables and the related
income tax effect?
(3) Aggregate net gain or loss on transfers of assets recognized
during the period?
(4) Per-share amount, if applicable, of the aggregate gain on
restructuring of payables, net of related income tax effect?
[SFAS 15, par. 25 (AC D22.121)]
h. For periods after a troubled debt restructuring, do disclosures include:

(2)

Extent to which amounts contingently payable are included
in the carrying amount of restructured payables?
(2) Total amounts contingently payable, if applicable, and con
ditions under which those amounts would become payable
or forgiven?
[SFAS 15, par. 26 (AC D22.122)]
i. If there is an early extinguishment of debt, is the difference be
tween reacquisition price and carrying amount identified as a
separate or extraordinary item?
[SFAS 4, par. 8; SFAS 64, par. 4 (AC D14.105)]
j. If there is an early extinguishment of debt, is the difference be
tween reacquisition price and carrying amount identified as in
come in the period of extinguishment as gain or loss?
[APB 26, pars. 20 and 21 (AC D14.103 and .104)]
k. Do disclosures related to gains and losses classified as extraordi
nary include the following:
(1) A description of the extinguishment transactions, including
the sources of any funds used to extinguish debt if it is
practicable to identify the sources?

(1)

(2)
(3)

The income tax effect in the period of extinguishment?
The per-share amount of the aggregate gain or loss net of
related income tax effect?
[SFAS 4, par. 9 (AC D14.107)]

Note: SFAS 125, Accounting for Transfers and Servicing of Financial Assets
and Extinguishments of Liabilities, is effective for transfers and servicing of
financial assets and extinguishments of liabilities occurring after Decem
ber 31, 1996, and is to be applied prospectively. Earlier or retroactive
application is not permitted. SFAS 127, Deferral of the Effective Date of
Certain Provisions of SFAS 125, defers some provisions of SFAS 125. It does
not defer SFAS 125's provisions related to extinguishments of liabilities.
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l.

Yes

No

If debt was considered to be extinguished under the provisions of
SFAS 76 prior to the effective date of SFAS 125, do disclosures
include:

(1)

A general description of the transaction?

____

___

(2)

The amount of debt that is considered extinguished at the end
of the period as long as the debt remains outstanding?
[SFAS 125, par. 17b]

____

___

____

___

____

___

____

___

____

___

____

___

q. Is disclosure considered for any changes in the provider's activi
ties that could affect its tax-exempt status?
[AAG, par. 7.11]

____

___

r. Are disclosures appropriate regarding the provider's tax-exempt
status and any other significant tax matters?
[AAG, par. 7.11]

____

___

Debt-financed investments that are not functionally related
to the exempt purpose?

____

___

(2)

Certain related entities not engaged in an exempt activity?

____

___

(3)

Pharmacy operations in a medical building for the conven
ience of physicians' private patients?

____

___

m. If assets are set aside after the effective date of SFAS 125 solely for
satisfying scheduled payments of a specific obligation, is disclo
sure made describing the nature of restrictions placed on those
assets?
[SFAS 125, par. 17c]
n. Are long-term obligations that are or will be callable by the credi
tor, either because the debtor's violation of the debt agreement at
the balance-sheet/statement-of-financial-position date makes the
obligation callable, or because the violation (if not cured within a
specified grace period) will make the obligation callable, classified
as current unless one of the following conditions is met:

(1)

The creditor waives or subsequently loses the right to de
mand repayment for more than one year (or operating cycle,
if longer) from the balance-sheet date?

(2) The obligation contains a grace period within which the
debtor may cure the violation and it is probable that the
violation will be cured within that period, thus preventing
the violation from becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]

★ o. Does the not-for-profit provider report tax-exempt obligations
that were issued for its benefit as liabilities if the provider is
responsible for repayment?
[AAG, par. 7.15]
p. Is consideration given to the effects, if any, of current and prior tax
examinations on the financial statements and disclosures related
to the existence of contingent liabilities for unrelated business
income tax, additional payroll tax liabilities, or penalties and
interest on delinquent taxes?
[AAG, par. 7.11]

s. Is appropriate disclosure made if unrelated business income tax
has not been accrued on income from:

(1)
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N/A

Yes

(4)

(5)

A gift shop, cafeteria or food shop that the provider encour
ages the general public (except patients, visitors and employ
ees) to use?
A parking lot available to the general public (except patients,
visitors, and employees)?
[AAG, pars. 7.10 and 7.11]

____
____

G. Other Liabilities and Deferred Credits

1.

2.

3.

Are liabilities for special termination benefits to employees appropri
ately accrued and reported when the employees accept the offer and
the amount can be reasonably estimated?
[SFAS 88, par. 15 (AC P16.185)]
Are liabilities properly accrued and reported for employees' compen
sation for future absences?
[SFAS 43, par. 6 (AC C44.104)]
If an obligation for postemployment benefits is not accrued in accord
ance with SFAS 5 or SFAS 43 only because the amount cannot be
reasonably estimated, is the fact that the benefits have not been
accrued disclosed in the financial statements?
[SFAS 112, par. 7 (AC P32.105)]

____

____

____

H. Lessor Leases
1.

2.

For sales-type and direct financing leases, do disclosures include:

a. Appropriate components of the net investment in the leases as of
the date of each balance sheet/statement of financial position
presented?

____

b. Future minimum lease payments to be received for each of the five
succeeding fiscal years as of the latest balance-sheet/statement-offinancial-position date presented?

____

c. Total contingent rentals included in income for each period for
which an income statement/statement of activities is presented?
[SFAS 13, par. 23a (AC L10.119a)]

____

d. For direct financing leases, the amount of initial direct costs as part
of the investment?
[SFAS 91, par. 25d (AC L10.119a(1))]

____

For operating leases, do disclosures include:

a. Cost and carrying amount of property on lease or held for leasing
by major classes and the amount of accumulated depreciation as
of the date of the latest balance sheet/statement of financial posi
tion presented?

____

b. Minimum future rentals on noncancelable leases as of the date of
the latest balance sheet presented in the aggregate and for each of
the five succeeding fiscal years?

____

c. Total contingent rentals included in income for each period for
which an income statement/statement of operations is presented?
[SFAS 13, par. 23b (AC L10.119b)]
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____

No

N/A

Yes
I.

Lessee Leases
1.

For capital leases do disclosures include:

a. Gross amounts of assets recorded by major classes, as of the date
of each balance sheet/statement of financial position presented?
[SFAS 13, par. 16a.i. (AC L10.112a(1))]
b. Future minimum lease payments, as of the date of the latest
balance sheet/statement of financial position presented, in total
and for each of the next five years, with separate deductions for
executory costs and imputed interest to reduce net minimum lease
payments to present value?
[SFAS 13, pars. 10 and 16a.ii. (AC L10.106 and .112a(2))]

c. Total future minimum sublease rentals under noncancelable sub
leases as of the date of the latest balance sheet/statement of
financial position presented?
[SFAS 13, par. 16a.iii. (AC L10.112a(3))]

d. Total contingent rentals actually incurred for each period pre
sented?
[SFAS 13, par. 16a.iv. (AC L10.112a(4))]
e. Assets recorded under capital leases and the related accumulated
amortization, and obligations under those leases identified sepa
rately in the balance sheet/statement of financial position or a
note?
[SFAS 13, pars. 13 and 16 (AC L10.112a)]
2.

b. Total future minimum rentals under noncancelable subleases as
of the date of the latest balance sheet/statement of financial posi
tion presented?
[SFAS 13, par. 16b (AC L10.112b)]

★♦4.

★♦5.

★♦6.

____

____

____

____

For operating leases that have initial or remaining noncancelable lease
terms in excess of one year, do disclosures include:

a. Future minimum rental payments required as of the latest balance
sheet/statement of financial position presented in total and for
each of the next five years?

3.

____

For all operating leases, do disclosures include rental expense for each
period presented, with separate amounts for minimum rentals, con
tingent rentals, and sublease rentals?
[SFAS 13, par. 16c (AC L10.112c)]

____

____

____

Do disclosures include a general description of the lessee's leasing
arrangements including, but not limited to:
a. Bases for determination of contingent rentals?

____

b. Terms of any renewal or purchase options or escalation clauses?

____

c. Restrictive covenants?
[SFAS 13, par. 16d (AC L10.112d)]

____

Is the nature and extent of leasing transactions with related parties
disclosed?
[SFAS 13, par. 29 (AC L10.125)]
If material, is the accounting policy used in recognizing amounts
related to a modification of an operating lease (that does not change
the lease classification) disclosed?
[EITF 95-17]
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____

____

No

N/A

Yes
J.

Net Assets

♦ 1.

2.

Are the equity accounts of investor-owned providers presented in a
similar fashion as other investor-owned businesses?
[AAG, par. 9.01]
Is the nature of restrictions on donor-restricted resources disclosed?
[AAG, par. 9.07]

♦ 3.

Are limits on the use of unrestricted net assets (such as loan covenants
and board-designated endowments) and information about the na
ture and amounts of different types of permanent and temporary
restrictions disclosed?
[SFAS 117, par. 16 (AC No5.114); AAG, pars. 9.03 and 9.04]

★4.

Are net assets released from restriction, such as those related to the
fufillment of time or purpose restrictions, reported separately in the
financial statements or disclosed in the notes?
[AAG, par. 10.07]

♦ 5.

Shareholders' equity (corporations):

a. For each class of stock, do disclosures include the number of shares
authorized, issued and outstanding, and par or stated value per
share and changes therein?
[APB 12, par. 10 (AC C08.102)]
b. Do the financial statements include a description, in summary
form, sufficient to explain the pertinent rights and privileges of the
various securities outstanding, (e.g., dividend and liquidation
preferences, participation rights, call prices and dates, conversion
or exercise prices or rates and pertinent dates, sinking fund re
quirements, unusual voting rights, significant terms of contracts
to issue additional shares)?
[SFAS 129, par. 4]

c. Do disclosures include the number of shares issued upon conver
sion, exercise, or satisfaction of required conditions during at least
the most recent annual fiscal period and any subsequent interim
period presented?
[SFAS 129, par. 5]
d. Are the following disclosed on the face of the statement of financial
position or in the notes:

(1)

The aggregate or per-share amounts at which preferred stock
may be called or is subject to redemption through sinkingfund operations or otherwise?

(2)

The aggregate and per-share amounts of arrearages in cumu
lative preferred dividends?
[SFAS 129, par. 7]

e. For preferred stock that has a preference in involuntary liquida
tion considerably in excess of par or stated value of the shares, is
the liquidation preference disclosed? [Note: Disclosure shall be
made in the equity section of the statement offinancial position
in the aggregate, either parenthetically or "in short," rather than
on a per-share basis or through disclosure in the notes.]
[SFAS 129, par. 6]
39

No

N/A

Yes
f.

For redeemable stock, do disclosures include the amount of re
demption requirements, separately by issue or combined, for all
issues of capital stock that are redeemable at fixed or determinable
prices on fixed or determinable dates in each of the five years
following the date of the latest statement of financial position
presented?
[SFAS 129, par. 8]

g. For stock option and stock purchase plans, do disclosures include:
(1) Number of shares under option?

(2)

Option price?

(3)

Number of shares as to which options are exercisable?

(4)

For options exercised, the number of shares involved and
option price?
[ARB 43, Ch. 13B, par. 15 (AC C47.123)]

h. Are any appropriations of retained earnings for loss contingencies
clearly identified and included in stockholders' equity?
[SFAS 5, par. 15 (AC R70.103)]

i.

Are restrictions on payment of dividends disclosed?
[SFAS 5, pars. 18 and 19 (AC C59.120)]

j.

Are receivables for stock issued or subscribed appropriately iden
tified and presented as a deduction from capital or, if presented as
an asset, stated separately, clearly labeled, and their status clearly
described to distinguish them from any other type of assets?

♦ k. Is the carrying basis, the cost and the number of shares disclosed
for treasury stock?
[APB 6, par. 12b (AC C23.103)]
♦ l.

Does disclosure of the following aspects of capital instruments
include:

(1)

Bases for calculation of dividends?

(2)

Liquidation accounts for converted entities?

(3)

Dividend restrictions?

(4)

Changes in control provisions?

(5)

Other matters necessary for a clear understanding of the
entity's financial condition?
[APB 15, par. 50, fn. 16; SFAS 5, par. 18 (AC C59.120)]

♦ m. After completion of a quasi-reorganization, is a new retained
earnings account established and dated with the date being dis
closed in subsequent financial statements until it is no longer
deemed significant?
[ARB 43, Ch. 7A, par. 10; ARB 46, par. 2 (AC Q15.111)]

♦ n. Are stock dividends/splits through the issue date of financial
statements disclosed and, if appropriate, are all presented earn
ings per share restated?
[APB 15, par. 48 (AC E09.139)]

♦ o. Are the nature and extent to which retained earnings is restricted
indicated?
[APB 6, par. 13 (AC C23.104)]
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No

N/A

Yes

♦ p. Are unrealized holding gains and losses for available-for-sale
securities, including those classified as current assets, reported as
a net amount in a separate component of shareholders' equity until
realized?
[SFAS115, par. 13 (AC I80.110)]
6.

____

Changes in net assets:
a. When both financial position and results of operations are pre
sented:
(1)

(2)

Are changes in the separate component accounts of equity
disclosed?
[APB 12, par. 10 (AC C08.102)]
Are changes in the number of shares of capital stock disclosed
for at least the latest year and any subsequent interim periods
presented (for-profit only)?
[APB 12, par. 10 (AC C08.102)]

b. Are prior-period adjustments and their resulting effects (both
gross and net of applicable income taxes) appropriately presented
and disclosed?
[APB 9, par. 26 (AC A35.107)]
c. Are prior-period adjustments limited to correction of an error in
financial statements of prior periods?
[SFAS 109, par. 288m (AC A35.103)]

____

____

____

d. For a correction of an error, is the nature of the error disclosed in
the period in which the error was discovered and corrected?

____

(1) Nature of the error in previously issued financial statements?

____

Effect of its correction on income before extraordinary items,
net income, and related per-share amounts, if applicable?
[APB 20, par. 37 (AC C35.105)]

____

(2)

e. If an additional pension liability is required to be recognized and
exceeds unrecognized prior service cost, is the excess (which
would represent a net loss not yet recognized as net periodic
pension cost) reported as a separate component (i.e., a reduction)
of equity net of any tax benefits that result from considering such
losses as temporary differences?
[SFAS 87, par. 37 (AC P16.131)]
K.

____

____

Restricted Resources

★ 1.

★ 2.

Are cash or other assets received with a donor-imposed restriction
that limits their use to long-term purposes reported separately from
assets that are unrestricted and available for current use?
[SFAS 117, par. 11 (AC No5.109)]

Does the entity provide information about the nature and amounts of
different types of permanent restrictions and temporary restrictions
by reporting their amounts on the face of the statement of financial
position or by including relevant details in notes to financial state
ments?
[SFAS 117, par. 14 (AC No5.112)]
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____

____

No

N/A

Yes

III.

Statement of Activities/Income Statement/Statement of
Operations/Statement of Changes in Net Assets

A. General

★ 1.

★ 2.

★ 3.

Does the statement of activities/operations or statement of changes
in net assets report the amount of change in net assets for the period
for the provider as a whole (using a descriptive term such as "change
in net assets" or "change in equity"), and does that amount articulate
to the net assets reported in the statement of financial position?
[SFAS 117, par. 18 (AC No5.116)]
Does the statement of activities/operations or the statement of
changes in net assets report the amount of change in permanently
restricted net assets, temporarily restricted net assets, and unre
stricted net assets for the period?
[SFAS 117, par. 19 (AC No5.117)]

★ 5.

★ 6.

★ 7.

★ 8.

____

Does the statement of activities/operations report the following:

a. Revenues as increases in unrestricted net assets unless tine use of
the assets received is limited by donor-imposed restrictions?

____

b. Expenses as decreases in unrestricted net assets?

____

c. Events that simultaneously increase one class of net assets and
decrease another (reclassifications), including expiration of donorimposed restrictions, separately from revenues, expenses, gains,
and losses?
[SFAS 117, pars. 19 and 20 (AC No5.117 and .118); SFAS 116, par.
17 (AC No5.146)]
4.

____

Are revenues and expenses (arising from ongoing activities associated
with health care services) classified as operating and displayed as
gross amounts?
[SFAS 117, par. 24 (AC No5.121)]

If the entity reports an intermediate measure of operations (for exam
ple, excess or deficit of operating revenues over expenses), is this
intermediate measure reported only in a financial statement that, at a
minimum, reports the change in unrestricted net assets for the period?
[SFAS 117, par. 23 (AC No5.120)]
If the entity's use of the term operations is not apparent from the details
provided on the face of the statement of activities, does a note to
financial statements describe the nature of the reported measure of
operations or the items excluded from operations?
[SFAS 117, par. 23 (AC No5.120)]

If the entity reports net gains and losses or revenue and expense on
its statement of activities/operations, do these net amounts result
from peripheral or incidental transactions or from events largely
beyond the control of the entity and its management?
[SFAS 117, pars. 25 and 138 (AC No5.122)]

Does the not-for-profit provider report total income or loss in a
statement that, at a minimum, also presents the total changes in
unrestricted net assets?
[AAG, par. 10.16]
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____

____

____

____

____

____

No

N/A

Yes
★♦ 9.

Is management's policy for providing charity care, as well as the level
of charity care provided, disclosed?
[AAG, par. 10.20]

★ 10. Does the statement of activities/operations include a performance
indicator that reports results of operations and that is clearly labeled
with a descriptive term such as revenues over expenses, revenues and
gains over expenses and losses, earned income, or performance earnings?
[AAG, par. 10.16]
★ 11. Do the notes to the financial statements include a description of the
nature and composition of the performance indicator?
[AAG, par. 10.16]

____

____

____

★♦ 12. Does the organization report the following items separately from the
performance indicator:

a. Transactions with owners acting in that capacity?

____

b. Equity transfers involving other entities that control the reporting
entity, are controlled by the reporting entity, or are under common
control with the reporting entity?

____

c. Receipt of restricted contributions, including temporary restric
tions (such as time or purpose) or permanent restrictions?

____

d. Contributions of (and assets released from donor restrictions re
lated to) long-lived assets?

____

e. Unrealized gains and losses on investments not restricted by
donors or by law, except for those investments classified as trading
securities?

____

f.

Investment returns restricted by donors or by law?

g. Other items that are required by GAAP to be reported separately
(such as extraordinary items, the effect of discontinued operations,
or the cumulative effect of accounting changes)?
[AAG, par. 10.17]

★♦13. For investments in common stock accounted for by the equity
method, is the investor's share of earnings shown as a single amount
except for investee extraordinary items and prior-period adjustments
that are material to the investor?
[APB 18, par. 19c and d (AC 182.109c and d)]

____

____

____

★♦ 14. Are total research and development costs charged to expenses dis
closed for each period for which a statement of activities/income
statement is presented?
[SFAS 2, pars. 12 and 13 (AC R50.108 and .109); FASBI4, par. 5 (AC
B50.152); FASBI 6, par. 8 (AC R50.117); SFAS 86, par. 3 (AC Co2.102)]

____

★♦ 15. If the provider accounts for its obligation under a research and devel
opment arrangement as a contract to perform research and develop
ment for others, is there disclosure of:
a. The terms of significant agreements under the research and devel
opment arrangement as of the date of each balance sheet pre
____

sented?
b. The amount of compensation earned or costs incurred under such
contracts for each period for which a statement of revenues and
expenses (statement of operations) is presented?
[SFAS 68, par. 14 (AC R55.112)]
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____

No

N/A

Yes
♦ 16. Are the following excluded from the determination of net income or
results of operations under all circumstances:

a. Adjustments or charges or credits resulting from transactions in
the provider's own capital stock?

____

b. Transfers to and from accounts properly designated as appropri
ated retained earnings?

____

c. Adjustments made pursuant to a quasi-reorganization?
[APB 9, par. 28 (AC C08.101)]

Note: SFAS128, Earnings per Share, is effective for financial statements for
both interim and annual periods ending after December 15,1997. Earlier
application is not permitted. However, an entity is permitted to disclose
pro forma earnings per share amounts computed using SFAS 128 in the
notes to the financial statements in periods prior to required adoption.
After the effective date, all prior-period earnings per share data presented
shall be restated (including interim financial statements, summaries of
earnings, and selected financial data) to conform with the provisions of
SFAS 128.
If SFAS 128 is effective, follow steps 17 and 18.
If SFAS 128 is not effective, follow step 19.

♦ 17. For public companies, has earnings per share been computed and
presented in accordance with SFAS 128 and is the following disclosed
for each period for which an income statement is presented:
a. A reconciliation of the numerators and the denominators of the
basic and diluted per-share computations for income from con
tinuing operations?
b. The effect that has been given to preferred dividends in arriving
at income available to common stockholders in computing basic
earnings per share?

c. Securities (including those issuable pursuant to contingent stock
agreements) that could potentially dilute basic earnings per share
in the future that were not included in the computation of diluted
earnings per share because to do so would have been antidilutive
for the period(s) presented?
[SFAS 128, par. 40]
♦ 18. For the latest period for which an income statement is presented, do
disclosures include a description of any transaction that occurs after
the end of the most recent period but before issuance of the financial
statements that would have changed materially the number of com
mon shares or potential common shares outstanding at the end of the
period if the transaction had occurred before the end of the period?
[SFAS 128, par. 41]

♦ 19. Is earnings per share information for public companies presented on
the face of the income statement accompanied by appropriate disclo
sure that includes the basis of the calculation?
[APB 15, par. 12 (AC E09.103): SFAS 21, par. 15 (AC E09.102)]

♦ 20. Are net assets released from restriction, such as those related to the
fulfillment of time or purpose restrictions, reported separately in the
financial statements or disclosed in the notes?
[AAG, par. 10.07]
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____

No

N/A

Yes
B.

Revenue
1.

Is revenue classified based on the type of service (such as patient or
resident) rendered or contracted to be rendered?
[AAG, par. 10.04]

★♦2.

Are gains, losses, and interest earned properly classified and re
ported?
[AAG, par. 10.07]

★♦3.

Is patient service revenue reported net of provisions for contractual
charity care and other adjustments?
[AAG, par. 10.19]

4.

Do disclosures include methods of revenue recognition?
[AAG, par. 10.19]

5.

With regard to contractual adjustments and third-party settlements,
does the provider identify and explain the estimated amounts payable
or receivable?
[AAG, par. 10.19]

★ 6.

Is significant revenue earned under capitation arrangements reported
separately?
[AAG, par. 10.19]

C.

Income Taxes

♦ 1.

Are the types of significant temporary differences and carryforwards
disclosed?
[SFAS 109, par. 43 (AC I27.142)]

♦ 2.

Are the following significant components of income tax expense
attributable to continuing operations for each year presented dis
closed in the financial statements or notes thereto:

a. Current tax expense or benefit?
b. Deferred tax expense or benefit (exclusive of the effects of other
components listed below)?

c. Investment tax credits?

d. Government grants (to the extent recognized as a reduction of
income tax expense)?
e. The benefits of operating loss carryforwards?
f.

Tax expense that results from allocating certain benefits, either
directly to contributed capital or to reduce goodwill or other
noncurrent intangible assets of an acquired entity?

g. Adjustments of a deferred tax liability or asset for enacted changes
in tax laws or rates or a change in the tax status of the provider?
h. Adjustments of the beginning-of-the-year balance of a valuation
allowance because of a change in circumstances that causes a
change in judgment about the realizability of the related deferred
tax asset in future years?

i.

Any portion of the valuation allowance for deferred tax assets for
which subsequently recognized tax benefits will be allocated to re45

No

N/A

Yes

duce goodwill or other noncurrent intangible assets of an acquired
entity or directly to contributed capital?
[SFAS 109, pars. 45 and 48 (AC I27.144 and .147)]

♦ 3.

Is the amount of income tax expense or benefit allocated to continuing
operations and the amounts separately allocated to other items dis
closed for each year for which those items are presented?
[SFAS 109, pars. 35-39 and 46 (AC I27.134-.138 and .145)]

♦ 4.

a.

Is the nature of significant items for public enterprises disclosed
by the use of percentages or dollars for (i) the reported amount of
income tax expense attributable to continuing operations for the
year to date and (ii) the amount of income tax expense that would
result from applying domestic federal statutory rates to pretax
income from operations?

b. Is the nature of significant reconciling items (omission of numeri
cal reconciliation is permitted) for a non-public enterprise dis
closed?

c. If not otherwise evident, are the nature and effect of any other
significant matters affecting comparability of information for all
periods present?
[SFAS 109, par. 47 (AC 127.145)]

♦ 5.

Are the amounts and expiration dates of operating loss and tax credit
carryforwards for tax purposes disclosed?
[SFAS 109, par. 48 (AC I27.147)]

♦ 6.

If the provider is a member of a group that files a consolidated tax
return, are the following items disclosed in its separately-issued finan
cial statements:

a. The aggregate amount of current and deferred tax expense for
each period presented, and the amount of any tax-related balances
due to or from affiliates as of the date of each balance sheet
presented?
b. The method by which the consolidated amount of current and
deferred tax expense is allocated to members of the group and the
nature and effect of any changes in that method (and in determin
ing related balances to or from affiliates) for each period pre
sented?
[SFAS 109, par. 49 (AC I27.148)]

♦ 7.

Are the amounts of income taxes applicable to the results of discon
tinued operations disclosed on the income statement or in related
notes?
[APB 30, par. 8 (AC I13.105)]

♦ 8.

Are the income taxes applicable to extraordinary events disclosed on
the face of the income statement or in related notes?
[APB 30, par. 11 (AC I17.102)]

D. Discontinued Operations
1.

Are operations of a segment that are discontinued or are the subject
of a formal plan for disposition:
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No

N/A

Yes
a. Reported separately from continuing operations and as a compo
nent (including applicable income taxes) of operations before
extraordinary items?
b. Accompanied by disclosure in the notes of revenue applicable to
the discontinued operations?
[APB 30, par. 8 (AC I13.105)]

★♦2.

Is gain or loss from disposal of a discontinued segment reported
separately (including applicable income taxes) in conjunction with
results of discontinued operations as a component of income before
extraordinary items?
[APB 30, pars. 8,13, and 15-18 (AC I13.101-.103, .105, .106, .108, and
.109)]

★♦3.

If a provider has accounted for the discontinuance of a segment in
accordance with APB 30 and subsequently decides to retain the seg
ment, is any impairment write-down of the individual assets classi
fied in continuing operations?
[EITF 90-16]

4.

If the entity plans to dispose of two segments of a business, and a net
gain is expected (one has a net gain and the other a net loss), is that
gain shown net?
[EITF 85-36]

5.

Are the revenues applicable to the discontinued operations disclosed
in the notes to the financial statements?
[APB 30, par. 8 (AC I13.105)]

★♦6.

For the period encompassing the measurement date, do notes to
financial statement disclose:

a. Identity of the segment discontinued?
b. Expected disposal date, if known?

c. Expected manner of disposal?
d. Description of the remaining assets and liabilities of the discontin
ued segment at the balance-sheet date?

e. Results of operations and any proceeds from disposal of the
discontinued segment during the period from the measurement
date to the balance-sheet date?
f.

The fact that the loss on disposal cannot be estimated within
reasonable limits, if applicable?
[APB 30, par. 18 and par. 18, fn. 7 (AC I13.108 and .109)]

7.

For periods after the measurement date and including the disposal,
do notes to financial statements disclose the information required for
the period encompassing the measurement date and the actual date
and results of disposal compared with the prior estimates?
[APB 30, par. 18 (AC I13.108 and .109)]

8.

If the entity decides to dispose of a segment of a business and the
measurement date occurs after the balance-sheet/statement-of-finan
cial-position date but before the financial statements for the prior
period have been issued:
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No

N/A

Yes
a. Are the segment's operating results presented as discontinued
operations in the income statement/statement of operations of the
not-yet-released financial statements?

b. Is the estimated loss on disposal recognized in the period that
includes the measurement date, if the decision to dispose of the
segment results from a discrete and identifiable event that occurs
unexpectedly after the balance-sheet date?

c. Is the estimated loss on disposal recognized in the period prior to
the measurement date, if the decision to dispose of the segment
does not result from a discrete and identifiable event that occurs
unexpectedly after the balance-sheet date?
[EITF 95-18]
E. Extraordinary Items
1.

Are extraordinary items segregated and shown (including applicable
income taxes) after income before extraordinary items and before net
income?
[APB 30, pars. 10-12 (AC I17.102 and .103)]

★♦2. Are descriptive captions and amounts (including applicable income
taxes) presented for individual extraordinary events or transactions,
preferably on the face of the statement of operations/income state
ment, if practicable?

3.

Do disclosures include descriptions of extraordinary events or trans
actions and the principal items entering into determination of extraor
dinary gains or losses?
[APB 30, par. 11 (AC I17.102)]

4.

For an adjustment of an extraordinary item reported in a prior period
(except for correction of an error):

a. Is the adjustment classified separately as an extraordinary item in
the current period?
b. Are the nature, origin, and amount of the item disclosed?
[SFAS 16, par. 16(c) (AC I17.119)]
F.

Unusual or Infrequent Items
1.

Are material events or transactions that are either unusual in nature
or of infrequent occurrence, but not both (and therefore not meeting
criteria for extraordinary items):

a. Reported as a separate component of income from continuing
operations?
b. Accompanied by disclosure of the nature and financial effects of
each event?
[APB 30, par. 26 (AC I22.101)]
G. Advertising Costs

1.

Do disclosures for advertising costs include:

a. The accounting policy selected from the two alternatives in the
beginning of paragraph 26 of SOP 93-7 for reporting advertising,
indicating whether such costs are expensed as incurred or the first
time the advertising takes place?
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No

N/A

Yes
b. A description of the direct-response advertising reported as assets
(if any), the accounting policy for it, and the amortization period?

____

c. The total amount charged to advertising expense for each state
ment of activities/income statement presented, with separate dis
closure of amounts, if any, representing a write-down to net
realizable value?

____

d. The total amount of advertising reported as assets in each balance
sheet/statement of financial position presented?
[SOP 93-7, par. 49]

____

H. Donated or Contributed Services

★ 1.

If the provider receives contributed services, does it disclose the
following:

a. A description of the programs or activities for which those services
were used, including the nature and extent of contributed services
received for the period and the amount recognized as revenues for
the period?

b. The fair value of contributed services received but not recognized,
if practicable (optional)?

c. Nonmonetary information such as the number and trends of
donated hours received or service outputs provided by volunteer
efforts (optional)?
d. Dollar amount of contributions raised by volunteers (optional)?
[SFAS 116, pars. 10 and 123 (AC C67.110)]
I.

Fund Raising
Note: In September 1993, the AICPA issued an exposure draft of a pro
posed Statement of Position, Accountingfor Costs ofMaterials and Activities
of Not-for-Profit Organizations and Local Government Entities That Include a
Fund-Raising Appeal. The proposed SOP would apply to all not-for-profit
organizations and governmental entities that report expenses by function
and would require reporting the costs of all materials and activities that
include a fund-raising appeal as fund-raising expenses, unless a program
or management and general function has been conducted in conjunction
with the appeal for funds. The disclosure requirements of the exposure
draft of the SOP are not reflected in this checklist. The final SOP is expected
to be issued in the third quarter of 1997.

J.

Contributions/Pledges

★ 1.

★ 2.

Does the provider distinguish between contributions received with
permanent restrictions, those received with temporary restrictions,
and those received without donor-imposed restrictions, so that they
are reported as support increasing permanently restricted net assets,
temporarily restricted net assets, or unrestricted net assets, respec
tively?
[SFAS 116, par. 14 (AC No5.143)]
If donor-restricted contributions whose restrictions are met in the
same reporting period are reported as unrestricted support, is such
treatment consistent from period to period and is the policy disclosed?
[SFAS 117, par. 21; SFAS 116, par. 14 (AC No5.143)]
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____

____

No

N/A

Yes

★3.

Does the provider report receipt of unconditional promises to give
with payments due in future periods as restricted support, unless
explicit donor stipulations or circumstances surrounding the receipt
of the promise make clear that the donor intended the contribution to
be used to support activities of the current period?
[SFAS 116, par. 15 (AC No5.144)]

★4.

Does an entity that receives gifts of long-lived assets without donor
stipulation about how long the donated asset must be used:

a. Disclose its accounting policy of implying or not implying a time
restriction that expires over the useful life of the asset?
b. Report such support as restricted if it is the provider's policy to
imply a time restriction that expires over the useful life of the
donated asset?

c. Report such support as unrestricted in the absence of such a
policy?
[SFAS 116, par. 16 (AC No5.145)]

★5.

Does a provider that receives unconditional promises to give, in
which cash promised will be received in future periods, measure the
fair value of the contribution as the present value of estimated future
cash flows, using a discount rate commensurate with the risks in
volved, and report subsequent accruals of the interest element as
contribution income increasing either the temporarily or permanently
restricted class of net assets if the underlying promise to give is donor
restricted?
[SFAS 116, par. 20 (AC C67.116)]

★ 6.

In discounting unconditional promises to give (as described in Step
5), are the provisions of APB 21 applied?
[SOP 94-2, par. 20]

7.

Are pledges/contributions reported in the period in which they were
made?

★♦8.

Are unrestricted pledges/contributions reported in the statement of
operations?
[AAG, par. 10.08]

K. Expenses

★ 1.

Does the provider provide information about expenses reported by
their functional classification (such as major classes of program serv
ices and supporting services) either in the statement of activities or in
notes to financial statements?
[SFAS 117, par. 26 (AC No5.123)]

★ 2.

For deferred compensation agreements, are estimated amounts to be
paid properly accrued?
[APB 12, pars. 6 and 7 (AC C38.101 and .102)]

L. Wills

★♦1.

If the entity receives a promise to give conditioned on a future
uncertain event that is contained in a will and the will has been
declared valid by the probate court, has the provider disclosed the
conditional promise to give?
[SFAS 116, par. 208]
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No

N/A

Yes

No

N/A

M. Endowments

★ 1.

Does the provider report gains and losses on endowments in the
following manner:

a. As an increase or decrease in permanently restricted net assets if
the governing board has determined that the relevant law requires
the entity to retain permanently some portion of gains on invest
ments?
[SFAS117, pars. 22 and 129 (AC No5.119)]

b. As an increase or decrease in unrestricted or temporarily restricted
net assets, whichever is consistent with the reporting of the en
dowment's income in the absence of such a law noted in Step a.?
[SFAS 117, par. 129 (AC No5.119, fn. 8)]

IV.

____

____

Statement of Cash Flows5
1.

Is a statement of cash flows presented as a basic financial statement
for each period for which both a statement of financial position/bal
ance sheet and a statement of activities/income statement is pre
sented?
[SFAS 95, par. 3, as amended by SFAS 117, par. 30a (AC C25.101);
AAG, par. 1.07]

2.

Does the statement of cash flows show the change in cash and cash
equivalents?
[SFAS 95, par. 7 (AC C25.105)]

3.

Is the policy for defining cash equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]

Note: Any change in policy for determining which items are treated as
cash equivalents is a change in accounting principle.

★♦4.

5.

If the direct method is used, is a separate schedule provided to
reconcile net income of an investor-owned provider or change in net
assets (or excess of revenue and support over expenses) of a not-forprofit provider to net cash flow from operating activities?
[SFAS 95, par. 29, as amended by SFAS 117, par. 30f (AC C25.128)]
If the indirect method is used:

a. Is the same amount for net cash flow from operating activities
reported indirectly by adjusting net income of an investor-owned
provider or change in net assets (or excess of revenue and support
over expenses) of a not-for-profit provider to reconcile it to net
cash flow from operating activities?
[SFAS 95, par. 28, as amended by SFAS 117, par. 30f (AC C25.126)]
5 SFAS 95, Statement of Cash Flows, and GASB Statement 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds and
Governmental Entities That Use Proprietary Fund Accounting, established standards for cash flow reporting for investor-owned
organizations and governmental entities, respectively. SFAS 95 excludes not-for-profit organizations from its scope; however, not-forprofit health care entities should apply the provisions of SFAS 95 to ensure that their financial statements are comparable with those of
investor-owned entities. The statement of cash flows may be prepared using the direct or indirect method of reporting cash flows.
(SFAS 117 amends SFAS 95 to extend its provisions to not-for-profit organizations and to extend its description of cash flows from
financing activities to include certain donor-restricted cash that must be used for long-term purposes.)
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Yes
b. Is the reconciliation of net income of an investor-owned provider
or change in net assets (or excess of revenue and support over
expenses) of a not-for-profit provider to net cash flows from
operating activities reported, either within the statement of cash
flows or provided in a separate schedule, with the statement of
cash flows reporting only the net cash flow from operating activi
ties?
[SFAS 95, par. 30, as amended by SFAS117, par. 30f (AC C25.128)]

6.

Are cash receipts and cash payments from operating activities shown
separately on the statement of cash flows?
[SFAS 95, par. 27 (AC C25.125)]

7.

Are cash receipts and cash payments for the following transactions
classified as cash flows from operating activities:

a. Interest received on loans?
b. Insurance proceeds except those directly related to investing or
financing activities?

c. Interest paid to creditors?
d. Payments to suppliers and employees?

e. Payments to governments for taxes, duties, fines, and other fees
or penalties?
f.

Payments to settle lawsuits?

g. Contributions to charities?
[SFAS 95, pars. 22 and 23 (AC C25.120 and .121); SFAS 115, par. 18
(AC I80.117)]
h. Cash flows from purchases, sales, and maturities of trading secu
rities?
[AAG, par. 4.14]
8.

Are cash receipts and cash payments from investing activities shown
separately on statement of cash flows?
[SFAS 95, par. 31 (AC C25.129)]

9.

Are cash receipts and cash payments for the following transactions
classified as cash flows from investing activities:

a. Receipts from collections or sales of loans?
b. Receipts from sales of property?

c. Loans to others?

d. Payments to acquire property?

e. Purchases of and proceeds from sales of available-for-sale securi
ties?
f.

Proceeds from maturities of available for sale and held-to-matur
ity securities?

g. Purchases of held-to-maturity securities?
[SFAS 95, pars. 16 and 17 (AC C25.114 and .115); SFAS 115, par. 18
(AC I80.117)]
10. Are cash receipts and cash payments from financing activities shown
separately on the statement of cash flows?
[SFAS 95, par. 31 (AC C25.129)]
52

No

N/A

Yes
★♦11. Are cash receipts and cash payments for the following transactions
classified as cash flows from financing activities:
a. Proceeds from issuing debt?

____

b. Repayments for amounts borrowed?
[SFAS 95, pars. 19 and 20 (AC C25.117 and .118)]

____

c. Cash payments for debt issue costs?
[EITF 95-13]

____

★♦ 12. Are investing and financing activities that affect recognized assets or
liabilities but that do not result in cash receipts or cash payments
disclosed?
[SFAS 95, par. 32, as amended by SFAS 117, par. 30g (AC C25.134)]
★♦ 13. In its statement of cash flows, does the organization include in cash
flows from financing activities any amounts received with donor-im
posed stipulations that they must be used for long-term purposes?
[SFAS 117, par. 30c (AC C25.116)]

____

____

★♦ 14. Are the following classes of operating cash receipts and payments for
providers using the direct method, at a minimum, separately dis
closed:

a. Cash received from service recipients?

____

b. Cash received from contributors?

____

c. Interest and dividends received?

____

d. Cash collected on contributions receivables?

____

e. Other operating cash receipts, if any?

____

f.

Cash paid to employees and suppliers?

____

g. Interest paid?

____

h. Income taxes paid?

____

i.

Grants paid?

____

j.

Other operating cash payments, if any?
[SFAS 95, par. 27, as amended by SFAS 117, par. 30e (AC C25.125)]

____

★♦ 15. If the indirect method of reporting cash flows is used, are the amounts
of interest paid (net of amounts capitalized) and income taxes paid
disclosed for each year presented (the reconciliation of net income or
change in net assets or excess of revenue and support over expenses
to net cash provided by or used in operating activities should sepa
rately report all major reconciling items, including at a minimum
changes in receivables, inventory, and payables)?
[SFAS 95, par. 29, as amended by SFAS 117, par. 30f (AC C25.127)]

V. Continuing Care Retirement Communities (CCRCs)
A. Refundable Advance Fees

★♦ 1.

Is the estimated amount of advance fees expected to be refunded to
current residents reported as a liability?
[AAG, par. 14.22]

★♦ 2.

Is the remaining amount of advance fees reported in the balance sheet
as deferred revenue?
[AAG, par. 14.22]
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____

No

N/A

Yes
3.

Are the following disclosed:

a. The gross amount of contractual refund obligations under existing
contracts?
b. The CCRC's refund policy?
[AAG, par. 14.22]

★♦4.

5.

B.

____

Are amounts refunded disclosed in the statement of cash flows as a
financing transaction?
[AAG, par. 14.22]

____

Is the method of accounting, including the amortization method, for
deferred revenue disclosed?
[AAG, par. 14.23]

____

Fees Refundable to Residents Only From Reoccupancy Proceeds of a
Contract Holder's Unit
1.

Are the following reported as deferred revenue:

a. The portion of fees to be paid to current residents or their desig
nees, only to the extent of a contract holder's unit reoccupancy
proceeds, if law and management policy and practice support the
withholding of refunds under this condition?
b. Similar amounts received from new residents in excess of the
amount to be paid to previous residents or their designees?
[AAG, par. 14.25]

C. Nonrefundable Advance Fees
1.

★♦2.

Are nonrefundable advance fees reported as deferred revenue?
[AAG, par. 14.26]
Is unamortized deferred revenue reported as revenue upon a resi
dent's death or contract termination?
[AAG, par. 14.23]

D. Obligation to Provide Future Services and Use of Facilities to Current
Residents

★♦1.

If the obligation to provide future services and use of facilities to
current residents under continuing-care contracts results in a liability,
are the following disclosed:

a. The carrying amount of the liability that is presented at present
value in the financial statements (if not separately disclosed in the
balance sheet/statement of financial position)?
b. The interest rate used to discount that liability?
[AAG, par. 14.31]
E.

____

Costs of Acquiring Initial Continuing-Care Contracts
1.

Are costs of acquiring initial continuing-care contracts capitalized if
they are expected to be recovered from future contract revenues?
[AAG, par. 14.33]

2.

Are continuing-care contract acquisition costs expensed if incurred
after (a) the CCRC is substantially occupied or (b) one year following
completion?
[AAG, par. 14.33]
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____
____

No

N/A

Yes

F.

Other

★♦1.

★♦2.

Do the notes to the financial statements of the CCRC include a
description of the CCRC and the nature of the related continuing-care
contracts entered into by the CCRC?
[AAG, par. 14.35]

Do the notes to the financial statements of the CCRC include the
statutory escrow or similar requirements?
[AAG, par. 14.35]

____

____

Exhibit A
Stock-Based Compensation
♦ 1.

♦2.

♦3.

♦4.

♦5.

If an entity continues to apply APB 25 in accounting for its stock-based
compensation arrangements, is the pro forma net income and, if pre
sented, earnings per share (determined as if the fair value based
method had been applied in measuring compensation cost) disclosed?
[SFAS 123, pars. 11 and 45]
If an entity has one or more stock-based compensation plans, is a
description of the plan(s), including the general terms of awards
under the plan(s), disclosed?
[SFAS 123, par. 46]

Is the information in paragraph 47 of SFAS 123 disclosed for each year
for which an income statement is presented?
[SFAS 123, par. 47a-f]
If an entity grants options under multiple stock-based employee
compensation plans, are the items in paragraph 47 disclosed sepa
rately for different types of awards to the extent that the differences
in the characteristics of the awards make separate disclosure impor
tant to an understanding of the entity's use of stock-based compensa
tion?
[SFAS 123, par. 47]

____

____

____

____

Are the following disclosed for options outstanding at the date of the
latest statement of financial position presented:

a. The range of exercise prices?

____

b. The weighted-average exercise price?

____

c. The weighted-average remaining contractual life?
[SFAS 123, par. 48]

____

♦6.

If the range of exercise prices is wide, are they segregated into ranges?
[SFAS 123, par. 48]

____

♦7.

Are the following disclosed for each range identified in Step 6:

a. The number, weighted-average exercise price, and weighted-av
erage remaining contractual life of options outstanding?
b. The number and weighted-average exercise price of options cur
rently exercisable?
[SFAS 123, par. 48]

55

____
____

No

N/A

FSP Section 11,300
Auditors’ Reports Checklist
.01 This checklist has been developed by the staff of the Accounting and Auditing Publications Team of
the AICPA as a nonauthoritative practice aid.

.02 Explanation of References:

SAS =

AICPA Statement on Auditing Standards

AU =

Reference to section number in AICPA Professional Standards (vol. 1)

SSARS =

AICPA Statements on Standards for Accounting and Review Services

AR =

Reference to section number in AICPA Professional Standards (vol. 2)

.03 Checklist Questionnaire:

Yes
1.

Does the auditor's report include appropriate:

a. Addressee?
[SAS 58, par. 9, as amended by SAS 79 (AU 508.09)]

b. Date (or dual dates) of the report?
[SAS 1, sec. 530.05 (AU 530.05)]
c. A title that includes the word "independent"?
[SAS 58, par. 8a, as amended by SAS 79 (AU 508.08a)]

2.

If the auditor is not independent, is the appropriate disclaimer ex
pressed, regardless of the extent of services provided?
[SAS 26, par. 10 (AU 504.10); SSARS 1, pars. 22 and 38 (AR 100.22 and
38)]

3.

Does the reporting language conform with the auditor's standard
report on:

a. Financial statements of a single year or period?

b. Comparative financial statements?
[SAS 58, par. 8, as amended by SAS 79 (AU 508.08)]

4.

Does the report include appropriate language for the following situ
ations:

a. Only one basic financial statement is presented and there are no
scope limitations?
[SAS 58, pars. 33 and 34, as amended by SAS 79 (AU 508.33 and
.34)]
b. Audited and unaudited financial statements are presented in com
parative form?
[SAS 26, pars. 14-17 (AU 504.14-.17)]
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No

N/A

5.

a. There is substantial doubt about the entity's ability to continue as
a going concern for a reasonable period of time and that conclusion
is expressed through the use of the phrase "substantial doubt
about its (the entity's) ability to continue as a going concern"?
[SAS 64, par. 1 (AU 341.12 and .13)]
b. In a going-concern explanatory paragraph, is conditional lan
guage not used in expressing a conclusion concerning the exist
ence of substantial doubt about the entity's ability to continue as
a going concern?
[SAS 59, as amended by SAS 77, par. 13, fn. 5]
c. There is a material change between periods in accounting princi
ples or in the method of their application?
[SAS 58, pars. 16-18, as amended by SAS 79 (AU 508.16-.18)]
d. In an updated report on comparative financial statements, the
current opinion on the prior period is different from the one
previously expressed?
[SAS 58, pars. 68,69,72, and 73, as amended by SAS 79 (AU 508.68,
.69, .72, and .73)]
e. The prior period financial statements are audited by a predecessor
auditor whose report is not presented?
[SAS 64, par. 2 (AU 508.74)]
f. The auditor's opinion is based in part on the report of another
auditor?
[SAS 1, sec. 543 (AU 543); SAS 58, pars. 12 and 13 (AU 508.12 and
.13)]
g. The financial statements contain a departure from a promulgated
accounting principle when conformity with GAAP would result
in a misleading presentation?
[SAS 58, pars. 14 and 15 (AU 508.14 and .15)]
h. Other information in a document containing audited financial
statements is materially inconsistent with information appearing
in the financial statements?
[SAS 8, par. 4 (AU 550.04)]
i. The auditor decides to emphasize a matter in the report?
[SAS 58, par. 19, as amended by SAS 79 (AU 508.19); Interpretation
38 of SAS 1, sec. 410 (AU 9410.17); Interpretation 1 of SAS 57 (AU
9342.03)]
6.

Yes

No

N/A

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

____

Is an explanatory paragraph (or other explanatory language) added
to the standard report if:

Is a qualified opinion or disclaimer of opinion expressed if scope
limitations preclude application of one or more auditing procedures
considered necessary in the circumstances?1
[SAS 58, pars. 22-27 (AU 508.22-.27); SAS 31, par. 22 (AU 326.23); SAS
19, par. 12 (AU 333.12)]

Note: Consult the Topical Index to the AICPA Professional Standards
under "Scope of Audit—Limitations" for additional references to specific
types of scope limitations that could result in either a qualified or dis
claimer of opinion.
1 This includes when the auditor is unable to obtain sufficient, evidential matter to support management's assertions about the
nature of a matter involving an uncertainty and its presentation or disclosure in the financial statements. [SAS 58, par. 31, as amended
by SAS 79]
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Yes

7.

No

N/A

Is a qualified opinion or adverse opinion expressed if a lack of
conformity with GAAP (including inadequate disclosure) is pre
sent?2
[SAS 58, pars. 35-57 (AU 508.35-.57); SAS 32, par. 3 (AU 431.03)]

Note: Consult the Topical Index to the AICPA Professional Standards
under "Departures from Established Principles," "Adverse Opinions,"
and "Qualified Opinions" for additional references to specific types of
GAAP departures that could result in either a qualified or adverse
opinion.
8.

If a qualified opinion, adverse opinion, or disclaimer of opinion is
expressed, are all the substantive reasons for the opinion or disclaimer
disclosed and is the reporting language appropriately modified?
[SAS 58, pars. 21,59,60, and 62 (AU 508.21, .59, .60, and .62)]

9.

If information accompanies the basic financial statements and audi
tor's report in an auditor-submitted document, does the report on the
accompanying information:
a. State that the audit is performed for the purpose of forming an
opinion on the basic financial statements taken as a whole?
b. Specifically identify the accompanying information?
c. State that the accompanying information is presented for purposes
of additional analysis and is not a required part of the basic
financial statements?

d. State whether the accompanying information is subject to the
auditing procedures applied in the audit of the basic financial
statements and the appropriate expression of opinion or dis
claimer?
[SAS 29, pars. 6-11 (AU 551.06-.11)]
10. Is the reporting form and content of SAS 60, paragraphs 9-19, fol
lowed when communicating internal control related matters noted in
an audit?3
[SAS 60, pars. 9-19 (AU 325.09-.19)]

11. Is the reporting form and content of SAS 72, as amended by SAS 76,
followed for comfort letters submitted to underwriters and other
requesting parties on tax-exempt bond offerings?
[SAS 72, as amended by SAS 76 (AU 634)]
12. If, during a GAAS audit of the financial statements, the auditor
becomes aware that the entity is subject to an audit requirement of
legal, regulatory, or contracted nature not encompassed in the en
gagement, did the auditor consider the client's actions in response to
2 The auditor should express a qualified or an adverse opinion if the auditor concludes that (a) a matter involving a risk or an
uncertainty is not adequately disclosed, (b) the accounting principles used cause the financial statements to be materially misstated
when the inability to make a reasonable estimate raises questions about the appropriateness of the accounting principles used, and (c)
management's estimate is unreasonable and its effect is to cause the financial statements to be materially misstated. [SAS 58, pars.
46-49, as amended by SAS 79]

3 Reportable conditions in internal control structure that have not been corrected must be communicated, preferably in writing, to
senior management and the board of trustees or its audit committee. [SAS 60]
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such requirement including the potential effect on the financial state
ments and the auditor's report?
[SAS 74, par. 23 (AU 801.22 and .23)]
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Yes

No

____

___

N/A

FSP Section 11,400
Auditors' Reports on Audits Performed
Under Government Auditing Standards
and Under OMB Circular A-133 Checklist
NOTE
The single audit policy is currently undergoing a massive overhaul. Several important developments have
already taken place and others continue to be finalized. At the time this checklist went to print, guidance is
still being developed on reporting under the Single Audit Act Amendments of 1996 and OMB Circular A-133.
The new guidance will be effective for fiscal years beginning after June 30,1996.

A brief rundown of four key pieces of guidance which have been or are currently being revised follows:
1. Single Audit Act Amendments of 1996 (1996 Amendments)
Passed July 5,1996

Effective date: Fiscal years beginning after June 30,1996
For more info.:

— Nov. 1996 Journal of Accountancy, "Auditing Federal Awards, a New Approach"
— AICPA Fax Hotline, dial (201) 938-3787 from a fax machine and select document # 402
— Full text available online at http://www.sbaonline.sba.gov/ignet

2. OMB Circular A-133

Proposed revision issued November 5,1996; final document expected to be issued in May, 1997

Effective date: Fiscal years beginning after June 30,1996
Once finalized, final revision available from:
— Federal Register

— OMB fax information line (202) 395-9063, document # 1133
— OMB Internet home page at http://www.whitehouse.gov/WH/EOP/OMB/html/ombhome.html

— Call or write the OMB
3. Compliance Supplement

Provisional supplement expected to be issued in May 1997; final supplement anticipated for 1998.
Auditors should use the provisional supplement until the final supplement is issued.
For more info.:

— AICPA's CPA Letter
— AICPA Internet home page at http://www.aicpa.org
— OMB Internet home page
— Full text available from the Government Printing Office
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4. AICPA Statement of Position (SOP)
As a result of the changes described in 1-3 above, SOP 92-9, Audits ofNot-for-Profit Organizations
Receiving Federal Awards, has become outdated. The AICPA is in the process of developing a new
SOP that will supersede SOP 92-9. It is expected to be issued in late summer 1997 and it will include
guidance on the work performed and reports issued for audits under the 1996 Amendments and
Circular A-133. It will also include simplified illustrative audit reports. The new illustrative
reports will include one report on the financial statements, one that will meet the requirements
for reporting on compliance and internal control under Government Auditing Standards, and one
report that will meet the requirements of the 1996 Amendments and Circular A-133 for reporting
on single audits of federal awards. The AICPA expects to make these illustrative audit reports
available on the AICPA Internet home page and the AICPA Fax Hotline before the final issuance of
the new SOP.

The reporting guidance in the new SOP and illustrative audit reports will be included in section
11,400, as an update to the looseleaf service, as it becomes available. Additionally, it will be
incorporated into the 1998 bound edition of this checklist.
Auditors issuing reports on audits performed under Government Auditing Standards and under
OMB Circular A-133 for fiscal years beginning after June 30,1996 should closely follow develop
ments in this area and look for the illustrative audit reports on the AICPA Internet home page or
the AICPA Fax Hotline.
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FSP Section 11,500
Illustrative Financial Statements
.01 The following illustrative financial statements demonstrate the practical applications of the reporting
practices discussed in the June 1996 AICPA Audit and Accounting Guide Health Care Organizations (the
Guide). The checklists and illustrative financial statements do not include all disclosures and presentation
items promulgated. Pronouncements deemed remote for audits of health care providers are not included in
this document. Specific types of health care organizations have been selected to illustrate a wide diversity of
reporting practices; it is not intended that these illustrations represent either the only types of disclosure or
the only statement formats that would be appropriate. Health care providers are urged to develop financial
statement formats that are appropriate for their individual circumstances while being consistent with the
accounting and reporting practices discussed in the Guide.

The illustrative financial statements have been prepared to reflect accounting literature through FASB
Statement No. 129, AICPA Statement of Position 96-1, EITF Consensuses adopted up to and including the
March 13,1997 EITF meeting, and the May 1997 AICPA Audit and Accounting Guide Health Care Organiza
tions.
This section contains illustrative financial statements for the following types of health care organizations:
•

Not-for-Profit Hospital

•

For-Profit Nursing Home

•

Not-for-Profit Continuing Care Retirement Community

•

Not-for-Profit Home Health Agency

•

Not-for-Profit Health Maintenance Organization

•

Not-for-Profit Ambulatory Care Organization
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The checklists and illustrative financial statements do not include all disclosures
and presentation items promulgated.

ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NOT-FOR-PROFIT HOSPITAL
.02

Sample Not-for-Profit Hospital
Balance Sheets

December 31,19X7 and 19X6
(in thousands)
19X7

19X6

Assets

Current assets:
Cash and cash equivalents
Short-term investments
Assets limited as to use
Patient accounts receivable, net of allowance
for doubtful accounts of $2,500 in 19X7
and $2,400 in 19X6
Other current assets
Total current assets
Assets limited as to use:
Internally designated for capital acquisition
Held by trustee

$

$

15,100
2,670
39,334
12,000
6,949
18,949
(970)
17,979
4,680
320
51,038
1,695

5,877
10,740
1,300

14,194
2,856
34,967

$115,046

12,500
7,341
19,841
(1,300)
18,541
4,680
520
50,492
1,370
$110,570

$

$

Less amount required to meet current obligations

Long-term investments
Long-term investments restricted for capital acquisition
Property and equipment, net
Other assets
Total assets

4,758
15,836
970

Liabilities and Net Assets

Current liabilities:
Current portion of long-term debt
Accounts payable and accrued expenses
Estimated third-party payor settlements
Other current liabilities
Total current liabilities
Long-term debt, net of current portion
Other liabilities
Total liabilities
Net assets:
Unrestricted
Temporarily restricted
Permanently restricted
Total net assets

1,470
5,818
2,143
1,969
11,400
23,144
3,953
38,497
70,846
2,115
3,588

76,549
$115,046

Total liabilities and net assets
See accompanying notes to financial statements.
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1,750
5,382
1,942
2,114
11,188
24,014
3,166
38,368
66,199
2,470
3,533
72,202

$110,570

.03

FORMAT A

Sample Not-for-Profit Hospital
Statements of Operations
Years Ended December 31,19X7 and 19X6

(in thousands)
19X7

19X6

$85,156
11,150
2,601
300

$78,942
10,950
5,212

99,207

95,104

88,521
4,782
1,752
1,000
2,000

80,585
4,280
1,825
1,300
1,300

Total expenses

98,055

89,290

Operating income
Other income:
Investment income

1,152

5,814

3,900

3,025

Excess of revenues over expenses

5,052

8,839

300

375

Unrestricted revenues, gains and other support:
Net patient service revenue
Premium revenue
Other revenue
Net assets released from restrictions used for operations

Total revenues, gains and other support
Expenses:
Operating expenses
Depreciation and amortization
Interest
Provision for bad debts
Other

Change in net unrealized gains and losses on other than
trading securities
Net assets released from restrictions used for purchase of
property and equipment
Contributions from Sample Hospital
Foundation for property acquisitions
Transfers to parent

Increase in unrestricted net assets, before extraordinary item

Extraordinary loss from extinguishment of debt

200
235
(640)
5,147

See accompanying notes to financial statements.
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6,699

(500)

$ 4,647

Increase in unrestricted net assets

485
(3,000)

$ 6,699

.04
FORMAT B

Sample Not-for-Profit Hospital
Statements of Operations
Years Ended December 31,19X7 and 19X6
(in thousands)

Unrestricted revenues, gains and other support:
Net patient service revenue
Premium revenue
Other, primarily investment income
Net assets released from restrictions used for operations

Total revenues, gains and other support

Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Depreciation and amortization
Interest
Provision for bad debts
Other
Total expenses

Excess of revenues, gains, and other support over expenses

Change in net unrealized gains and losses on other than
trading securities
Net assets released from restrictions used for purchase of
property and equipment
Contributions from Sample Hospital
Foundation for property acquisitions
Transfers to parent
Increase in unrestricted net assets, before extraordinary item
Extraordinary loss from extinguishment of debt
Increase in unrestricted net assets

19X7

19X6

$85,156
11,150
6,501
300

$78,942
10,950
8,237

103,107

98,129

53,900
26,532
8,089
4,782
1,752
1,000
2,000

49,938
22,121
8,526
4,280
1,825
1,300
1,300

98,055

89,290

5,052

8,839

300

375

200

235
(640)
5,147
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6,699

(500)

$ 4,647

See accompanying notes to financial statements.

485
(3,000)

$ 6,699

.05

Sample Not-for-Profit Hospital
Statements of Changes in Net Assets
Years Ended December 31,19X7 and 19X6

(in thousands)

Unrestricted net assets:
Excess of revenues over expenses
Net unrealized gains on investments, other than trading
securities
Contributions from Sample Hospital Foundation for
property acquisitions
Transfers to parent
Net assets released from restrictions used for purchase
of property and equipment
Increase in unrestricted net assets before
extraordinary item
Extraordinary loss from extinguishment of debt
Increase in unrestricted net assets

Temporarily restricted net assets:
Contributions for charity care
Net realized and unrealized gains on investments
Net assets released from restrictions
Increase (decrease) in temporarily restricted net assets

19X7

19X6

$ 5,052

$ 8,839

300

375

235
(640)

485
(3,000)

200
5,147
(500)

6,699

4,647

6,699

140
5
(500)

996
8

(355)

1,004

Permanently restricted net assets:
Contributions for endowment funds
Net realized and unrealized gains on investments

50
5

411
2

Increase in permanently restricted net assets

55

413

Increase in net assets

Net assets, beginning of year
Net assets, end of year
See accompanying notes to financial statements.
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4,347

8,116

72,202

64,086

$76,549

$72,202

.06

Sample Not-for-Profit Hospital
Statements of Cash Flows (Indirect Method)
Years Ended December 31,19X7 and 19X6
(in thousands)
Cash flows from operating activities:
Change in net assets
Adjustments to reconcile change in net assets to net
cash provided by operating activities:
Extraordinary loss from extinguishment of debt
Depreciation and amortization
Net realized and unrealized gains on investments,
other than trading
Transfers to parent
Provision for bad debts
Restricted contributions and investment income
received
(Increase) decrease in:
Patient accounts receivable
Trading securities
Other current assets
Other assets
Increase (decrease) in:
Accounts payable and accrued expenses
Estimated third-party payor settlements
Other current liabilities
Other liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of investments
Capital expenditures
Net cash used in investing activities
Cash flows from financing activities:
Transfers to parent
Proceeds from restricted contributions and restricted
investment income
Payments on long-term debt
Payments on capital lease obligations
Proceeds from issuance of long-term debt
Net cash used in financing activities
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

19X7

19X6

$ 4,347

$ 8,116

500
4,782

4,280

(450)
640
1,000

(575)
3,000
1,300

(290)

(413)

(1,906)
215
186
(325)

(2,036)

436
201
(145)
787
9,978

679
305
(257)
(128)
11,549

(3,769)
(4,728)
(8,497)

(2,150)
(5,860)
(8,010)

(640)

(3,000)

290
(24,700)
(150)
22,600
(2,600)
(1,119)
5,877
$ 4,758

413
(804)
(100)
500
(2,991)
548
5,329
$ 5,877

(2,481)
(241)

Supplemental Disclosures of Cash Flow Information:

The Hospital entered into capital lease obligations in the amount of $600,000 for new
equipment in 19X7.
Cash paid for interest (net of amount capitalized) in 19X7 and 19X6 was $1,780,000
and $1,856,000, repectively.

See accompanying notes to financial statements.
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.07

Sample Not-for-Profit Hospital

Notes to Financial Statements
December 31,19X7 and 19X6
1. Description of Organization and Summary of Significant Accounting Policies
Organization. The Sample Not-for-Profit Hospital (the Hospital), located in Tulsa, Oklahoma,
is a not-for-profit acute care hospital. The Hospital provides inpatient, outpatient and emergency
care services for residents of northeastern Oklahoma. Admitting physicians are primarily practi
tioners in the local area. The Hospital was incorporated in Oklahoma in 19X1 and is affiliated with
the Sample Health System.

Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include certain investments in highly
liquid debt instruments with original maturities of three months or less.

The Hospital routinely invests its surplus operating funds in money market mutual funds. These
funds generally invest in highly liquid U.S. government and agency obligations.

Investments. Investments in equity securities with readily determinable fair values and all
investments in debt securities are measured at fair value in the balance sheet. Investment income
or loss (including realized gains and losses on investments, interest and dividends) is included in
the excess of revenues over expenses unless the income or loss is restricted by donor or law.
Unrealized gains and losses on investments are excluded from the excess of revenues over
expenses unless the investments are trading securities.

Assets limited as to use. Assets limited as to use primarily include assets held by trustees under
indenture agreements and designated assets set aside by the Board of Trustees for future capital
improvements, over which the Board retains control and may at its discretion subsequently use
for other purposes. Amounts required to meet current liabilities of the hospital have been
reclassified in the balance sheet at December 31,19X7 and 19X6.
Property and equipment. Property and equipment acquisitions are recorded at cost. Depreciation
is provided over the estimated useful life of each class of depreciable asset and is computed using
the straight-line method. Equipment under capital lease obligations is amortized on the straightline method over the shorter period of the lease term or the estimated useful life of the equipment.
Such amortization is included in depreciation and amortization in the financial statements.
Interest cost incurred on borrowed funds during the period of construction of capital assets is
capitalized as a component of the cost of acquiring those assets.

Gifts of long-lived assets such as land, buildings, or equipment are reported as unrestricted
support, and are excluded from the excess of revenues over expenses, unless explicit donor
stipulations specify how the donated assets must be used. Gifts of long-lived assets with explicit
restrictions that specify how the assets are to be used and gifts of cash or other assets that
must be used to acquire long-lived assets are reported as restricted support. Absent explicit
donor stipulations about how long those long-lived assets must be maintained, expirations of
donor restrictions are reported when the donated or acquired long-lived assets are placed in
service.
69

Temporarily and permanently restricted net assets. Temporarily restricted net assets are those
whose use by the Hospital has been limited by donors to a specific time period or purpose.
Permanently restricted net assets have been restricted by donors to be maintained by the Hospital
in perpetuity.

Excess of revenues over expenses. The statement of operations includes excess of revenues over
expenses. Changes in unrestricted net assets which are excluded from excess of revenues over
expenses, consistent with industry practice, include unrealized gains and losses on investments
other than trading securities, permanent transfers of assets to and from affiliates for other than goods
and services, and contributions of long-lived assets (including assets acquired using contributions
which by donor restriction were to be used for the purposes of acquiring such assets).
Net patient service revenue. The Hospital has agreements with third-party payors that provide
for payments to the Hospital at amounts different from its established rates. Payment arrange
ments include prospectively determined rates per discharge, reimbursed costs, discounted
charges, and per diem payments. Net patient service revenue is reported at the estimated net
realizable amounts from patients, third-party payors, and others for services rendered, including
estimated retroactive adjustments under reimbursement agreements with third-party payors.
Retroactive adjustments are accrued on an estimated basis in the period the related services are
rendered and adjusted in future periods as final settlements are determined.

Premium revenue. The Hospital has agreements with various Health Maintenance Organiza
tions (HMOs) to provide medical services to subscribing participants. Under these agreements,
the Hospital receives monthly capitation payments based on the number of each HMO's participants,
regardless of services actually performed by the Hospital. In addition, the HMOs make fee-for-service
payments to the Hospital for certain covered services based upon discounted fee schedules.
Charity care. The Hospital provides care to patients who meet certain criteria under its charity care
policy without charge or at amounts less than its established rates. Because the Hospital does not
pursue collection of amounts determined to qualify as charity care, they are not reported as revenue.

Donor-restricted gifts. Unconditional promises to give cash and other assets to the Hospital are
reported at fair value at the date the promise is received. Conditional promises to give and
indications of intentions to give are reported at fair value at the date the gift is received. The gifts
are reported as either temporarily or permanently restricted support if they are received with
donor stipulations that limit the use of the donated assets. When a donor restriction expires, that
is, when a stipulated time restriction ends or purpose restriction is accomplished, temporarily
restricted net assets are reclassified as unrestricted net assets and reported in the statement of
operations as net assets released from restrictions. Donor-restricted contributions whose restric
tions are met within the same year as received are reported as unrestricted contributions in the
accompanying financial statements.
Estimated malpractice costs. The provision for estimated medical malpractice claims includes
estimates of the ultimate costs for both reported claims and claims incurred but not reported.

Income taxes. The Hospital is a not-for-profit corporation and has been recognized as tax-ex
empt pursuant to Sec. 501(c)(3) of the Internal Revenue Code.
2. Net Patient Service Revenue

The Hospital has agreements with third-party payors that provide for payments to the Hospital
at amounts different from its established rates. A summary of the payment arrangements with
major third-party payors follows:
•

Medicare. Inpatient acute care services rendered to Medicare program beneficiaries are
paid at prospectively determined rates per discharge. These rates vary according to a pa70

tient classification system that is based on clinical, diagnostic, and other factors. Inpatient
nonacute services, certain outpatient services, and defined capital and medical education
costs related to Medicare beneficiaries are paid based on a cost reimbursement methodol
ogy. The Hospital is reimbursed for cost reimbursable items at a tentative rate with final
settlement determined after submission of annual cost reports by the Hospital and audits
thereof by the Medicare fiscal intermediary. Beginning in 19X3, the Hospital claimed
Medicare payments based on an interpretation of certain "disproportionate share" rules.
The intermediary disagreed and declined to pay the excess reimbursement claimed under
that interpretation. Through 1996, the Hospital has not included the claimed excess in net
patient revenues pending resolution of the matter. In 19X7, the intermediary accepted the
claims and paid the outstanding claims, including $950,000 applicable to 19X6 and $300,000
applicable to 19X5 and prior, which has been included in 19X7 net revenues.

•

Medicaid. Inpatient and outpatient services rendered to Medicaid program beneficiaries
are reimbursed under a cost reimbursement methodology. The Hospital is reimbursed at
a tentative rate with final settlement determined after submission of annual cost reports
by the Hospital and audits thereof by the Medicaid fiscal intermediary.

The Hospital also has entered into payment agreements with certain commercial insurance
carriers, health maintenance organizations, and preferred provider organizations. The basis for
payment to the Hospital under these agreements includes prospectively determined rates per
discharge, discounts from established charges, and prospectively determined daily rates.

3. Investments

Assets Limited as to Use
The composition of assets limited as to use at December 31,19X7 and 19X6, is set forth in the
following table. Investments are stated at fair value.

19X7
Internally designated for capital acquisition:
Cash
U.S. Treasury obligations
Interest receivable
Held by trustee under indenture agreement:
Cash and short-term investments
U.S. Treasury obligation
Interest receivable

$

545,000
11,435,000
20,000
12,000,000

352,000
6,505,000
92,000
6,949,000
$18,949,000

19X6
$

350,000
12,115,000
35,000
12,500,000

260,000
7,007,000
74,000
7,341,000
$19,841,000

Other Investments
Other investments, stated at fair value, at December 31,19X7 and 19X6, include:

Trading:
U.S. Corporate Bonds
Other:
U.S. Treasury obligations
Interest receivable
Less:
Long-term investments
Long-term investments restricted for capital
acquisitions
Short-term investments
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19X7

19X6

$ 1,260,000

$ 1,475,000

$19,266,000
310,000
20,836,000

$14,233,000
232,000
15,940,000

4,680,000

4,680,000

320,000
$15,836,000

520,000
$10,740,000

Investment income and gains for assets limited as to use, cash equivalents, and other invest
ments are comprised of the following for the years ending December 31,19X7 and 19X6:
Income:
Interest income
Realized gains on sales of securities
Unrealized gains on trading securities

Other Changes in Unrestricted Net Assets:
Unrealized gains on other than trading securities

19X7

19X6

$3,585,000
150,000
165,000
$3,900,000

$2,725,000
200,000
100,000
$3,025,000

$ 300,000

$ 375,000

Property and Equipment

A summary of property and equipment at December 31,19X7 and 19X6, follows:
Land
Land improvements
Buildings and improvements
Equipment
Equipment under capital lease obligations

Less accumulated depreciation and amortization
Construction in progress
Property and equipment, net

19X7
$ 3,000,000
472,000
46,852,000
29,190,000
2,851,000
82,365,000
34,928,000
47,437,000
3,601,000
$51,038,000

19X6
$ 3,000,000
472,000
46,636,000
26,260,000
2,752,000
79,120,000
30,661,000
48,459,000
2,033,000
$50,492,000

Depreciation expense for the years ended December 31,19X7 and 19X6 amounted to approxi
mately $4,782,000 and $4,280,000. Accumulated amortization for equipment under capital lease
obligations was $689,000 and $453,000 at December 31,19X7 and 19X6, respectively. Construction
contracts of approximately $7,885,000 exist for the remodeling of Hospital facilities. At December
31,19X7, the remaining commitment on these contracts approximated $4,625,000.

Long-Term Debt
A summary of long-term debt and capital lease obligations at December 31, 19X7 and 19X6,
follows:
19X7

7.25 percent 19X7 Tax-Exempt Revenue Bonds, principal mat
uring in varying annual amounts, due November 1, 20XX,
collateralized by a pledge of the Hospital's gross receipts

$21,479,000

8.50 percent 19X2 Tax-Exempt Revenue Bonds, principal
maturing in varying annual amounts, due June 1,19XX
7.75 percent mortgage loan, principal maturing in varying
annual amounts, due January 20XX, collateralized by a
mortgage on certain property and equipment

7.75 percent note payable, payable in monthly installments
of $12,000, including interest, due March 19XX, unsecured
Capital lease obligations, at varying rates of imputed interest from
6.8 percent to 9.3 percent collateralized by leased equipment
Less current portion
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19X6

$22,016,000

2,010,000

2,127,000

125,000

671,000

1,000,000

950,000

24,614,000
1,470,000

25,764,000
1,750,000

$23,144,000

$24,014,000

Under the terms of the 19X7 and 19X2 revenue bond indentures, the Hospital is required to
maintain certain deposits with a trustee. Such deposits are included with assets limited as to use.
The revenue note indenture also places limits on the incurrence of additional borrowings and
requires that the Hospital satisfy certain measures of financial performance as long as the notes
are outstanding.
Scheduled principal repayments on long-term debt and payments on capital lease obligations
are as follows:
Year Ending
December 31,

Long-Term
Debt

19X8
19X9
20Y0
20Y1
20Y2
Thereafter

$

Capital Leases

970,000
912,000
983,000
1,060,000
1,143,000
18,546,000

$ 550,000
260,000
260,000
45,000
—
—

$23,614,000

1,115,000

Less amount representing interest under
capital leases obligations

115,000

$1,000,000

A summary of interest cost and investment income on borrowed funds held by the trustee under
the 19X7 and 19X2 revenue bond indentures during the years ended December 31,19X7 and 19X6,
follows:

Interest cost:
Capitalized
Charged to operations

Total
Investment income:
Capitalized
Credited to other revenue

Total

19X7

19X6

$ 740,000
1,752,000

$ 700,000
1,825,000

$2,492,000

$2,525,000

$ 505,000
330,000

$ 663,000
386,000

$ 835,000

$1,049,000

6. Temporarily and Permanently Restricted Net Assets
Temporarily restricted net assets are available for the following purposes or periods at Decernber 31,19X7 and 19X6:

Health care services
Purchase of equipment
Indigent care
Health education
For periods after December 31,19X9
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19X7

19X6

$ 320,000
840,000
350,000
605,000

$ 520,000
950,000
400,000
600,000

$2,115,000

$2,470,000

Permanently restricted net assets at December 31,19X7 and 19X6, are restricted to:
Investments to be held in perpetuity, the income
from which is expendable to support health care
services (reported as operating income)
Endowment requiring income to be added to
original gift until fund value is $1,500,000

19X7

19X6

$2,973,000

$2,923,000

615,000
$3,588,000

610,000
$3,533,000

During 19X7, net assets were released from donor restrictions by incurring expenses satisfying
the restricted purposes of indigent care and health care education in the amounts of $250,000 and
$50,000, respectively.

7. Medical Malpractice Claims
The Hospital purchases professional and general liability insurance to cover medical malprac
tice claims. There are known claims and incidents that may result in the assertion of additional
claims, as well as claims from unknown incidents that may be asserted arising from services
provided to patients. The Hospital has employed independent actuaries to estimate the ultimate
costs, if any, of the settlement of such claims. Accrued malpractice losses have been discounted
at 7 percent and in management's opinion provide an adequate reserve for loss contingencies.
On March 15,19X7, a patient filed a suit against the Hospital for malpractice during care received
as an inpatient. The Hospital believes it has meritorious defenses against the suit; however, the
ultimate resolution of the matter could result in a loss. The patient has claimed $16 million in
actual damages. Under state law, punitive damages are determined at trial. The Hospital main
tains insurance coverage for malpractice claims. The coverage does not include punitive damages
awards. Trial is scheduled to occur within the next year.

8. Pension Plan
The Hospital has a defined benefit pension plan covering substantially all of its employees. The
plan benefits are based on years of service and the employees' compensation during the last five
years of covered employment. Contributions are intended to provide not only for benefits
attributed to service to date but also for those expected to be earned in the future.

The actuarially computed net periodic pension cost for 19X7 and 19X6 included the following
components:
19X7
19X6
Service cost—benefits earned during the period
Interest cost on projected benefit obligation
Actual return on plan assets
Net amortization and deferral

$905,000
700,000
(950,000)
70,000

$770,000
650,000
(800,000)
80,000

Net periodic pension cost

$725,000

$700,000

Assumptions used in accounting for net periodic pension cost were as follows:
At December 31,
Discount rates
Rates of increase in compensation levels
Expected long-term rate of return on assets
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19X7

19X6

7.0%
6.0
8.0

7.0%
6.0
8.0

The following table sets forth the plan's funded status and amounts recognized in the Hospital's
financial statements at December 31,19X7 and 19X6:
19X7
19X6
Actuarial present value of benefit obligations:
$ 8,020,000 $6,800,000
Vested benefit obligation
1,930,000
1,900,000
Nonvested benefit obligation
8,730,000
9,920,000
Accumulated benefit obligation
980,000
1,000,000
Effect of projected future compensation levels
9,710,000
10,920,000
Projected benefit obligation
Plan assets at fair value (primarily listed stocks
9,800,000
11,050,000
and U.S. bonds)
130,000
90,000
Plan assets in excess of projected benefit obligation
Unrecognized net gain from past experience
(40,000)
(30,000)
different from that assumed
Prior service cost not yet recognized in net
50,000
55,000
periodic pension cost
(20,000)
(15,000)
Unrecognized net asset being recognized over 15 years
Prepaid pension cost, included in other assets
$ 135,000 $ 85,000
in the accompanying balance sheets

9. Postretirement Plans

The Hospital sponsors two defined benefit postretirement plans that cover both salaried and
nonsalaried employees. One plan provides medical and dental benefits, and the other provides
for the payment of life insurance premiums. The postretirement health care plan is contributory,
with retiree contributions adjusted annually; the life insurance plan is noncontributory. The
accounting for the health care plan anticipates future cost-sharing changes to the written plan
that are consistent with the Hospital's expressed intent to increase retiree contributions each year
to 50 percent of the excess of the expected general inflation rate over 6 percent. On July 24,19X6,
the Hospital amended its postretirement health care plan to provide vision coverage. Beginning
in 19X7, the Hospital adopted a funding policy for its postretirement health care plan similar to
its funding policy for its life insurance plan—an amount equal to a level percentage of the
employees' salaries is contributed to the plan annually. For 19X7, that percentage was 4.25, and
the aggregate contribution for both plans was $34,000.
The following table sets forth the plans' combined funded status reconciled with the amount
shown in the Hospital's balance sheet at December 31,19X7 and 19X6:
19X6
19X7
Accumulated postretirement benefit obligation:
Retirees
$(195,000) $(187,000)
Fully eligible active plan participants
(105,000)
(100,000)
Other active plan participants
(310,000)
(297,400)
(610,000)
(584,400)
Plan assets at fair value (primarily listed stocks and
U.S. bonds)
100,000
87,960
Accumulated postretirement benefit obligation in
(510,000)
(496,440)
excess of plan assets
Unrecognized net gain from past experience different
from that assumed and from changes in assumptions
(40,000)
(30,000)
Prior service cost not yet recognized in net periodic
postretirement benefit cost
16,000
19,000
Unrecognized transition obligation
445,500
470,250
Accrued postretirement benefit cost, included in
other current liabilities in the accompanying
balance sheets
$ (78,500) $ (47,190)
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Net periodic postretirement benefit cost for 19X7 and 19X6 include the following components:

Service cost—benefits attributed to service
during the period
Interest cost on accumulated postretirement
benefit obligation
Actual return on plan assets
Amortization of transition obligation over
20 years
Net amortization and deferral
Net periodic postretirement benefit cost

19X7

19X6

$14,500

$15,000

50,000
(4,500)

44,400
(3,960)

24,750
1,000

24,750
1,000

$85,750

$81,190

For measurement purposes, a 7 percent annual rate of increase in the per capita cost of covered
health care benefits was assumed for 19X8; the rate was assumed to decrease gradually to 5 percent
over the next five years and remain at that level thereafter. The health care cost trend rate
assumption has the assumed health care cost trend rates increasing by one percentage point in
each year. This would increase the accumulated postretirement benefit obligation as of December
31,19X7, by $73,000 and the aggregate of the service and interest cost components of net periodic
postretirement benefit cost for the year then ended by $13,000.

The weighted-average discount rate used in determining the accumulated postretirement
benefit obligation was 7 percent. The expected long-term rate of return on plan assets after
estimated taxes was 6.6 percent. The rate of increase in compensation used for the life insurance
plan was 4 percent.
10. Concentrations of Credit Risk

The Hospital grants credit without collateral to its patients, most of whom are local residents
and are insured under third-party payor agreements. The mix of receivables from patients and
third-party payors at December 31,19X7 and 19X6, was as follows:
Medicare
Medicaid
Blue Cross
Other third-party payors
Patients

19X7

19X6

51%
17
18
7
__ 7

53%
14
17
9
7

100%

100%

11. Commitments and Contingencies

Operating leases. The Hospital leases various equipment and facilities under operating leases
expiring at various dates through April 20X2. Total rental expense in 19X7 and 19X6 for all
operating leases was approximately $859,000 and $770,000, respectively.

The following is a schedule by year of future minimum lease payments under operating leases
as of December 31,19X7, that have initial or remaining lease terms in excess of one year.
Year Ending
December 31,

Amount

19X8
19X9
20Y0
20Y1
20Y2

$517,000
506,000
459,000
375,000
343,000
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Litigation. The Hospital is involved in litigation and regulatory investigations arising in the
course of business. After consultation with legal counsel, management estimates that these
matters will be resolved without material adverse effect on the Hospital's future financial position
or results from operations.

Allowance for doubtful accounts. Beginning in 19X5, the Hospital has provided care under an
agreement with Associated HMO. The HMO currently owes the Hospital $950,000, substantially
all of which is overdue. The Hospital has notified the HMO that further services under the contract
cannot be provided without payment on the outstanding balance. The HMO has assured the
Hospital that additional funds are being obtained in order to pay the overdue balance and
continue service under the agreement, however, if the HMO is unable to make payments,
additional allowances for bad debts would need to be accrued.

12. Extraordinary Loss

In 19X7, the Hospital advance refunded its 19X2 Revenue Bonds in the amount of $22 million
by issuing 19X7 Revenue Bonds. As a result of this in-substance defeasance transaction, an
extraordinary loss totaling $500,000 was recorded. As of December 31, 19X7, $21 million of
advance refunded bonds, which are considered extinguished, remain outstanding.
13. Related Party Transactions

During the years ended December 31,19X7 and 19X6, the Hospital contributed capital to Sample
Health System, an affiliate with some board members in common with the Hospital, in the
amounts of $640,000 and $3 million, respectively.
The Sample Hospital Foundation (the Foundation), which is controlled by Sample Health
System, was established to solicit contributions from the general public and to support the
Hospital. Funds are distributed to the Hospital as determined by the Foundation's Board of
Directors. A summary of the foundation's assets, liabilities, net assets, results of operations, and
changes in net assets follows.

December 31,

19X6

19X7

$521,000

$472,000

11,000
510,000

10,000
462,000

Total liabilities and net assets

$521,000

$472,000

Support and revenue
Expenses
Distributions to Sample Hospital for property acquisitions
Other

$269,000

$535,000

235,000
13,000

485,000
16,000

248,000

501,000

21,000
27,000
462,000

34,000
17,000
411,000

$510,000

$462,000

Assets, principally cash and cash equivalents
Liabilities
Net assets

Total expenses

Excess of support and revenue over expenses
Other changes in net assets
Net assets, beginning of year
Net assets, end of year

Liabilities include $10,000 payable at the end of each year to Sample Hospital. These amounts
were paid after the end of each year.
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14. Functional Expenses
The Hospital provides general health care services to residents within its geographic location.
Expenses related to providing these services are as follows (in thousands):
December 31,
19X7
19X6
$86,000 $78,647
12,055
10,643
$98,055 $89,290

Health care services
General and administrative

15. Fair Value of Financial Instruments

The following methods and assumptions were used by the Hospital in estimating the fair value
of its financial instruments:
Cash and cash equivalents: The carrying amount reported in the balance sheet for cash and cash
equivalents approximates its fair value.
Investments: Fair values, which are the amounts reported in the balance sheet, are based on
quoted market prices, if available, or estimated using quoted market prices for similar securi
ties.
Assets limited as to use: These assets consist primarily of cash and short-term investments and
interest receivable. The carrying amount reported in the balance sheet is fair value.

Accounts payable and accrued expenses: The carrying amount reported in the balance sheet for
accounts payable and accrued expenses approximates its fair value.

Estimated third-party payor settlements: The carrying amount reported in the balance sheet for
estimated third-party payor settlements approximates its fair value.

Long-term debt: Fair values of the Hospital's revenue notes are based on current traded value.
The fair value of the Hospital's remaining long-term debt is estimated using discounted cash
flow analyses, based on the Hospital's current incremental borrowing rates for similar types
of borrowing arrangements.

The carrying amounts and fair values of the Hospital's financial instruments at December 31,19X7
and 19X6, are as follows (In thousands):
19X7
Carrying
Amount
Fair Value

Cash and cash equivalents
Short-term investments
Assets limited as to use
Long-term investments
Long-term investments restricted
for capital acquisition
Accounts payable and
accrued expenses
Estimated third-party
payor settlements
Long-term debt

19X6

Carrying
Amount

Fair Value

$ 4,758
15,836
18,949
4,680

$ 4,758
15,836
18,949
4,680

$ 5,877
10,740
19,841
4,680

$ 5,877
10,740
19,841
4,680

320

320

520

520

5,818

5,818

5,382

5,382

2,143
24,614

2,143
23,980

1,942
25,764

1,942
24,918

16. Promises to Contribute

At December 31,19X7, the Hospital had received $1,500,000 of conditional promises to contrib
ute to the building of a new facility for outpatient services. These contributions will be recorded
as temporarily restricted support when received. The Hospital had no material outstanding
unconditional promises of support at December 31,19X7.
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17. Charity Care
The amount of charges foregone for services and supplies furnished under the Hospital's charity
care policy aggregated approximately $4,500,000 and $4,100,000 in 19X7 and 19X6, respectively.

18. Subsequent Event
On February 9,19X8, the Hospital signed a contract in the amount of $1,050,000 for the purchase
of certain real estate.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NURSING HOME

Sample For-Profit Nursing Home, Inc.
Balance Sheets

December 31,19X5 and 19X4
19X5

Assets
Current assets:
Cash and cash equivalents
Investments
Assets limited as to use
Patient accounts receivable, net of allowance
for doubtful accounts of $6,700 in 19X5 and
$5,300 in 19X4
Estimated third-party payor settlements
Interest receivable
Supplies
Prepaid expenses
Deferred tax asset
Total current assets
Assets limited as to use, net of amount required
for current liabilities
Property and equipment:
Land
Land improvements
Buildings
Furniture, fixtures, and equipment
Less accumulated depreciation
Property and equipment, net
Other assets
Total assets

Liabilities and Shareholders' Equity
Current liabilities:
Current maturities of long-term debt
Accounts payable
Accrued expenses
Deposits from patients
Other current liabilities
Total current liabilities
Deferred tax liability
Long-term debt, net of current maturities
Shareholders' equity:
Common stock, $20 par value; authorized
5,000 shares; issued and outstanding
3,500 shares
Retained earnings
Total shareholders' equity
Total liabilities and shareholders' equity
See accompanying notes to financial statements.
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$

19X4

95,000
150,000
50,000

$ 129,000

162,000
71,000
7,000
47,000
3,000
12,000
597,000

152,000
62,000
43,000
2,000
14,000
452,000

173,000

150,000

205,000
37,000
1,399,000
228,000
1,869,000
210,000
1,659,000
150,000
$2,579,000

205,000
32,000
1,399,000
189,000
1,825,000
141,000
1,684,000
127,000
$2,413,000

$

$

50,000
78,000
175,000
50,000
74,000
427,000
6,000
1,700,000

70,000
376,000
446,000
$2,579,000

50,000

50,000
52,000
188,000
45,000
15,000
350,000
14,000
1,750,000

70,000
229,000
299,000
$2,413,000

.09

Sample For-Profit Nursing Home, Inc.
Statements of Income and Retained Earnings

Years Ended December 31,19X5 and 19X4

Revenue:
Net patient service revenue
Other revenue
Interest on investments held by trustee
Total revenue

Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest
Total expenses

Operating income
Nonoperating income:
Other interest income

19X5

19X4

$2,163,000
67,000
13,000

$1,949,000
22,000
7,000

2,243,000

1,978,000

969,000
511,000
216,000
92,000
69,000
164,000

919,000
499,000
176,000
83,000
57,000
172,000

2,021,000

1,906,000

222,000

72,000

5,000

Income before provision for income taxes
Provision for income taxes

Net income
Retained earnings, beginning of year

Retained earnings, end of year
See accompanying notes to financial statements.

81

227,000

72,000

80,000

29,000

147,000

43,000

229,000

186,000

$ 376,000

$ 229,000
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Sample For-Profit Nursing Home, Inc.

Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
Cash flows from operating activities:
Cash received from residents and third-party payors
Cash received from others
Cash paid to employees and suppliers
Interest and dividends received
Interest paid
Taxes paid
Deposits received from patients
Deposits refunded to patients

19X5

19X4

$2,019,000
67,000
(1,679,000)
10,000
(160,000)
(29,000)
35,000
(30,000)

$1,796,000
22,000
(1,495,000)
10,000
(170,000)
(30,000)
15,000
(20,000)

Net cash provided by operating activities

233,000

Cash flows from investing activities:
Purchase of investments
Proceeds from sale of property
Capital expenditures
Purchase of assets limited as to use
Net cash used in investing activities

128,000

(150,000)
2,000
(79,000)

(44,000)
(23,000)

Cash flows from financing activities:
Repayment of long-term debt

Net cash used in financing activities

(217,000)

(77,000)

(50,000)

(50,000)

(50,000)

(50,000)

Net increase (decrease) in cash and cash equivalents

(34,000)

1,000

Cash and cash equivalents, beginning of year

129,000

128,000

95,000

$ 129,000

Cash and cash equivalents, end of year

$

Reconciliation of net income to net cash
provided by operating activities:

Net income
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation
Provision for bad debts
Loss on sale of property
Change in deferred income taxes
(Increase) decrease in:
Patient accounts receivable
Other current assets
Estimated third-party payor settlements
Interest receivable
Other assets
Increase (decrease) in:
Accounts payable and accrued expenses
Deposits from patients
Other current liabilities

Net cash provided by operating activities
See accompanying notes to financial statements.
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$ 147,000

$

43,000

69,000
92,000
—
(6,000)

57,000
83,000
11,000
(14,000)

(102,000)
(21,000)
(9,000)
(7,000)
(7,000)

(41,000)
(15,000)
(10,000)
(3,000)
(10,000)

13,000
5,000
59,000

43,000
(5,000)
(11,000)

$ 233,000

$ 128,000
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Sample For-Profit Nursing Home, Inc.
Notes to Financial Statements

December 31,19X5 and 19X4
1. Description of Organization and Summary of Significant Accounting Policies
Organization. The Sample Nursing Home, Inc. (the Company) was incorporated in New State
in 19X1 and operates a 128-bed nursing home in Abacus, New State. A summary of the Company's
significant accounting policies follows:
Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in highly liquid debt
instruments with an original maturity of three months or less, excluding amounts whose use is
limited by note indenture.

Investments. Investments in debt instruments, including assets limited as to use, are classified
as held-to-maturity because the Company has the positive intent and ability to hold the securities
until maturity. Held-to-maturity securities are carried at cost adjusted for amortization of premi
ums and accretion of discounts.
Assets limited as to use. Assets deposited with a trustee under terms of the note indenture and assets
set aside by the Board of Directors for capital improvements are classified as assets limited as to use.
Amounts required to meet current liabilities have been reclassified in the balance sheet.

Property and equipment. Property and equipment are recorded at cost. Depreciation is calculated
on the straight-line method over the estimated useful lives of depreciable assets.

Bond issuance costs. Costs incurred in issuing the Series 19X1 bonds are being amortized based
on the effective interest method.
Net patient service revenue. Net patient service revenue is reported at the estimated net realizable
amounts from residents, third-party payors, and others for service rendered.

Revenue under third-party payor agreements is subject to audit and retroactive adjustment.
Provisions for estimated third-party payor settlements are provided in the period the related
services are rendered. Differences between the estimated amounts accrued and interim and final
settlements are reported in operations in the year of settlement.

Income taxes. The provisions for income taxes are based on amounts estimated to be currently
payable and those deferred because of temporary differences between the financial statement and tax
bases of assets and liabilities. These differences consist principally of bad debts and depreciation.
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2. Assets Limited as to Use
Assets limited as to use include:

Assets held by trustee under the Series 19X1 note indenture agreement
at December 31,19X5 and 19X4.

19X5
U.S. Government obligations
Cash
Accrued interest income

$150,000
24,000
2,000
176,000

19X4
$130,000
21,000
2,000
153,000

$ 45,000
2,000
47,000
$223,000

$ 45,000
2,000
47,000
$200,000

Internally designated by the Board of
Directors for capital improvements
Certificate of deposit
Accrued interest

3.

Investments
The amortized cost and approximate fair value of held-to-maturity securities at December 31
19X5 and 19X4, are as follows:
December 31,19X5
Gross
Gross
Unrealized
Unrealized
Gains
(Losses)

Amortized
Cost

U.S. Treasury obligations
U.S. Government agency
obligations
Other debt securities

$150,000

83,000
67,000
$300,000

Approximate
Fair Value

$11,000

$(16,000)

$145,000

$11,000

(7,000)
(18,000)
$(41,000)

76,000
49,000
$270,000

December 31,19X4

Gross
Unrealized
Gains

Amortized
Cost
U.S. Treasury obligations
U.S. Government agency
obligations

$103,000

$

27,000
$130,000

2,000
$2,000

Gross
Unrealized
(Losses)

Approximate
Fair Value

$(10,000)

$ 93,000

$(10,000)

29,000
$122,000

Maturities of held-to-maturity securities at December 31,19X5, are as follows:

Amortized
Cost

One year or less
After one through five years
After five through ten years
After ten years
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Approximate
Fair Value

$131,000
31,000
68,000
70,000

$126,000
29,000
62,000
53,000

$300,000

$270,000

4. Long-Term Debt
Long-term debt at December 31,19X5 and 19X4, was as follows:

9.5 percent bonds payable to the City
of Abacus, maturing $50,000 annually
through November 1,19YY, with a
final maturity of $1 million on
November 1,19YY
Less current maturities

19X5

19X4

$1,750,000
50,000

$1,800,000
50,000
$1,750,000

$1,700,000

The notes are collateralized by a first-mortgage lien on all property and equipment of the
Company and a security interest in all of its receipts. The note indenture requires the maintenance
of certain deposits with a trustee, which are included in assets limited as to use.

Future maturities of long-term debt as of December 31,19X5, follow:
Year ending December 31,

Amount

$

50,000
50,000
50,000
50,000
50,000
1,500,000
$1,750,000

19X6
19X7
19X8
19X9
19Y0
Thereafter
Total
Income Taxes

The provisions for income taxes are as follows:
Current:
Federal
State
Total current

Deferred:
Federal
State
Total deferred
Total provision for income taxes

19X5

19X4

$72,000
2,000
74,000

$15,000

6,000

13,000
1,000
14,000
$29,000

6,000
$80,000

15,000

Deferred income taxes are provided for the temporary differences between the financial report
ing basis and the tax basis of the Company's assets and liabilities.
For the years ended December 31, 19X5 and 19X4, the effective tax rate approximated the
statutory rate of 34 percent and 40 percent, respectively.

The net current and noncurrent components of deferred income taxes recognized in the balance
sheet at December 31,19X5 and 19X4, follows:
19X5
19X4
Net current assets
$12,000
$14,000
Net noncurrent liabilities
6,000
14,000
$ 6,000

$_____ 0

Management has determined that no valuation allowance related to deferred tax assets is
necessary at December 31,19X5 and 19X4, respectively.
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6. Concentration in State Medicaid Program

The Company has 100 of its 128 beds designated for care of patients under the state's Medicaid
program. The current funding of that program is 90 days behind filed claims. The current state
budget has no provision for reducing that lag and, while the proposed budget for 19X6 includes
additional funding, there is no assurance that the final budget will include the needed additional
funds.
7. Risks and Uncertainties Disclosures
*
8. Pension Plan
*

9. Postretirement Benefits
*
10. Fair Values of Financial Instruments
*
11. Concentrations of Credit Risk
*

*The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS
FOR A CONTINUING CARE RETIREMENT COMMUNITY
.12

Sample Not-for-Profit Continuing Care Retirement Community

Balance Sheets
December 31,19X5 and 19X4
19X4

19X5

Assets
Current assets:
Cash
Assets limited as to use
Accounts receivable, net of allowance for
doubtful accounts of $4,000 in 19X5 and
$5,000 in 19X4
Supplies
Prepaid expenses

$

$

330,000
170,000

187,000
40,000
115,000

197,000
21,000
73,000

982,000

791,000

1,865,000
14,893,000

1,583,000
15,280,000

83,000

90,000

$17,823,000

$17,744,000

$

$

Total current assets

Assets limited as to use, net of amount required
for current liabilities
Property and equipment, net
Deferred financing costs, net of accumulated
amortization of $28,000 in 19X5 and
$21,000 in 19X4
Total assets

375,000
265,000

Liabilities and Net Assets
Liabilities:
Current maturities of long-term debt
Accounts payable
Accrued expenses
Deposits on unoccupied units
Total current liabilities
Long-term debt, less current maturities
Refundable fees
Estimated obligation to provide future
services, in excess of amounts received
or to be received
Deferred revenue from advance fees

Total liabilities
Net assets:
Unrestricted
Temporarily restricted
Permanently restricted

Total net assets

Total liabilities and net assets

See accompanying notes to financial statements.
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90,000
180,000
161,000
22,000

77,000
174,000
178,000
40,000

453,000

469,000

8,871,000
59,000

8,935,000
144,000

88,000
6,304,000

100,000
6,585,000

15,775,000

16,233,000

1,286,000
311,000
451,000

833,000
294,000
384,000

2,048,000

1,511,000

$17,823,000

$17,744,000
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Operations

Years Ended December 31,19X5 and 19X4

Revenue, gains, and other support:
Resident services, including amortization
of advance fees of $935,000 in 19X5
and $915,000 in 19X4
Patient revenue from nonresidents
Change in obligation to provide future services
Contributions
Net assets released from restrictions used for
operations
Investment income
Other
Total revenue, gains, and other support

Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Depreciation
Interest
Total expenses

Operating income (loss)
Net assets released from restriction—
purchase of equipment

Increase (decrease) in unrestricted net assets
See accompanying notes to financial statements.
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19X5

19X4

$3,946,000
249,000
12,000
54,000

$3,152,000
275,000
(82,000)
39,000

24,000
29,000
75,000

50,000
30,000
68,000

4,389,000

3,532,000

1,708,000
543,000
291,000
452,000
967,000

1,250,000
742,000
311,000
447,000
955,000

3,961,000

3,705,000

428,000

(173,000)

25,000

45,000

$ 453,000

$ (128,000)
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Sample Not-for-Profit Continuing Care Retirement Community

Statements of Changes in Net Assets
Years Ended December 31,19X5 and 19X4

Unrestricted net assets:
Operating income (loss)
Net assets released from restriction—
purchase of equipment

Increase (decrease) in unrestricted net assets

Temporarily restricted net assets:
Contributions
Net assets released from restrictions used
for operations
Net assets released from restriction—
purchase of equipment
Investment income
Increase (decrease) in temporarily restricted
net assets

Permanently restricted net assets:
Contributions
Increase in permanently restricted net assets
Increase (decrease) in net assets

Net assets, beginning of year
Net assets, end of year
See accompanying notes to financial statements.
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19X5

19X4

$ 428,000

$ (173,000)

25,000

45,000

453,000

(128,000)

40,000

15,000

(24,000)

(50,000)

(25,000)
26,000

(45,000)
15,000

17,000

(65,000)

67,000

52,000

67,000

52,000

537,000

(141,000)

1,511,000

1,652,000

$2,048,000

$1,511,000
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Sample Not-for-Profit Continuing Care Retirement Community

Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
19X5
Cash flows from operating activities:
Cash received from residents and
third-party payors
Advance fees received
Other receipts from operations
Investment income received
Contributions received
Cash paid to employees and suppliers
Interest paid
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of property and equipment
Purchase of assets limited as to use
Net cash used in investing activities

Cash flows from financing activities:
Permanently restricted funds received
Refunds of deposits and refundable fees
Proceeds from issuance of long-term debt
Principal payments of long-term debt
Net cash used in financing activities
Net increase in cash
Cash, beginning of year
Cash, end of year

Reconciliation of change in net assets to
net cash provided by operating activities:
Change in net assets
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
Advance fees received
Restricted net assets received
Amortization of advance fees
Loss (gain) on obligation to provide
future services
Depreciation
Amortization of deferred financing costs
Provision for bad debts
(Increase) decrease in:
Accounts receivable
Other assets
Increase (decrease) in:
Accounts payable and accrued expenses
Net cash provided by operating
activities
See accompanying notes to financial statements.
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19X4

$3,252,000
654,000
75,000
68,000
51,000
(2,576,000)
(950,000)
574,000

$2,341,000
857,000
68,000
53,000
44,000
(2,040,000)
(945,000)
378,000

(65,000)
(377,000)

(250,000)
229,000

(442,000)

(21,000)

67,000
(103,000)
26,000
(77,000)
(87,000)
45,000
330,000

52,000
(52,000)

(307,000)
(307,000)
50,000
280,000

$ 375,000

$ 330,000

$ 537,000

$ (141,000)

654,000
(67,000)
(935,000)

857,000
(52,000)
(915,000)

(12,000)
452,000
7,000
3,000

82,000
447,000
34,000
3,000

7,000
(61,000)

(33,000)
(4,000)

(11,000)

100,000

$ 574,000

$ 378,000
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Sample Not-for-Profit Continuing Care Retirement Community
Notes to Financial Statements

December 31,19X5 and 19X4
1. Description of Organization and Summary of Significant Accounting Policies1
Organization. The Sample Continuing Care Retirement Community (the CCRC) is a nonprofit
organization that principally provides housing, health care, and other related services to residents
through the operation of a retirement facility containing 249 apartments and a 78-bed health care
facility located in Evergreen Park, Illinois. The CCRC was incorporated in Illinois in 19X1. A
summary of significant accounting policies follows.

Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Investments. Investments, which consist of U.S. Treasury obligations, are measured at fair value
in the balance sheet. Investment income (including realized gains and losses on investments,
interest, and dividends) is included in operating income (loss) unless restricted by donor or law.
Unrealized gains and losses on investments, if any, are excluded from operating income (loss).
Deferred financing costs. Deferred financing costs are amortized using the effective interest
method over the term of the related financing agreement.

Advance fees. Fees paid by a resident upon entering into a continuing care contract, net of the
portion thereof that is refundable to the resident, are recorded as deferred revenue and are
amortized to income using the straight-line method over the estimated remaining life expectancy
of the resident.
Obligation to provide future services. The CCRC annually calculates the present value of the net
cost of future services and the use of facilities to be provided to current residents and compares
that amount with the balance of deferred revenue from advance fees. If the present value of the
net cost of future services and the use of facilities exceeds the deferred revenue from advance fees,
a liability is recorded (obligation to provide future services and use of facilities) with the
corresponding charge to income. The obligation is discounted at 9 percent, based on the expected
long-term rate of return on government obligations.

Donor restrictions. The CCRC reports gifts of cash and other assets as restricted support if they
are received with donor stipulations that limit the use of the donated assets. When a donor
restriction expires (that is, when a stipulated time restriction ends or a purpose restriction is
accomplished), temporarily restricted net assets are reclassified as unrestricted net assets and
reported in the statement of operations as net assets released from restrictions. Donor-restricted
contributions whose restrictions are met within the same year as received are reflected as
unrestricted contributions in the accompanying financial statements.

The CCRC reports gifts of property and equipment (or other long-lived assets) as unrestricted
support unless explicit donor stipulations specify how the donated assets must be used. Gifts of
long-lived assets with explicit restrictions that specify how the assets are to be used and gifts of
cash or other assets that must be used to acquire long-lived assets are reported as restricted
support. Absent explicit donor stipulations about how long those long-lived assets must be
maintained, the CCRC reports expirations of donor restrictions when the donated or acquired
long-lived assets are placed in service.
1 Does not include all disclosures common to all health care entities.
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Income taxes. The CCRC has been recognized by the Internal Revenue Service as a not-for-profit
corporation as described in Sec. 501(c)(3) of the Internal Revenue Code (IRC) and is exempt from
federal income taxes pursuant to Sec. 501(a) of the IRC.
Property and equipment. Property and equipment are stated at cost. Donated property is re
corded at its estimated fair value at the date of receipt. Depreciation is computed on the
straight-line method based on the following estimated useful lives:

20 years
40 years
5-15 years

Land improvements
Buildings and improvements
Furniture and equipment

Operating income (loss). The statement of operations includes operating income (loss). Changes in
unrestricted net assets which are excluded from operating income (loss), consistent with industry
practice, include unrealized gains and losses on investments other than trading securities,
permanent transfers of assets to and from affiliates for other than goods and services, and
contributions of long-lived assets (including assets acquired using contributions which by donor
restriction were to be used for the purposes of acquiring such assets).

2. Property and Equipment

A summary of property and equipment at December 31,19X5 and 19X4, follows:
19X4

19X5

557,000 $ 557,000
205,000
203,000
14,573,000
14,564,000
752,000
698,000
16,087,000
16,022,000
(1,194,000)
(742,000)
$14,893,000 $15,280,000
$

Land
Land improvements
Buildings and improvements
Furniture and equipment
Less: accumulated depreciation

3. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
19X5
$169,000
142,000
$311,000

Purchase of equipment
Charity care

19X4
$152,000
142,000
$294,000

Net assets were released from donor restrictions by incurring expenses satisfying the restricted
purposes or by occurrence of other events specified by donors:
19X5
$24,000
$25,000

Charity care
Purchase of equipment

19X4
$50,000
$45,000

4. Permanently Restricted Net Assets
Permanently restricted net assets are restricted to investment in perpetuity, the income from
which is expendable to support:
19X5
19X4
$168,000
283,000
$451,000

Charity care
Community activities
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$168,000
216,000
$384,000

5. Long-Term Debt
Long-term debt at December 31,19X5 and 19X4, is as follows:
10.75 percent mortgage note payable
Notes payable to bank—unsecured
Other

Less current maturities

19X5
$8,901,000
34,000
26,000
8,961,000
90,000
$8,871,000

19X4
$8,965,000
14,000
33,000
9,012,000
77,000
$8,935,000

The mortgage note is payable in consecutive monthly installments of principal and interest of
$85,425 to May 20XX. The note is collateralized by a first mortgage on property and equipment with
a depreciated cost at December 31,19X5, of $14,893,000 and by a pledge of all operating revenue.

As required by the mortgage note agreement, the CCRC established an initial debt service
reserve fund of $1,000,000 at April 15,19X3. All resident fees received thereafter, net of resident
fee refunds and debt service payments not to exceed $300,000 annually in the first four years and
$200,000 annually thereafter, are to be added to the debt service reserve fund until the total sum
of $2,050,000 is accumulated. Since June 1,19X4, the CCRC has been required to deliver to the
trustee $5,500 per month to establish maintenance reserves until the aggregate of such payments
equals a residential unit reserve and a health care center reserve of $240,000 and $90,000,
respectively. At December 31,19X5 and 19X4, the trustee held investments aggregating $2,130,000
and $1,753,000, respectively. Such amount has been classified as assets limited as to use.

Scheduled annual principal maturities of long-term debt for the next five years are as follows:

Year ending December 31,
19X6
19X7
19X8
19X9
20Y0

Amount
$ 90,000
90,000
95,000
105,000
105,000

6. Classification of Expenses

19X5
3,368,000
593,000
$3,961,000

Program activities
General and administrative

19X4
3,135,000
570,000
$3,705,000

7. Assets Limited as to Use
*

8. Risks and Uncertainties Disclosures
*
9. Pension Plan
*

10. Postretirement Benefits
*
11. Fair Values of Financial Instruments
*
12. Concentrations of Credit Risk
*

13. Investments
*
* The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
the not-for-profit hospital and, therefore, are not repeated here.
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Sample Not-for-Profit Home Health Agency
Balance Sheets
December 31,19X5 and 19X4
19X5

19X4

Assets
Current assets:
Cash and cash equivalents
Investments
Accounts receivable, net of allowance for doubtful
accounts of $61,000 in 19X5 and $30,000 in 19X4
Other receivables

$

74,000
147,000

$ 41,000
137,000

752,000
27,000

476,000
22,000

1,000,000

676,000

100,000

100,000

56,000
50,000

39,000
37,000

106,000
(45,000)

76,000
(24,000)

61,000

52,000

20,000

25,000

$1,181,000

$853,000

$

13,000
40,000
496,000
28,000
70,000

$ 13,000
21,000
352,000
31,000
66,000

647,000

483,000

Total current assets

Investments
Equipment:
Medical and office equipment
Vehicles
Less accumulated depreciation

Equipment, net
Deferred finance charges, net of accumulated amortization of $15,000 in 19X5 and $10,000 in 19X4

Total assets
Liabilities and Net Assets

Current liabilities:
Current maturities of long-term debt
Accounts payable
Accrued payroll and vacation costs
Estimated third-party payor settlements
Advances from third-party payors
Total current liabilities

Long-term debt, less current maturities
Total liabilities

Net assets:
Unrestricted
Temporarily restricted
Permanently restricted
Total net assets
Total liabilities and net assets

See accompanying notes to financial statements.
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105,000

118,000

752,000

601,000

330,000
9,000
90,000

167,000
5,000
80,000

429,000

252,000

$1,181,000

$853,000

.18
FORMAT A

Sample Not-for-Profit Home Health Agency

Statements of Operations
Years Ended December 31,19X5 and 19X4

Revenue, gains, and other support:
Net patient service revenue
Contributions
Net assets released from restrictions
Investment income
Other revenue
Total revenue, gains, and other support
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest

Total expenses

Excess of revenue over expenses and
change in unrestricted net assets

19X5

19X4

$4,042,000
5,000
5,000
13,000
27,000

$2,687,000
22,000
—
6,000
32,000

4,092,000

2,747,000

2,714,000
1,042,000
90,000
46,000
21,000
16,000

1,835,000
675,000
83,000
21,000
15,000
19,000

3,929,000

2,648,000

$ 163,000

See accompanying notes to financial statements.
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$

99,000

.19

FORMAT B

Sample Not-for-Profit Home Health Agency

Statements of Operations
Years Ended December 31,19X5 and 19X4

19X5

19X4

$4,042,000
5,000
5,000
27,000

$2,687,000
22,000
—
32,000

4,079,000

2,741,000

2,714,000
1,042,000
90,000
46,000
21,000
16,000

1,835,000
675,000
83,000
21,000
15,000
19,000

Total expenses

3,929,000

2,648,000

Operating income

150,000

93,000

13,000

6,000

Revenue, gains, and other support:
Net patient service revenue
Contributions
Net assets released from restrictions
Other revenue
Total revenue, gains, and other support

Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest

Other income:
Investment income

Excess of revenue over expenses and
change in unrestricted net assets

$ 163,000

See accompanying notes to financial statements.
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$

99,000
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Sample Not-for-Profit Home Health Agency
Statements of Changes in Net Assets

Years Ended December 31,19X5 and 19X4
19X5

19X4

$163,000

$ 99,000

163,000

99,000

Unrestricted net assets:
Excess of revenue over expenses

Increase in unrestricted net assets

Temporarily restricted net assets:
Contributions
Net assets released from restrictions

9,000
(5,000)

5,000
—

4,000

5,000

10,000

6,000

10,000

6,000

Increase in net assets

177,000

110,000

Net assets, beginning of year

252,000

142,000

$429,000

$252,000

Increase in temporarily restricted net assets
Permanently restricted net assets:
Contributions

Increase in permanently restricted net assets

Net assets, end of year
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency
Statements of Cash Flows
Years Ended December 31,19X5 and 19X4
19X5
Cash flows from operating activities:
Cash received from patients and
third-party payors
Other receipts from operations
Cash paid to employees and suppliers
Interest paid
Nonoperating revenue

$3,721,000
22,000
(3,679,000)
(11,000)
23,000

Net cash provided by operating activities
Cash flows from investing activities:
Purchase of equipment
Purchase of investments

Net cash used in investing activities
Cash flows from financing activities:
Proceeds from contributions restricted for:
Endowment

Other financing activities:
Payment of long-term debt

19X4

$2,542,000
32,000
(2,541,000)
(14,000)
22,000

76,000

41,000

(30,000)
(10,000)

(19,000)
(15,000)

(40,000)

(34,000)

10,000

6,000
__

(13,000)

Net cash provided by (used in) financing activities

(3,000)

6,000

Net increase in cash and cash equivalents

33,000

13,000

Cash and cash equivalents, beginning of year

41,000

28,000

Cash and cash equivalents, end of year

$

74,000

$

41,000

Reconciliation of change in net assets to net
cash provided by operating activities:

Change in net assets
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
Increase in permanently restricted net assets
Provision for bad debts
Depreciation
Amortization of deferred financing charges
(Increase) decrease in:
Accounts receivable
Other receivables

$ 177,000

Increase (decrease) in:
Accounts payable, accrued payroll, and
vacation costs
Estimated third-party payor settlements

Net cash provided by operating activities

See accompanying notes to financial statements.
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$

$ 110,000

(10,000)
46,000
21,000
5,000

(6,000)
21,000
15,000
5,000

(322,000)
(5,000)

(150,000)
4,000

163,000
1,000

38,000
4,000

76,000

$

41,000
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Sample Not-for-Profit Home Health Agency
Notes to Financial Statements
Years Ended December 31,19X5 and 19X4
1. Description of Organization and Summary of Significant Accounting Policies
Organization. The Sample Home Health Agency (the Agency) was incorporated in 19X0 in New
State as a not-for-profit corporation. The Agency provides health and supportive services to
individuals at their homes, primarily in the New State area.
Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in highly liquid debt
instruments with an original maturity of three months or less.

Investments. Investments, which consist of U.S. Treasury obligations, are measured at fair value
in the balance sheet. Investment income (including realized gains and losses on investments,
interest and dividends) is included in excess of revenues over expenses unless restricted by donor
or law. Unrealized gains and losses on investments, if any, are excluded from excess of revenues
over expenses.
Equipment. Equipment is recorded at cost. Depreciation is computed using the straight-line
method over the estimated useful lives of the assets.

Deferredfinancing costs. Deferred financing costs are being amortized using the effective interest
method over the term of the related financing agreement.

Donor restrictions. The Agency reports gifts of cash and other assets as restricted support if they
are received with donor stipulations that limit the use of the donated assets. When a donor
restriction expires, that is, when a stipulated time restriction ends or purpose restriction is
accomplished, temporarily restricted net assets are reclassified as unrestricted net assets and
reported in the statement of operations as net assets released from restrictions. When long-lived
assets are placed in service, thus satisfying purpose restrictions, the amount is included as a
change in net assets, restricted and unrestricted. Donor-restricted contributions whose restrictions
are met within the same year as received are reflected as unrestricted contributions in the
accompanying financial statements.
The Agency reports gifts of equipment (or other long-lived assets) as unrestricted support unless
explicit donor stipulations specify how the donated assets must be used. Gifts of long-lived assets
with explicit restrictions that specify how the assets are to be used and gifts of cash or other assets
that must be used to acquire long-lived assets are reported as restricted support. Absent explicit
donor stipulations about how long those long-lived assets must be maintained, the Agency
reports expirations of donor restrictions when the donated or acquired long-lived assets are
placed in service.
Net patient service revenue. Net patient service revenue represents the estimated net realizable
amounts from patients, third-party payors, and others for services rendered.

Charity care. The Agency has a policy of providing charity care to patients who are unable to
pay. Such patients are identified based on financial information obtained from the patient and
subsequent analysis. Since the Agency does not expect payment, estimated charges for charity
care are not included in revenue.
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Income taxes. The Agency has been recognized by the Internal Revenue Service as a not-forprofit corporation as described in Sec. 501(c)(3) of the Internal Revenue Code (IRC) and is exempt
from federal income taxes on related income pursuant to Sec. 501(a) of the IRC.
Excess of revenue over expenses. The statement of operations includes excess of revenue over
expenses. Changes in unrestricted net assets which are excluded from excess of revenue over
expenses, consistent with industry practice, include unrealized gains and losses on investments
other than trading securities, permanent transfers of assets to and from affiliates for other than goods
and services, and contributions of long-lived assets (including assets acquired using contributions
which by donor restriction were to be used for the purposes of acquiring such assets).

2. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:

19X5

19X4
$5,000

$9,000

$5,000

Charity care
Purchase of equipment

Net assets were released from donor restrictions by incurring expenses satisfying the restricted
purposes or by occurrence of other events specified by donors:
19X4
19X5

$5,000

Charity care expenditures

$ —

3. Permanently Restricted Net Assets
Permanently restricted net assets are restricted in perpetuity, the income from which is expendable to support:
19X5
19X4
Program A activities
$10,000 $ —
80,000
80,000
Any activities of the Agency
$90,000 $80,000

4. Third-Party Rate Adjustments and Revenue

Approximately 38 percent in 19X5 and 37 percent in 19X4 of net patient service revenue was
derived under federal and state third-party reimbursement programs. These revenues are based,
in part, on cost reimbursement principles and are subject to audit and retroactive adjustment by
the respective third-party fiscal intermediaries. In the opinion of management, retroactive adjust
ments, if any, would not be material to the financial position or results of operations of the Agency.
5. Internally-Designated Assets

The Board of Directors has designated investments aggregating $135,000 to be used for future
major capital improvements. Those assets are classified in the balance sheet as investments.

6. Long-Term Debt
Long-term debt at December 31,19X5 and 19X4, is as follows:
Note payable to bank, interest at 15 percent,
payable in monthly installments of $2,200 per
month, including interest, collateralized by
equipment with a depreciated cost of $42,000
Less current maturities

100

19X5

19X4

$118,000
13,000

$131,000
13,000

$105,000

$118,000

Scheduled maturities of long-term debt at December 31,19X5, are as follows:
Year ending December 31,

Amount

19X6
19X7
19X8
19X9
20Y0
Thereafter
Total

$ 13,000
13,000
13,000
13,000
13,000
53,000
$118,000

7. Classification of Expenses

_____________ Program_________
Expenses incurred for the
year ended December 31,
19X5, were for:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest
Total expenses
Expenses incurred for the
year ended December 31,
19X4, were for:
Salaries and benefits
Medical supplies and drugs
Insurance and other
Provision for bad debts
Depreciation
Interest
Total expenses

Total

A

B

$2,714,000
1,042,000
90,000
46,000
21,000
16,000
$3,929,000

$1,363,000
511,000
58,000
16,000
5,000
10,000
$1,963,000

$699,000
246,000

3,000
$978,000

$648,000

$1,835,000
675,000
83,000
21,000
15,000
19,000
$2,648,000

$ 915,000
335,000
64,000
21,000
6,000
12,000
$1,353,000

$463,000
211,000

$216,000
129,000

____ C

$363,000
285,000

General and
Administrative

$289,000
32,000

30,000
16,000
3,000
$340,000

$241,000
19,000

5,000
$679,000

$345,000

9,000
2,000
$271,000

(The preparer of the financial statements may wish to include a brief description of the types of programs.)

8. Charity Care

Charity care represented approximately 3 percent and 4 percent of visits in 19X5 and 19X4,
respectively.

9. Risks and Uncertainties Disclosures
*
10. Pension Plan
*
11. Postretirement Benefits
*

12. Fair Value of Financial Statements
*
13. Concentrations of Credit Risk
*
14. Investments
The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
the not-for-profit hospital and, therefore, are not repeated here.
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Sample Not-for-Profit Health Maintenance Organization

Balance Sheets
June 30,19X5 and 19X4
19X5

19X4

$2,937,000

$1,021,000

358,000
263,000
190,000
197,000

407,000
261,000
184,000
99,000

Assets

Current assets:
Cash and cash equivalents
Premiums receivable, net of allowance for
doubtful accounts of $36,000 in 19X5
and $42,000 in 19X4
Other receivables
Supplies
Prepaid expenses

3,945,000

1,972,000

5,756,000

5,626,000

150,000

150,000

18,000

21,000

$9,869,000

$7,769,000

Total current assets
Property and equipment, net

State guaranty fund deposit
Debt issuance costs, net of accumulated
amortization of $42,000 in 19X5 and
$39,000 in 19X4

Total assets
Liabilities and Net Assets

Current liabilities:
Unsecured 12 percent note payable to a bank
Current maturities of long-term debt
Accounts payable—medical services
Other accounts payable and accrued expenses
Unearned premium revenue
Total current liabilities

Long-term debt, less current maturities
Total liabilities

Net assets—unrestricted

Total liabilities and net assets
See accompanying notes to financial statements.
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$

241,000
2,245,000
829,000
141,000

$

44,000
109,000
1,471,000
661,000
202,000

3,456,000

2,487,000

4,295,000

2,382,000

7,751,000

4,869,000

2,118,000

2,900,000

$9,869,000

$7,769,000

.24

Sample Not-for-Profit Health Maintenance Organization
Statements of Operations and Changes in Net Assets

Years Ended June 30,19X5 and 19X4

Revenue:
Premiums earned
Coinsurance
Interest and other income
Total revenue
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Provision for bad debts
Depreciation
Interest

Total expenses

Operating income (loss)

19X5

19X4

$27,682,000
689,000
242,000

$22,500,000
500,000
100,000

28,613,000

23,100,000

16,154,000
8,507,000
3,963,000
19,000
367,000
385,000

13,328,000
5,988,000
2,463,000
20,000
336,000
375,000

29,395,000

22,510,000

(782,000)

Net assets, beginning of year
Net assets, end of year
See accompanying notes to financial statements.
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590,000

2,900,000

2,310,000

$ 2,118,000

$ 2,900,000
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Sample Not-for-Profit Health Maintenance Organization

Statements of Cash Flows
Years Ended June 30,19X5 and 19X4
Cash flows from operating activities:
Cash received from premiums,
stop-loss insurance recoveries,
and coinsurance
Cash paid to employees and to
providers of health care services
Interest and other income received
Interest paid
Net cash provided by operating activities

19X5

19X4

$28,969,000

$24,410,000

(28,405,000)
230,000
(382,000)

(22,818,000)
90,000
(372,000)

412,000

1,310,000

(497,000)

(121,000)

Net cash used in investing activities

(497,000)

(121,000)

Cash flows from financing activities:
Proceeds from long-term debt
Principal payments on long-term debt
Principal payments on note payable

2,300,000
(255,000)
(44,000)

—
(1,000,000)
—

2,001,000

(1,000,000)

Cash flows from investing activities:
Capital expenditures

Net cash provided by (used in)
financing activities

Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of year

Cash and cash equivalents, end of year

1,916,000
1,021,000

189,000
832,000

$ 2,937,000

$ 1,021,000

$ (782,000)

$

Reconciliation of change in net assets to net cash
provided by operating activities:
Change in net assets
Adjustments to reconcile change in net assets to
net cash provided by operating activities:

Depreciation and amortization
Provision for bad debts

(Increase) decrease in:
Premiums receivables
Other current assets
Increase (decrease) in:
Accounts payable—medical services
Other accounts payable and accrued expenses
Unearned premium revenue

Net cash provided by operating activities
See accompanying notes to financial statements.
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590,000

370,000
19,000

339,000
20,000

30,000
230,000

64,000
(93,000)

774,000
(168,000)
(61,000)

335,000
(60,000)
115,000

$ 412,000

$ 1,310,000
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Sample Not-for-Profit Health Maintenance Organization
Notes to Financial Statements

June 30,19X5 and 19X4
1. Organization

The Sample Health Maintenance Organization (the HMO) was incorporated in 19X0 in New
State as a not-for-profit corporation for the purpose of providing comprehensive health care
services on a prepaid basis and for the purpose of establishing and operating organized health
maintenance and health care delivery systems.
The HMO has been determined to be a qualified health maintenance organization under Title
XIII of the Public Health Service Act.

2. Summary of Significant Accounting Policies

Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in highly liquid debt
instruments with an original maturity of three months or less.
Supplies. Inventories of drugs and other supplies are stated at the lower of cost (first-in,
first-out) or market.

Property and equipment. Property and equipment are recorded at cost. Maintenance and repairs
are charged to expense, and betterments are capitalized. Property and equipment costing approxi
mately $700,000 was financed by health maintenance organization initial development grants
received in 19X1 and 19X2 from the U.S. Department of Health and Human Services (HHS). This
property will be owned by the HMO as long as the equipment and facilities are used for projects
related to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated useful lives of the
related assets as follows:

Building
Improvements
Data processing and laboratory
equipment and automobiles
Medical equipment
Office equipment

40years
20-25years

3-7years
10years
5-10years

Amortization of debt issuance costs. Debt issuance costs are deferred and amortized using the
effective interest method over the term of the related debt.
Health care service cost recognition. The HMO contracts with various health care providers for
the provision of certain medical care services to its members. The HMO compensates these
providers on a capitation basis. As part of a cost control incentive program, the HMO retains up
to 20 percent of the capitation as a risk-sharing fund. In the event of hospital utilization in excess
of budget, those providers bear the risk to the extent of 15 percent of the capitation fee. Operating
expenses include all amounts incurred by the HMO under the aforementioned contracts.
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The cost of other health care services provided or contracted for is accrued in the period in which
it is provided to a member based in part on estimates, including an accrual for medical services
provided but not reported to the HMO.
Premiums revenue. Membership contracts are on a yearly basis subject to cancellation by the
employer group or the HMO upon 30 days written notice. Premiums are due monthly and are
recognized as revenue during the period in which the HMO is obligated to provide services to
members.
Reinsurance (stop-loss insurance). Reinsurance premiums are reported as health care costs, and
reinsurance recoveries are reported as a reduction of related health care costs.
Federal income tax. The HMO is exempt from federal income taxes under Sec. 501(c)(4) of the
Internal Revenue Code; accordingly, no provision for federal income taxes has been made in the
accompanying financial statements.

3. Property and Equipment
Property and equipment at June 30,19X5 and 19X4, consists of the following:

19X5

19X4

Land
Buildings and improvements
Furniture and equipment

$ 300,000
5,473,000
1,786,000

$ 300,000
5,459,000
1,303,000

Less accumulated depreciation

7,559,000
(1,803,000)

7,062,000
(1,436,000)

$5,756,000

$5,626,000

4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost of $4,943,000. A summary of
long-term debt at June 30,19X5 and 19X4, follows.

HHS loan, interest at 7.5 percent,
payable in monthly installments
of $50,000, including interest
HHS loan, interest at 9.25 percent,
payable in monthly installments
of $10,000, including interest
Secured equipment loans, payable
in monthly installments of $15,000,
including interest

Less current maturities

19X5

19X4

$2,020,000

$ 111,000

1,658,000

1,694,000

858,000

686,000

4,536,000
241,000

2,491,000
109,000

$4,295,000

$2,382,000

Scheduled principal payments on long-term debt are as follows:
Year ending December 31,

Amount

19X6
19X7
19X8
19X9
20Y0

$ 241,000
259,000
280,000
800,000
2,956,000
$4,536,000
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5. State Guarantee Fund Deposit

In August 19X4 the state in which the HMO is domiciled enacted legislation specifically
governing HMOs. Under this legislation, the corporation is required to maintain a deposit of
$150,000 with the director of the division of insurance of the state.
6. Employee Retirement Plan

The HMO has a contributory defined contribution retirement plan covering substantially all
employees. Expense determined in accordance with the plan formula (4 percent to 10 percent of
eligible covered compensation) was $354,000 and $275,000 for the years ended June 30,19X5 and
19X4, respectively.
7. Stop-Loss Insurance

The HMO entered into a stop-loss insurance agreement with an insurance company to limit its
losses on individual claims. Under the terms of this agreement, the insurance company will
reimburse the HMO approximately 25 percent of the cost of each member's annual hospital
services, in excess of a $1,000 deductible, up to a lifetime limitation of $500,000 per member. In
the event the HMO ceases operations, (a) plan benefits will continue for members who are
confined in an acute care hospital on the date of insolvency until their discharge, and (b) plan
benefits will continue for any other member until the end of the contract period for which
premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are included in insurance
expense (Note 9) in 19X5 and 19X4, respectively. Approximately $600,000 and $400,000 in stop-loss
insurance recoveries are deducted from insurance expense in 19X5 and 19X4, respectively.

Included in other receivables is approximately $50,000 recoverable from insurers.
8. Malpractice Claims

Malpractice claims have been asserted against the HMO by various claimants. The claims are in
various stages of processing, and some may ultimately be brought to trial. In the opinion of counsel,
the outcome of these actions will not have a significant effect on the financial position or the operating
income of the HMO. Incidents occurring through June 30, 19X5, may result in the assertion of
additional claims. Other claims may be asserted arising from past services provided. Management
believes that these claims, if asserted, would be settled within the limits of insurance coverage.

9. Classification of Expenses
Program activities
General and administrative

19X5

19X4

26,921,000
2,474,000

20,909,000
1,601,000

$29,395,000

$22,510,000

10. Risks and Uncertainties Disclosures
*

11. Pension Plan
*
12. Postretirement Benefits
*
13. Fair Value of Financial Instruments
*

14. Concentrations of Credit Risk
*
*The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
the not-for-profit hospital and, therefore, are not repeated here.

107

ILLUSTRATIVE FINANCIAL STATEMENTS
FOR AN AMBULATORY CARE ORGANIZATION
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Sample Not-for-Profit Ambulatory Care, Inc.
Balance Sheets

December 31,19X5 and 19X4
19X4

19X5

Assets

Current assets:
Cash
Patient accounts receivable, net of allowance for
doubtful accounts of $15,000 in 19X5 and
$5,000 in 19X4
Estimated retroactive adjustments—third-party payors
Accounts receivable—other
Supplies
Prepaid expenses and deposits

$

65,000

$

76,000

290,000
19,000
13,000
21,000
5,000

278,000
32,000
8,000
18,000
9,000

413,000

421,000

Property and equipment, at cost:
Land
Land improvements
Buildings
Equipment

100,000
322,000
682,000
1,390,000

100,000
322,000
682,000
1,389,000

Less accumulated depreciation

2,494,000
217,000

2,493,000
100,000

Property and equipment, net

2,277,000

2,393,000

14,000

5,000

$2,704,000

$2,819,000

$ 138,000
52,000
33,000
30,000
—

$ 144,000
87,000
22,000
24,000
1,000

253,000

278,000

2,451,000

2,541,000

$2,704,000

$2,819,000

Total current assets

Other assets:
Advances receivable

Total assets
Liabilities and Net Assets

Current liabilities:
Notes payable
Accounts payable
Accrued payroll, benefits, and taxes
Estimated retroactive adjustments—third-party payors
Financing advance from third-party payors
Total current liabilities

Net assets—unrestricted

Total liabilities and net assets

See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc.
Statements of Operations and Changes in Net Assets

Years Ended December 31,19X5 and 19X4

Revenue and gains:
Net patient service revenue
Other
Total revenue and gains

Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Provision for bad debts
Depreciation
Interest
Total expenses

Operating loss

19X5

19X4

$ 860,000
29,000

$ 357,000
15,000

889,000

372,000

485,000
189,000
154,000
14,000
117,000
20,000

243,000
66,000
98,000
4,000
100,000
18,000

979,000

529,000

(90,000)

Net assets, beginning of year

Net assets, end of year
See accompanying notes to financial statements.
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(157,000)

2,541,000

2,698,000

$2,451,000

$2,541,000

.29

Sample Not-for-Profit Ambulatory Care, Inc.
Statements of Cash Flows
Years Ended December 31,19X5 and 19X4

Cash flows from operating activities:
Cash received from patients and third-party payors
Cash received from others
Interest received
Interest paid
Cash paid to employees and suppliers

19X5

19X4

$866,000
21,000
3,000
(15,000)
(870,000)

$ 368,000
6,000
11,000
(16,000)
(432,000)

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchase of equipment
Advances made to XYZ Affiliate
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from notes payable
Payments on notes payable

(63,000)

(1,000)
(9,000)

(4,000)
(5,000)

(10,000)

(9,000)

(6,000)

144,000
—

(6,000)

144,000

(11,000)

72,000

76,000

4,000

$ 65,000

$ 76,000

$(90,000)

$(157,000)

Net cash provided by (used in) financing activities

Net increase (decrease) in cash

Cash, beginning of year

Cash, end of year

5,000

Reconciliation of change in net assets
to net cash provided by (used in)
operating activities:
Change in net assets
Adjustments to reconcile change in net
assets to net cash provided by (used in)
operating activities:
Depreciation
Provision for bad debts

117,000
14,000

100,000
4,000

(Increase) decrease in:
Patient accounts receivable
Other current assets

(12,000)
1,000

(19,000)
(2,000)

Increase (decrease) in:
Accounts payable and accrued payroll,
benefits, and taxes
Other current liabilities

(24,000)
(1,000)

10,000
1,000

Net cash provided by (used in)
operating activities

$

See accompanying notes to financial statements.
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5,000

$ (63,000)

.30

Sample Not-for-Profit Ambulatory Care, Inc.
Notes to Financial Statements

December 31,19X5 and 19X4
1. Description of Organization and Summary of Significant Accounting Policies

Organization. Ambulatory Care, Inc. was incorporated on September 7,19X3, in New State, to
operate an ambulatory care health facility to treat or prevent injury and disease, to provide funds
or to expend funds to further the treatment or prevention of injury or disease, and to develop and
participate in activities designed to promote the general health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and GHI Hospital—en
tered into a members' agreement to develop this ambulatory care center. In accordance with this
agreement, each hospital contributed capital of $947,000 to Ambulatory Care, Inc. Ambulatory
Care, Inc. began operations in October 19X3.

Use of estimates. The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.

Supplies. Supplies are stated at the lower of cost (first-in, first-out) or net realizable value.
Depreciation. Depreciation of property and equipment is computed on the straight-line method
over the estimated lives of depreciable assets.
Third-party contractual adjustments. Retroactively calculated third-party contractual adjust
ments are accrued on an estimated basis in the period the related services are rendered. Net patient
service revenue is adjusted as required in subsequent periods based on final settlements.
Net patient service revenue. Patient service revenue is reported at the estimated net realizable
amounts from patients, third-party payors, and others for services rendered.

Charity care. Ambulatory Care, Inc. has a policy of providing charity care to patients who are
unable to pay. Such patients are identified and related charges are estimated, based on financial
information obtained from the patient and subsequent analysis. Since management does not
expect payment for charity care, the estimated charges are excluded from revenue.
Income taxes. Ambulatory Care, Inc. has been recognized by the Internal Revenue Service as a
not-for-profit corporation as described in Sec. 501(c)(3) of the Internal Revenue Code (IRC) and
is exempt from federal income taxes on related income pursuant to Sec. 501(a) of the IRC.

2. Advances Receivable
In May 19X4, Ambulatory Care, Inc. entered into a five-year agreement with XYZ Affiliates
(XYZ). Under this agreement, XYZ is to provide emergency medical services as well as charge
and bill each patient treated at Ambulatory Care, Inc. Ambulatory Care, Inc. has guaranteed that XYZ
will collect at least $18,000 per month during the term of this agreement. In any month in which XYZ
does not collect the minimum guarantee, Ambulatory Care, Inc. advances funds to XYZ to cover the
deficiency. Such advances are to be repaid to the extent XYZ's net cash collections exceed the minimum
guarantee amount. Management estimates that the advances will be fully recovered in 19X8.

3. Related-Party Transactions
During 19X3, Ambulatory Care, Inc. entered into a contract with one of the member hospitals
(the managing hospital) for the management of the business and affairs of Ambulatory Care, Inc.
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Under this agreement, Ambulatory Care, Inc. pays $4,000 per month to the managing hospital.
The agreement with the managing hospital was to remain in effect through December 31,19X5,
but has been extended on a month-to-month basis.

In addition, during 19X4 each hospital loaned $48,000 to Ambulatory Care, Inc. in the form of
promissory notes at an interest rate of prime rate plus 1 percent (effective rates of 10 percent and
9 percent in 19X5 and 19X4, respectively). Of the total $144,000 liability, $48,000 is payable on
demand after November 28,19X5, to one member hospital, with the remaining portion ($96,000)
payable on demand after December 8,19X5, to the other two member hospitals. During 19X5,
Ambulatory Care, Inc. paid $2,000 to each member hospital, thereby reducing the obligation to
$138,000.

4. Revenue From Contracting Agencies
Ambulatory Care, Inc. participates as a provider of health care services to Blue Cross, Medicare,
and County Indigent Plan patients. Reimbursement for covered services is based on tentative
payment rates. Final reimbursement is determined after submission of annual cost reports and
audits thereof by the fiscal intermediaries. Provisions for estimated reimbursement adjustments
are reported in the financial statements in the period that the services are rendered.

5. Charity Care
Ambulatory Care, Inc. has a policy of providing charity care to indigent patients in emergency
situations. These services, which are excluded from revenues, amounted to $27,000 and $13,000
in 19X5 and 19X4, respectively, when measured at Ambulatory Care, Inc.'s established rates.

6. Classification of Expenses
Program
Total

Expenses incurred for the
year ended December 31,
19X5, were for:
Salaries and benefits
Medical supplies and drugs
Insurance
Provision for bad debts
Depreciation
Interest
Total expenses
Expenses incurred for the
year ended December 31,
19X4, were for:
Salaries and benefits
Medical supplies and drugs
Insurance
Provision for bad debts
Depreciation
Interest
Total expenses

ABC

General and
Administrative

$485,000
189,000
154,000
14,000
117,000
20,000
$979,000

$216,000
98,000
79,000
9,000
100,000
9,000
$511,000

$102,000
43,000
45,000
—
—
—
$190,000

$121,000
48,000
14,000
5,000
17,000
—
$205,000

$46,000
—
16,000
—
—
11,000
$73,000

$243,000
66,000
98,000
4,000
100,000
18,000
$529,000

$111,000
31,000
45,000
—
56,000
7,000
$250,000

$ 46,000
15,000
19,000
4,000
—
—
$ 84,000

$ 57,000
20,000
26,000
—
44,000
—
$147,000

$29,000
—
8,000
—
—
11,000
$48,000

(The preparer of the financial statements may wish to include a brief description of the types of
programs.)
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7. Risks and Uncertainties Disclosures
*
8. Pension Plan
*
9. Postretirement Benefits
*
10. Fair Value of Financial Instruments
*
11. Concentrations of Credit Risk
*

The disclosures contained in these notes would be similar to the disclosures contained in the notes to the financial statements for
the not-for-profit hospital and, therefore, are not repeated here.
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Comment Letter
We welcome any comments and suggestions you have regarding this Checklist. Please send this
completed form to: AICPA, Accounting and Auditing Publications, Harborside Financial Center, 201
Plaza Three, Jersey City, NJ, 07311-3881. Thank you.

Checklist Title:

Comments and Suggestions:

TECHNICAL HOTLINE
The AICPA Technical Hotline answers
inquiries about specific audit or accounting problems.

Call Toll Free
(800) TO-AICPA or
(800) 862-4272
This service is free to AICPA members.

008709

